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Abstract 
 
Stem cell research promises to transform current medical practices by providing alternative 
solutions for degenerative diseases, bodily injuries, organ failures, and cancers. One area that 
has been most extensively researched over the past decades is the use of genomics and 
transcriptomics to unravel the underlying molecular mechanisms of stem cell biology. 
However there are a number of reasons why information at the DNA and mRNA levels alone 
does not provide a complete profile of cellular activities. Proteins are ultimately the main 
functional macromolecules in living organisms and therefore study at the protein level is of 
importance in providing a more complete understanding of cellular behaviour.  Recent 
developments in proteomics technology provide the tools to analyse functional protein 
profiles and determine key molecular factors in stem cell maintenance and differentiation 
processes.  
 
To date the current state-of-art proteomics approaches provide powerful tools for 
investigating the molecular basis of stem cell behaviour for both fundamental and applied 
research. The improvement in proteomic technologies is a key component in understanding 
stem cell biology, which is paving the way for the generation of unlimited cells of specific 
phenotypes for cell-based therapy and incorporation into engineered tissue constructs.  
 
This thesis will focus on the improvement of gel-based proteomics technology and the 
applications of proteomics in human embryonic stem cell research.  
 
A general workflow for gel-based proteomics is as follows: 
 
 
 
 
Scheme 1. A General Workflow for Gel-based Proteomics. 
 
iv 
 
Chapter 1 includes an introduction in general to proteomics and stem cell biology.  
 
Chapter 2, 3 and 4 illustrate experimental results in the improvement of gel-based proteomics 
workflow. These improvements are in the areas of protein sample quality screening, 
economical alternatives for pre-stained fluorescent labelling in electrophoretic separations, 
and suitable image analysis software for fluorescent gel-based electrophoresis, respectively. 
 
In chapter 2, a new approach to screen and quickly analyse the quality of samples before 
running 2-DE was developed to save valuable time and materials. Multi-pixel detection 
combined with capillary electrophoresis was used as a screening tool for analysing the quality 
of samples prior to 2-DE. The results showed high resolution and reproducibility, accurate 
molecular weight assignment, relative quantitation, and absolute quantification of known 
proteins. This work is an important step towards the standardisation of gel-based proteomics, 
providing a rapid and visual evaluation method for the quality assessment of 2-DE samples. 
 
In chapter 3, an alternative set of cyanine dyes, which have similar chemical properties and a 
price much lower than the DIGE CyDyes, was investigated for comparative quantitation 
capability. Through multiple sample analyses these dyes were demonstrated to produce 
practically identical results to DIGE CyDyes, which allowed sample multiplexing and 
accurate quantitation for differential proteome expression analysis. This alternative set of 
cyanine dyes provides a useful approach for staff training, optimisation of experimental 
methods, and for preliminary results. 
 
 In chapter 4, three commonly available DIGE enabled software packages were compared of 
their performance in DIGE experiments. The results demonstrated that all three software 
packages performed in a generally satisfactory manner, each with strengths and weaknesses. 
However, based on matching accuracy, Progenesis SameSpots software outperformed the 
other two software packages, possibly benefiting from its unique algorithm by outlining 
identical spot across all the gels. 
 
Chapter 5 presents comparative proteome profiles of human embryonic stem cells and human 
induced pluripotent stem cells using gel-based proteomics that provide insight into stem cell 
biology. The proteomic results showed that 24 protein spots from the gel between two cell 
populations differentially expressed more than two-fold change, being relatively 22 down-
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regulated and 2 up-regulated in iPSC population. Of those 24 spots, two identified proteins, 
being ATP dependent DNA helicase II protein (Ku80 protein) and heat shock 70kDa protein 
9 protein (mortalin protein), were selected for further validation by q-PCR and western 
blotting.  
 
The final chapter gives a summary and suggests future direction of the work. 
 
Taken together, the work in this thesis has produced four experimental publications (three 
published and one intended for publication in Journal of Cellular Biochemistry) in the 
enhancement of gel-based proteomics workflow and the application of proteomics in stem 
cell biology to decipher the relationship between the molecular phenotype of native and 
induced pluripotent stem cells.   
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CHAPTER 1 
 
General Introduction 
 
 
1.1 Genomics and Proteomics 
 
1.1.1 Genomics Background 
 
The science of genetics began with the work of Gregor Mendel who discovered the 
fundamental laws of inheritance. He reported that every cell contained pairs of “factors” 
which are now called genes and that each pair or gene determined a specific characteristic. 
James Watson and Francis Crick (1) deduced the structure of DNA in 1953 based on 
Chargaff’s rules and X-ray diffraction patterns of DNA fibres. They proposed that DNA 
existed as a right-handed double helix structure. During the past century, geneticists have 
determined the molecular structure of genes and the mechanisms by which they control the 
characteristics of an organism in biological systems.  
 
The central dogma of molecular biology embraces the ability of an organism to store and 
preserve its genetic information, pass that information to future generations, and express that 
information as it carries out all the processes of life. The major steps involve in handling the 
genetic information flow from DNA to DNA during its transmission from generation to 
generation (replication) and from DNA to protein or functional RNA product (expression) 
during its phenotypic expression in organisms, shown in Figure 1. 
 
          
 
 
 
 
 
Figure 1. The Central Dogma of Molecular Biology. The genetic 
information of an organism is transmitted from cell to cell by the accurate 
process of DNA replication. In essence, genes also specify all proteins 
and functional RNA products during gene expression via transcription and 
translation mechanisms.  
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The genome is defined as a complete copy of genetic information of an organism. The term 
was first coined by a German Botanist, Hans Winkler in 1920. The first complete genome for 
free-living organism, published in 1995, was that of Haemophilus influenza Rd (2). This 
work employed a method of random whole-genome shotgun sequencing and completed the 
1,830,137 base pair sequences of the gram-negative bacterium. A year later, the first 
complete nucleotide sequence of a eukaryotic genome was successfully determined with 16 
chromosomes of the budding yeast Saccharomyces cerevisiae being released as a result of 
worldwide cooperation (3). The yeast genome revealed a considerable amount of 
information, identifying approximately 6,000 genes with about 12 millions base pairs, and 
allowed scientists to elucidate the biological functions of these yeast genes. The development 
of new technologies has made it dramatically possible and easier to sequence many other 
more complex eukaryotic organisms (4, 5). One of the most influential breakthroughs in 
modern sciences was the completion of the human genome sequence by international global 
collaboration (6, 7). The Human Genome Project has produced a wealth of imperative 
information about the genetics of humans. Key findings of the first draft of human genome 
sequences were about three billion base pairs found and those comprised approximately 
25,000 genes. There is continuing incremental research on human genome data analysis and 
management. Completion of the human genome sequence has been rapidly followed by the 
emergence of high-throughput technologies which provide several beneficial impacts in terms 
of automation and miniarisation and enable biologically systematic surveys of human 
genome composition and gene expression.  
 
The study of the genome is termed “genomics” (8, 9). Genomics refers to the genetics 
subdiscipline of mapping, sequencing, and analysing the functions of entire genomes. As well 
as the description of complete human genome sequence, a major progress has been made 
towards understanding the function of genes and identifying different varieties of DNA 
markers and their roles in human. Functional genomics comprises the global experimental 
approaches to define gene function (8). Basically, functional genomics is the expansion of 
scope of biological investigation from studying single genes to studying all genes at the same 
time in a systematic fashion. With the use of high-throughput experimental methodologies 
combined with statistical and computational analysis of the amount of massive information 
produced, this allows scientists to interpret transcriptional changes in large-scale genome-
wide investigation.  
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Genomics technologies play an important part in understanding biological systems. 
Deciphering DNA sequences started in the late 1980s with two alternative methods of 
sequencing: the Maxam-Gilbert chemical cleavage technique (10) and the Sanger Chain 
termination method (11). Sanger’s method was suitable for automation, non radiolabelled-
fluorescence dyes and small capillary electrophoresis and left the Maxam-Gilbert method a 
historical technique. Sanger automation technique accelerated the pace of the Human 
Genome Project and when it was combined with the powerful shotgun sequencing approach 
by Craig Venter (12), the speed of discovery was even higher.  
 
Determination of the human genome sequence was just the start of exploring human genome 
data. Surprisingly, low number of genes were discovered from the Human Genome Project 
and non-overlapping sequence data from two major sources and genetic variations called 
polymorphisms, making human different to each other by 0.1%, were displayed (6, 7). The 
international HapMap project which described the common patterns of human genetic 
variation was launched at first two stages and discovered millions of polymorphisms in 
humans (13, 14). Rapid Single Nucleotide Polymorphism (SNP) genotyping by hybridization 
to DNA array (15) or mass spectrometry-based techniques combined with advances in 
computation and statistics helped in the discovery of hundreds of human genetic variations 
associated with common diseases. These were previously unsuspected due to the limitations 
of methods available at the time. Genome wide association studies (GWAS) of millions of 
SNPs flourished in the last decade and further details were being investigated to understand 
the association of these genetic variations with pathologies (16-18).  
 
In the past few years, emerging technologies for resequencing using real-time multiplexing, 
miniaturisation, chemical synthesis and digital photography techniques to resequence a 
human whole genome sequence (diploid) with gigabases in a week have emerged. Standard 
next-generation sequencing platforms (19) at present are Solexa (Ilumina) (20), 454 (Roche) 
(21, 22), SOLiD (ABI) (23), MinION (Oxford Nanopore) (24), and Ion Torrent (Life 
Technologies) (25). Cost of resequencing was dropped dramatically from 1 kilobases per 
dollar to 100 kilobases per dollar. This next-generation sequencing also has been used in the 
discovery of new kinds of variations which were copy number variations (26) and new 
regulatory molecules, microRNAs (27). In addition, to selectively sequence the whole coding 
regions (exome) of the genome was an optional tool to define disease-causing mutations (28). 
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The exome sequencing was successfully proved in helping in the diagnosis of several other 
rare genetic diseases in patients (29, 30) and profiling cancer genomics (31-33). 
 
The timeline of genomics technologies development in the past decades is given in Table 1 
and the significance of each innovative technology is described with brief details (34). 
  
Table 1. The Milestones of Major Development of Genomics Technologies. Each innovative 
technology is briefly detailed the year of event, importance of core technology and inventors. 
(Adapted from (34)) 
 
Year Technology Brief details Ref. 
1952 Electrophoresis Spotting hydrolysed ribonucleic acid on 
Whatman paper electrophoresis device first 
paved the way for genomic era  
(35) 
1967 Discovery of DNA ligase DNA ligase was the first ingredient for making 
recombinant DNA to be discovered, which 
became the cornerstone of modern molecular 
biology 
(36) 
1970 Discovery of reverse 
transcriptase 
Reverse transcriptase was used to synthesise 
cDNA and became hugely important in 
molecular biology extending from cloning to 
microarrays to the annotation of genomes  
(37, 
38) 
1972 Cloning Hybrid DNA molecule was established and 
inserted in bacteria 
(39) 
1977 DNA sequencing A fundamental breakthrough of the era of 
genetic engineering was the development of 
technology which allowed scientists to 
determine a DNA sequence  
(10, 
11) 
1980 Restriction fragment length 
polymorphism (RFLP)  
Linkage association among RFLPs could be 
established and genetic linkage analysis would 
allow gene to be mapped and defined  
(40) 
1982 Whole genome random 
sequencing 
DNA sequences were broken randomly, 
cloned, sequenced, and then joined together by 
analysing the overlap. 
(41) 
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Year Technology Brief details Ref. 
1985 Polymerase chain reaction 
(PCR) 
PCR technique revolutionised biological 
laboratory research and numerous applications 
of this method are currently widespread used 
(42, 
43) 
1987 Yeast artificial 
chromosomes 
A linear DNA molecule resembling a yeast 
chromosome was integrated to circular plasmid  
(44) 
1988 Chromatin 
immunoprecipitation 
This assay was developed to study protein-
DNA complexes and define specific regions of 
DNA interacting with particular proteins 
(45) 
1990 BLAST - the key to 
comparative genomics 
A computational and statistical framework for 
sequence alignment was invented and used for 
comparative genomics among the same and 
different species 
(46) 
1995 Microarray technology The expression level of many genes could be 
examined quantitatively in parallel and this 
technology has brought a large-scale approach 
to decipher biological questions 
(47) 
1998 RNA interference (RNAi) RNAi has created a novel way of gene 
silencing and exposed the value of non-coding 
RNA in gene expression regulation 
(48) 
1998 Sequencing by synthesis Next generation sequencing arrived with 
automation, miniaturisation, and multiplexing  
(49) 
2000 DNA assembly program Algorithms for assembling lots of DNA into 
whole genome sequences 
(50) 
2002 UCSC genome browser This clickable genome browser could present a 
view of genome at any scale and is still 
extensively used as a part of genomics research 
(51) 
2004 ENSEMBL -  gene 
annotation tool 
Data mining of genomes was at an ever-
increasing level of detail with gene annotation 
tools 
(52) 
2005 Sequencing by 
ligation/polony sequencing 
A sequencing approach allowed a multiplexing 
of both template amplification and sequencing 
of DNA known as polony 
(53) 
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Year Technology Brief details Ref. 
2005 HapMap data A large consortium for haplotype mapping was 
established to study whole-genome associations  
(13) 
2007 Copy number variation 
detection by next-generation 
sequencing 
A large-scale genomic-sequencing method to 
identify structural variants in human genome 
was established allowing high-throughput and 
massive paired-end mapping (PEM) 
(54) 
2009 Exome sequencing  Targeted sequencing of human protein-coding 
regions (“exome”) was first achieved by 
massively parallel sequencing 
(55) 
2012 “Whole genome in a day”  Illumina company introduced the HiSeq® 
2500, a next-generation sequencing system that 
will enable sequencing of an entire genome in 
approximately 24 hours. Oxford Nanopore and 
Life Technologies also launched the systems 
for sequencing whole genome in a day 
(25, 
56, 
57) 
 
 
It has been proved that the information generated by genomics will have significant effects on 
the prevention, diagnosis and management of human diseases.  Along with the success of 
genomics technology, biological systems have also been investigated at different levels. 
Information at the genome level alone is insufficient to completely explain complex 
biological activities. It has recognised that the genome represents the first layer of 
complexity. After the great achievements of genomics, many of the emerging fields of large-
scale biological studies have been designated by adding the suffix “-omics” onto particular 
terms such as transcritomics, proteomics and metabolomics (58) (Figure 2). 
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The triangle in Figure 2 exemplifies the layers of organism complexity from DNA to 
functional molecules in biological systems (58). Large-scale investigative approaches are 
portrayed in different layers of complexity. The first level on the top represents genomics, 
determination of the complete genome sequence, including coding, non-coding, and 
regulatory regions as well as sequence differences among individuals. High-throughput 
technologies for genomics have been well-established and generated a great amount of 
information. The next three levels down are to study the gene expression through mRNA 
transcripts and to determine biological complexity at the level of proteins and metabolites. 
Although the complexity at the level of proteins and metabolites is higher than those of DNA 
and mRNA, high-throughput technologies are still evolving for proteomics and metabolomics 
compared to genomics and transcriptomics. Each platform can contribute to the others in 
understanding cellular systems.  
 
1.1.2 Transcriptomics Background 
   
The field of transcription analysis was launched to decipher how genes exert their effects. 
Transcription regulation is complex involving activators, repressors and other transcription 
factors. Moreover, DNA methylation has also shown evidence of a role in transcription 
repression (59). Also, nucleosomes, the units of DNA with histone proteins, can themselves 
block an initiation of transcription both in vitro and in vivo (60, 61). Studies of gene 
expression were initially limited to assessing one or a few genes at a time. But around 1995, 
this limitation was overcome by an arrival of microarray technology (47), allowing thousands 
of transcripts to be studied in a single experiment. Since then, gene microarray technology 
Figure 2. Layers of Complexity within 
Organisms in Large-Scale Fashion. Flow 
of genetic information from genome level 
through certain transcripts to proteins and 
small functional molecules governing 
cellular functions and activities. When 
moving downward from genomics to 
metabolomics, the complexity increases 
extensively whereas the maturity of the 
technology to investigate this complexity 
decreases. (Adapted from (58)) 
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has turned into being almost ubiquitous in biomedical research for example in the 
classification and diagnosis of diseases (62). A general principle of a transcript profiling 
microarray experiment is depicted in Figure 3.  RNA is harvested from cell or tissue, 
converted to cDNA and labeled to generate the target. This is hybridized to the specific DNA 
probes which are affixed onto a solid matrix, chip or microchip. A quantitative measurement 
of the abundance of an individual sequence in the target population can be achieved. With 
bioinformatics tools for information analysis, differential mRNA patterns can be detected and 
translated into biological information. Broad details of DNA microarray technologies can 
also be seen in these comprehensive reviews (63, 64). 
 
 
                
 
 
 
 
 
However, biological function is not solely carried out by the static genome or even the 
dynamic transcriptome alone but primarily by the dynamic population of proteins determined 
by an interplay of gene and protein regulation with extracellular influences (58). Furthermore, 
it is importantly recognised that there are a number of reasons why complete gene sequence 
and transcript information very often does not provide an accurate profile of protein 
abundance, structure, activity and function. Firstly, the functions of proteins rely on their 
structures and interactions. Secondly, the abundance of a certain transcript may not indicate 
the abundance of the corresponding protein. Thirdly, the functions of proteins may depend on 
Figure 3. Differential DNA Microarray Process. Starting from the collection of 
samples through the preparation and hybridisation of the target to the microarray probe. 
Data analyses then were achieved by bioinformatics tools. Each stage in the process is a 
source of variability. The identification and control of these sources of error are a crucial 
aspect of the present microarray development. 
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their localisation rather than their absolute abundance. Moreover, post-translational 
modifications of proteins are at importance in controlling biological and cellular activities.  
 
Taking all these reasons together, there is an increasing interest in the field of protein studies. 
Particularly, this thesis will emphasise on the importance of proteomics technology and will 
detail and provide data on the improvement in proteomics technology that can be applied to 
decipher biological functions in a large-scale fashion. 
 
1.1.3 Proteomics Background 
 
The term proteome was first coined to describe the protein complement expressed by the 
genome (65). The study of the proteome, called proteomics, now bridges the gap between 
genome sequence and cellular phenotype. In the genomics era, with the deposition of large 
amounts of complete genome sequences in databases as well as transcriptome information, 
this is not sufficient to fully define biological function. The complexity of metabolic and 
regulatory pathways is hard to predict using genomics and transcriptomics alone. Proteins are 
responsible for almost all biological metabolisms and are the actual functional molecules of 
the cell. Exhibiting these functions by interacting with each other and with a diverse range of 
other molecules, proteins are functionally the most relevant constituents of biological systems 
and great insight into such systems can largely be generated from the direct study of the 
proteins. A proteomic approach is suitable in such cases as it looks directly at the protein 
levels. Proteomics essentially contributes the comprehension of biological and cellular 
systems and complements other functional genomics, including gene expression profiles, 
phenotypic profiles, and systematic genetics (66) (Figure 4). Large-scale data sets from high-
throughput proteomics technologies are interactively combined by comprehensive data 
mining and bioinformatics tools. 
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Figure 4. Large-scale Platforms for Proteomics and Functional Genomics. High-throughput 
methods in proteomics and functional genomics are represented in outer columns, outcome data 
sets in inner columns, and model system in the centre. (Adapted from (66)) 
 
 
To determine molecular, cellular and physiological functions for numerous proteins encoded 
by genomes is one paramount challenge in twenty-first century. The biochemical 
characteristics of proteins were commonly determined in vitro with purified materials. 
Although in vitro studies essentially provide significant tools for understanding and 
explaining the functions and activities of many proteins, it does suffer some drawbacks (67). 
Firstly, proteins do not function in an isolated fashion in living systems; they are interactive 
in complex metabolic and signaling networks. Secondly, in vivo proteins are also regulated 
by protein-protein interactions and post-translational modifications (PTMs) such as 
phosphorylation and glycosylation. In addition, proteins are dynamic molecules varying by 
spacial and temporal settings, thus an individual study of proteins does not completely 
embody an accurate profile of their activities, but more is slow to perform. These 
considerations challenge scientists to create a way to investigate proteins on a global scale. 
High-throughput proteomics technologies may not completely eliminate the limitation of in 
vitro study, which do not represent inclusive and real-time in vivo studies, nonetheless 
performing an experiment in vitro with robustness and automation assessing thousands of 
proteins simultaneously grants huge benefits for functional characterisation of proteins. 
 
Having accepted that large-scale genomics experiments provide value in systems biology, 
generation of genomic data enables us to make proteomics modules of optimal performance 
(68). For instance, the availability of genomic sequences facilitates mass spectrometry-based 
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protein identifications. Moreover, gene knockdown, gene overexpression, and RNA 
interference combined with array-based assays have proven to be powerful techniques in 
global scale at genomics. This systematic approach leads to an emerging field of systems 
biology in which all concurrent physiological and biochemical processes in a cell or tissue are 
investigated by globally large-scale measurement at different states (69) (Figure 5). With 
different conditions, an alteration of cell behaviour and signaling networks occur differently. 
For proteome-wide observations, key targeted experiments for large-scale proteomics 
analysis involve quantitation profiles, interaction maps, and post-translational modifications. 
Both observational models through a cell or tissue study and theoretical models via 
computational and mathematical parameters are incorporated to determine the effects of the 
perturbations on the cell or tissue. The data are gathered and integrated describing the system 
studied and discrepancies between the observed experimental data and the predicted 
informatics are used to refine the models. The process can be repeated with reconciled data or 
with more advanced instruments until model and observed data coverage. 
 
             
 
 
 
 
 
 
 
Figure 5. A Schematic Representation of Proteome-Wide Systems Biology Paradigm. 
Systematic genomic and proteomic methods are employed to analyse the experimental effects 
of the specific perturbations on the studied cells. Particularly information including quantitative 
protein profiles, profiles of regulatory modifications and protein interaction networks is largely 
investigated with broad-scale methods. The data are then integrated and reconciled with prior 
models and comparing the discrepancies between the predicted data and the experimental result 
to design new optimal perturbations. The process is repeated iteratively until model and 
observed data converge. (Adapted from (69)). 
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Technically, despite the hurdles of having high-throughput, reliable and reproducible 
proteomics technologies in an initial phase of evolution, two transforming technologies have 
been crucial to the fundamental recent advances in proteomics (70). Firstly, the new 
strategies for peptide sequencing using mass spectrometry (MS) have emerged. John B. Fenn 
and Koichi Tanaka who, in parallel, proposed MS-based strategy for macromolecule 
identification (71, 72) were then awarded the Nobel Prize in Chemistry 2002. 
Simultaneously, the automation, robustness and miniaturisation of liquid chromatography 
have also been continuously developed. These together allow a large molecule like protein to 
be studied with large-scale proteomics tools. Since then, proteome-wide observation has been 
investigated in many different milieu and circumstances. In particular, quantitative expression 
profiles, protein pathways and network analyses, and protein modifications and interaction 
studies are popularly investigated with broad-scale proteomics. A large number of advanced 
core proteomics technologies have been developed, fitting the purposes of protein studies in 
the past decade. They are briefly listed in Figure 6 (70) depicting core proteomics 
technologies from sample extraction to protein identification and quantification.  The simple 
technical workflow for quantitative proteomic expression profiles commonly begins with 
sample extraction and purification methods running to protein and peptide fractionation. Then 
with the combination of mass spectrometry and bioinformatics, protein identification and 
quantification can be examined. Further thorough details for each core technology in 
quantitative proteomics will be later discussed in section 1.3 of the introduction chapter in 
expressional proteomics and gel-based proteomics. Another challenging feature of proteome-
wide analysis is derivation of protein network and interaction maps. As the development of 
MS techniques becomes more sensitive and accurate; therefore, systematic mapping of 
cellular signaling and networks is achievable (73, 74). In principle, affinity tagging of 
proteins for interaction screens provides a more useful and generic method to purify protein 
network components compared to a conventional antibody-based process. Because of the 
multitude of possible interactions within cells and tissues, repetition of hundreds of samples 
need to be analysed by MS to generate a comprehensive network data and the interpretation 
of these data must be carefully organised. Consequently, validation tools are required for 
confirmation. In addition, protein signaling and networks are often governed by post-
translational modifications (PTMs). The next level of global proteome analysis points 
towards PTMs measurement. Based on attaching groups to the proteins, the difficulty of 
broad-scale discovery of PTMs can be various, in which phosphorylation or acetylation may 
be less challenging than glycosylation or ubiquitinylation. Although highly-efficient MS 
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allows identification thousands of phosphorylation or acetylation sites in a quantitative 
manner (75, 76) which has made widespread contributions to our understanding of protein 
signaling pathways; however, high-throughput PTM measurement not only require high 
resolution MS but also sophisticated chromatography methods and software analysis 
packages for peptide enrichment and modified peptide assignment. A marked PTMs 
investigation can also be dynamically assessed in vivo (77, 78). 
 
 
Figure 6. Proteomic Technologies for Sample Extraction to Protein Quantification. Classical 
proteomics workflow comprises sample extraction, protein or peptide fractionation, mass 
spectrometry and protein identification, and protein quantification. Each colour of the 
compartment represents each step in the proteomics workflow. Commonly used techniques and 
technologies are described in each compartment, many of which may be combined in one 
experimental study. (Adpated from (70)) 
 
 
Although there are several prospective challenges in proteomics technologies, currently the 
state of the art in proteomics advancement allows comprehensive applications for proteome 
researches. It is instructive to describe how rapidly gel-based and MS-based proteomics have 
been developed over the past decade. The foundations of core proteomics technologies in the 
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past decades have been summarised and provided in Table 2 in a chronological manner with 
concise details of their importance (79).  
 
 
Table 2. The Timeline of Major Development of Proteomics Technologies. Each major 
innovative technology is briefly detailed the year of event, importance of core technology and 
inventors. (Adapted from (79)) 
 
 
Year Technology Brief details Ref. 
1971 Automated Edman 
sequencing 
Automated protein sequencing designed by Pehr 
Edman and Geoffrey Begg was performed to 
sequence peptide at N-terminal sites 
(80, 
81) 
1975 High-resolution 2-DE Developed independently by O'Farrell and Klose for 
the separation of proteins by isoelectric focusing 
(IEF) and SDS electrophoresis as first and second 
dimensional separation, respectively 
(82, 
83) 
1982 IEF with immobilised 
pH gradients 
Immobilised pH gradients offered higher resolution 
and loading capacity. They also provided uniform 
conductivity and buffering capacity 
(84) 
1988 MALDI-TOF for 
macromolecules 
MALDI consists of two steps. First step is the 
desorption process by a UV laser beam. Second step 
is the ionisation of analyte molecules. The MS 
widely used with MALDI is a time-of-flgiht (TOF) 
mass analyser   
(72) 
1989 ESI MS Electrospray ionisation is used to disperse liquid 
containing macromolecules into a fine aerosol. The 
ions then are subjected into mass spectrometry for 
identifaction (More details described in section 1.3) 
(71) 
1989 Yeast two-hybrid 
system 
This technique has revolutionised the way protein 
interactions can be detected and has developed into a 
large-scale screening method for interacting proteins  
(85) 
1990 SELEX (aptamers) This in vitro selection systematically produced 
single-stranded DNA or RNA oligonucleotides for 
specific binding to targeted ligands, often proteins. 
(86, 
87) 
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Year Technology Brief details Ref. 
1992 Microchip capillary 
electrophoresis 
Microchip CE demonstrated that a significant 
improvement in speed was achievable by 
miniaturising conventional separation methods  
(88, 
89) 
1997 Difference in gel 
electrophoresis 
(DIGE) 
Major benefits of DIGE over conventional 2-DE 
enabled multiple samples running in the same gel 
with an internal standard and increased sensitivity 
and reproducibility 
(90) 
1997 First comprehensive 
2D LC/MS for protein 
mixtures 
This system used cation-exchange chromatography 
followed by reverse-phase chromatography. By this 
technique, complex mixtures of macromolecules 
could be thoroughly digested, separated and analysed 
with high speed and automation. 
(91) 
1999 Multidimensional 
protein identification 
technology (MudPIT) 
With multidimensional LC and tandem MS, this 
allowed the identification of more than 100 proteins 
in a single run. This platform made comprehensive 
analyses of large biomolecules and proteins possible 
(92) 
1999 Isotope coded affinity 
tags (ICAT) labeling 
A new class of chemical regents termed ICAT was 
developed in combination with mass spectrometry 
for relative global protein quantification in cells and 
tissues 
(93) 
1999 Protein microarrays Protein microarrays enabled researchers to survey a 
wide-scale proteome in a single experiment with 
automated and parallelised chips. Applications 
include identifying biomarkers, investigating protein-
protein interactions, and testing for the presence of 
antibodies in a sample 
(94, 
95) 
2002 SILAC labeling This was a non-radioactive isotopic labeling for 
quantitative proteomics. Pairs of chemically identical 
peptides with different stable isotope composition 
from cell cultures could be distinguished by mass 
spectrometry. This technique was widely used for 
various applications 
(96) 
16 
 
Year Technology Brief details Ref. 
2003 AQUA quantitation Absolute quantification peptide technology was built 
for proteomics. Such AQUA internal standard 
peptides were used for quantitative measurement of 
absolute levels of proteins and post-translationally 
modified proteins after proteolysis 
(97) 
2005 emPAI This referred to protein abundance index. It was 
developed for absolute protein quantification in 
protein complex mixtures 
(98) 
2006 QconCAT 
quantitation 
Artificial QconCAT proteins were developed in 
which they were concatamers of tryptic peptides of 
several proteins to use for absolute quantification of 
complex protein mixtures 
(99) 
2007 iTRAQ This was an alternative MS-based approach for 
relative and absolute protein quantification by using 
isobaric tags 
(100) 
2008 Absolute SILAC A new variant of SILAC method was developed for 
absolute quantitation. It allowed accurate quantitation 
of selected proteins in complex mixtures 
(101) 
2009 Unique Ion Signature 
(UIS) MS 
Robust theoretical assays for MS/MS data were 
established. Computational UIS methodology was 
developed for deterministic peptide identification  
(102) 
 
 
 
Proteomics technologies have been largely used in various applications among organisms, 
plants, animals, and humans. The applications have been extensive from simple protein 
analyses in vitro to complex in vivo studies. In general, the more the complexity of biological 
context is investigated, the better advanced technologies are developed and applied. 
Technical challenges in implementing the technologies to elucidate biological problems are 
mainly in aspects of expression profiling, PTM characterisation, marker discovery, network 
mapping, and organelle compositions. The success in a proteomics study is enabled by the 
available technology using an appropriate sample complexity. In Figure 7 (70), this shows the 
applications of proteomics from basic science research to translational studies and clinical 
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proteomics by using different technical approaches. At the upper left of the figure, the 
technical approach is straightforward compared to those at the bottom right which is more 
advanced and difficult to develop.       
 
 
 
 
 
Figure 7. Applications of Proteomic Technologies from Basic Researches to Translational 
Studies and Clinical Proteomics. The complexity of biological context, along X-axis in dark 
blue boxes, versus the technical difficulty of implementing the appropriate technology, along Y-
axis, is exemplified. At the upper left box, the technical expertise is uncomplicated while more 
advanced and complex technical development is needed for those towards the bottom right ones. 
(Adapted from (70)) 
 
 
The immense development and awareness of proteome research requires a structural 
organisation for fostering the development of new technologies, techniques and trainings. 
The Human Proteome Organization (HUPO) was established in 2001 by international 
collaborations and members, including both academic and industry. It is an international 
consortium where the focus is to gain a better or complete understanding of the human 
proteome. It also promotes proteomics research throughout the world and facilitates scientific 
collaborations via several Initiatives. Thus far, 13 Initiatives have been founded during the 
past decade by HUPO.  All Initiatives is listed in HUPO website (103). Two important 
18 
 
Initiatives which are related to this thesis also were embraced. They are Proteomic Standards 
Initiative (PSI) and Proteome Biology of Stem Cells Initiative. The former one represents an 
attempt to define community standards for data representation in proteomics to assist data 
comparison, exchange and verification, involving protein separation, mass spectrometry and 
proteomics data management. The latter one involves an attention to understand basic cellular 
processes of stem cells, particularly embryonic stem cells (ES cells). This Initiative has been 
established jointly by HUPO and the International Society for Stem Cell Research (ISSCR) 
and is represented by leading scientists from both fields, providing a platform for researchers 
from both communities to define projects and collaborations in stem cell biology requiring 
proteomic analysis. Because of embryonic stem cells’ unique properties to form all cells in 
humans, the focus on discovering insight into basic mechanisms of embryonic stem cells is 
intriguing, especially in the area of regenerative medicine. To explore how stem cell self-
renewal, maintenance and differentiation occur would expand our knowledge if stem cells are 
to reach their maximal potential particularly at the proteome level. 
 
 
1.2 Stem Cell Biology 
 
1.2.1 Stem Cell Principles 
 
Cells are the basic structural and functional units in biology. In mammalian development, it 
begins with the formation of unicellular zygote, which arises from the fertilisation process 
between a sperm and an egg from the paternal and maternal origins respectively. A total of 
10
14
 cells have been estimated to reside in the human body, and which can be categorised into 
approximately 230 specialised cell types according to their functional phenotypes (104). Stem 
cells are cells which possess an ability to maintain self-renewal or differentiate to any 
specialised cells. The stemness of every cell type arises from the inner cell mass (ICM) cells 
of the blastocyst in an embryonic stage (105, 106). Later on, these ICM cells give rise to all 
of different stem cell types or differentiated mature cells, forming tissues and organs. 
Characteristically, the particular stem cells have a restricted capacity to turn into only specific 
mature cells which phenotypically characterise the tissue where they reside. For instance, 
hematopoietic stem cells and epidermal stem cells differentiate into blood cells and skin cells, 
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respectively. However, there are some exceptions such as PDGFRα-positive bone marrow 
stem cells can develop into skin tissue (107).  
 
The initial concept of stem cell biology originated from the study back in 1961. James Till 
and Ernest McCulloch published serendipitous findings proving the existence of stem cells in 
hematopoietic tissues (108). Subsequent evidence of stem cells in the hematopoietic system 
has also been demonstrated in peripheral blood and bone marrow (109, 110). In addition, 
clinical experiments also proved the promise of bone marrow transplantation for the 
treatment of cancer and non-cancer hematopoietic diseases (111, 112). Taken all together, 
these findings in hematopoietic stem cells have led to an opening of the stem cell biology 
paradigm.   
 
In the basic principle of stem cell, stem cell fates and states are of importance and considered 
as a core of stem cell biology. Understanding cell-fate decisions in stem cell population is 
important for translating stem cell biology towards clinical medicine. While much still 
remain to be understood, the four cell-fate options for stem cell have been described (113), 
including self-renewal, differentiation and lineage-specification, programmed cell death or 
apoptosis, and quiescence (Figure 8). Self-renewal is division with maintenance of the 
undifferentiated state whereas quiescence is the undifferentiated state with no division. 
Furthermore, stem cells also undergo changes resulting in loss of stem cell state, either 
differentiation or death (apoptosis). These cell-fate decisions are regulated by both cell-
intrinsic mechanisms and cell-extrinsic signals from the niche, the microenvironment that 
stem cells populate. In addition, the developmental potency of stem cell can be classified into 
four categories according to differentiated progeny states, including totipotency, pluriotency, 
multipotency, and unipotency (Figure 8).   
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Figure 8. Stem Cell Fates and Developmental Potency of Stem Cells. (Left) Stem cells contain 
unique capacities for both retention of stemness and loss of stemness. While stem cells undergo 
stemness retention, they remain in either a self-renewal or quiescence state. In contrary to loss of 
stemness fate, they undergo either differentiation or apoptotic programs. (Right) Developmental 
potential of stem cell potency can be classified to totipotency, pluripotency, multipotency and 
unipotency. A potency state is associated with an ability of stem cell to differentiate into multiple 
cell types in the body. Examples of various cell types for each potency state are also described. 
(Adapted from (114, 115)) 
 
 
1.2.2 Resources of Stem Cells 
 
Resources of stem cells come from many sources in humans. They are categorised as adult 
stem cells, umbilical cord blood stem cells, embryonic germ cells, and embryonic stem cells. 
Besides, recently, reprogrammed stem cells and partially reprogrammed cells have also been 
created and identified. Briefly, adult stem cells or somatic stem cells populate, proliferate and 
generate differentiated offspring in a tissue or organ (116). Adult stem cells population in 
human body have been identified in, for instance, bone marrow, intestine, brain, epidermis 
and hair follicles (117-120). They are able to divide and differentiate into mature cells when 
needed in a particular tissue. Another stem cell resource, umbilical cord blood contains a 
stem cell population with a similar character to mesenchymal stem cells, namely Wharton's 
Jelly Mesenchymal Stem Cells (WJ-MSCs) (121). The cryopreservation of these WJ-MSCs is 
addressed for the potential use for regenerative medicine and hematologic malignancy 
treatment. Over 600,000 umbilical cord blood units have been banked worldwide with 
potential therapeutic uses, in particular, for allogeneic hematopoietic stem cell transplants 
(122).  
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1.2.3 Mouse and Human Embryonic Stem Cells 
 
In the past decades, one key scientific discovery was the derivation of mouse and human 
embryonic stem cells. Evidence has shown that these ES cells could be manipulated to 
generate various cell types from all three germ layers in vitro and in vivo. Since the discovery 
of mouse ES cells in 1981 by two independent research groups (Martin Evans and Matthew 
Kaufman MH; Gail Martin) (105, 106), great attention from scientists has been focussed 
towards insights into the biology of stem cell development. The establishment of mouse ES 
cells was derived from in vitro culture of primary mouse blastocysts on feeder cells. When 
these cells were injected into nude mice, they could give rise to teratoma, implying their 
pluripotent characteristics (123). Additionally, mouse ES cells could be used to produce live 
offspring and these ES cell-derived animals were normal, viable and fertile (124). This, in 
fact, also suggested the pluripotent properties of these mouse ES cells. Later, several subtypes 
of mouse pluripotent stem cells were identified, including mouse embryonic germ cells, adult 
germ line stem cells, and, recently, mouse epiblast stem cells (125-129). These cellular 
subtypes were discovered varying from different stages of mouse development.  
 
The consequent intellectual skeleton of human ES cell biology was originated and enabled 
from the comprehension and conception of mouse ES cells. In 1998, James Thomson and 
colleagues published the first derivation of human ES cells from human blastocysts (130). 
The established human ES cell lines expressed cell surface markers which characterised 
undifferentiated cells, including stage-specific embryonic antigen (SSEA)–3, SSEA-4, TRA-
l-60, TRA-1-81, and alkaline phosphatase. Five ES cell lines were derived, in which three 
cell lines had normal a XY karyotype and the rest had a normal XX karyotype. After multiple 
times of passages, the ES cells remained undifferentiated without karyotype changes. When 
all five cell lines were injected into severe combined immunodeficient (SCID)–beige mice, 
teratoma formed with all three germ layers. In addition, in vitro differentiation of one ES cell 
line for 2 weeks also indicated trophoblast differentiation capability. In sum, these ES cell 
lines should hold gigantic promise in studying human developmental biology, drug 
discovery, transplantation, and regenerative medicine. The derivation of pluripotent human 
ES cells (Figure 9) has opened new exciting paradigm for stem cell biology; however, there 
were still concerns about potential risks, such as uncontrolled or misdirected growth, and 
ethical controversy associated with the source of human ES cells.      
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Figure 9. Human Embryonic Stem Cell Derivation. The inner cell mass cells were separated 
from the blastocyst stage of donated embryo. The isolated inner cell mass cells were plated on 
culture dish with supporting cells (feeder cells) and environments. Clonal cell lines were created 
by growing up a single cell. These ES cells were fed and passaged for maintenance. These ES 
cells would support the unprecedented access to cells or tissues from the human body and 
provide the material for drug safety and efficacy screening. (Taken from (131)) 
 
 
Following the characterisation of first human ES cell lines in 1998, standard protocols have 
been steadily developed towards clinical-grade applications, including maintenance of these 
cells under animal-derived-free and defined culture components (132, 133). Moreover, 
essential protocols for induced differentiation processes of human ES cells into various 
differentiated cell lineages such as neurons, keratinocytes, and cardiomyocytes have been 
largely optimized (134-136). In addition, by integrating with an engineering approach, 
several of these envisioned applications of ES cells would require production of high number 
of stem cells and their derivatives in a scalable process, effective automated bioprocessing 
systems are required to achieve a large-scale production and to reduce the amount of 
associated labour and time (137, 138). Preclinical studies in animals have proved that 
derivatives of differentiated human ES cells could provide functional replacements in 
diseased tissues, typically marked by loss of cells, such as for Parkinson’s disease, macular 
degeneration and cardiac insufficiency following infarction (139-141), and clinical trials have 
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recently been approved for cellular therapy in humans for spinal cord injury (142) and 
macular degenerative disease (143). Nonetheless, the pioneering clinical trial of human ES 
cells for spinal cord injury was halted due to the formation of cysts in animal models of the 
treatment and the trial has been restarted, after addressing this concern, with the first patient 
in late 2010. Despite the promise of ES cells in regenerative medicine, there are essentially 
two major risks of immunogenicity and tumourigenicity which are potentially associated with 
clinical uses of ES cells. Besides these biological concerns, controversy about ethical issues 
of using human ES cells has been broadly debated (144). 
 
 
1.2.4 Mouse and Human Induced Pluripotent Stem Cells 
 
In 2006, Shinya Yamanaka and Kazutoshi Takahashi astonished the world by demonstrating 
that transcription factor-induced cell reprogramming was achievable in somatic cells (145). 
The enforced expression of four key transcription factors, Oct4, Sox2, Klf4, and c-Myc, 
could reprogram mouse fibroblasts to pluripotent states. These reprogrammed pluripotent 
cells expressed similar characters to ES cells and obtain comparable developmental potential 
as ES cells. “Induced Pluripotent Stem Cells or iPSCs” was first used to describe these 
reprogrammed cells (145). Subsequently, a year later, first human reprogrammed pluripotent 
stem cells were successfully generated from human fibroblasts by two independent research 
groups (146, 147). Yamanaka’s team successfully transformed human fibroblasts into iPSCs 
using the same four pivotal genes, OCT4, SOX2, KLF4, and c-MYC, with a retroviral-
mediated transfection system whereas another team, led by James Thomson, used different 
combination of genes, OCT4, SOX2, NANOG, and LIN28, with lentiviral system for cell 
reprogramming. The observation from these two independent results indicated that OCT4 and 
SOX2 were core transcription factors in common and might not be dispensable for human 
iPSC reprogramming. This phenomenal generation of iPSC has created the possibility that 
human iPSCs might provide the same therapeutic potential as human ES cells without ethical 
dilemma of using human embryos (Figure 10). Since this first establishment of human iPSCs, 
enormous scientific discoveries and techniques have been described to facilitate both 
mechanistic insights and translational studies of iPSCs for clinical settings.  
 
Over the past five years, various reports on generating iPSCs with a reduction in genetic 
manipulation and genome-integrating viruses with more efficiency have been described (148-
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150). In addition, microRNAs recently have been effectively applied for iPSC production 
without any required exogenous transcription factors (151, 152). Differentiation protocols for 
iPSCs into specific lineages have been established (153-155). Moreover, because these iPSCs 
can be derived from a patient's own cells, they gave researchers the ability to model human 
diseases and to promise a new framework in drug development in an unprecedented manner 
(156, 157). The proof-of-concept which iPSC technology can be used for the generation of 
disease-corrected and patient-specific cells with potential value for cell therapy applications 
has been demonstrated (158, 159). Patient-own iPSCs pose a reduced risk of immunological 
rejection and result in an avoidance of ethical dilemmas. Several concerns of iPSCs need to 
be addressed before patient-specific iPSCs can advance into the clinic. For instance, a single 
reprogramming experiment usually generates multiple iPS cell lines which are not always 
identical or even not fully reprogrammed iPSCs (160). Each individual iPS cell line needs to 
be fully characterised with reliable standard protocol to identify bona fide iPSCs and to 
ensure pluripotency capacity and safety (161, 162). Another risk of iPSCs when applying 
iPSC treatment to human subject is tumourigenicity. This problem also exists in human ES 
cell transplantation. Furthermore, genetic and epigenetic instability of iPSCs (163-165) must 
be considered. Thus, the justification of safety for the use of pluripotent stem cell or 
reprogrammed pluripotent stem cell is of utmost importance in clinical settings.  
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Figure 10. Human Induced Pluripotent Stem Cell Generation and the Schematic of iPS 
Cell-based Therapy. Somatic cells or adult stem cells are isolated and cultured from the patient 
and reprogrammed to generate iPS cells. In case of genetically disease-specific iPS cells, genetic 
defect can be repaired in iPS cells before further use. Directed differentiation of ready iPS cells 
into specific cell types can be used for drug screening, disease model, and cellular therapy in pre-
clinical animal studies, then for transplantation back into the patient to cure or alleviate the 
disease. (Taken from (161)) 
 
In stem cell biology, there is a growing need for advanced technologies which may help to 
unravel the molecular mechanisms of self-renewal, differentiation, and plasticity of stem 
cells. Major progress has been made in disclosing these signalling events with large-scale 
studies at the genomic and transcriptomic levels, but analysis of protein expression, 
interaction, and modification has been more limited since it requires differently sophisticated 
strategies (166). Excitement about the potential of proteomics technology has been developed 
among stem cell researchers (167). The underlying molecular mechanisms and cellular 
changes associated with stemness have been investigated using proteomics approach. 
Proteomics platforms allow a variety of studies for proteome or subproteome profiles, 
relative or absolute quantitation, post-translational modifications, and protein-protein 
interactions. In the next section, the comprehensive focus will be put on the context of 
technological development and technical details of expressional proteomics and, particularly, 
gel-based proteomics. 
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1.3 Expressional Proteomics and Gel-based Proteomics  
1.3.1 Expressional Proteomics Background 
 
Proteomics technologies offer considerable opportunities for physiological and biological 
understanding at the protein level. Advances in mass spectrometry are an essential key to the 
development of a central platform for proteomics. A number of other technologies and 
resources are also required for complex experiments, including protein separation science, 
imaging acquisition system, and bioinformatics tools. Expressional proteomics aims not only 
to identify the components of a proteome or subproteome but also to quantitatively compare 
two or more distinct proteomes identifying proteins with altered expression levels or post-
translational modifications in response to given stimulus (70). In biomedical applications of 
comparative proteomics, the objective is often to identify up or down-regulated proteins in a 
disease-specific manner for diagnostic and therapeutic purposes (168). Whereas in cellular 
signaling experiments such as in stem cells, quantitative experiments can be used to 
determine which proteins are increased or decreased in the differentiation process or self-
renewal mechanism, for instance, unraveling the regulatory mechanisms of stem cells (169). 
Thus, expressional proteomics becomes an intellectual discipline and offers a significant 
contribution to data and information on the working of cells in health and disease (58).  
 
There are several technical frameworks in expressional proteomics. For protein identification, 
a number of workflows are available for protein separation prior to mass spectrometry and 
subsequent bioinformatics analysis have been described, comprising 2D gel electrophoresis, 
liquid chromatography, and 1D gel electrophoresis coupled with liquid chromatography 
(GeLC). Further than protein identification, there are a range of established systems available 
for protein quantification. Broadly, two primary approaches have been addressed: so called 
gel-based and non-gel-based approach (MS-based approach) (170). Gel-based proteomics for 
quantification such as 2D-DIGE method has greatly improved the efficiency of gel 
electrophoresis as a quantitative differential display technology with high sensitivity and 
reproducibility. MS-based quantitative approach, consisting of labeling and label-free 
quantification methods, allows quantitative differential proteomics by comparing the peptide 
signals observed in samples prepared under different conditions and now increasingly 
becomes the method of choice in quantitative proteomics. Altogether, gel- and MS-based 
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approaches provide closely related but distinct information about proteins, signifying that 
they are complementary, or at least supplementary, methods for expressional proteomics. 
 
1.3.2 Gel-based Proteomics 
 
Gel-based proteomics technology still remains the core proteomics technology and widely-
used by scientists, evidently by more than 7,600 gel-based proteomics articles published in 
PubMed database, during the last 5 years, even though advancement of MS-based proteomics 
approach is becoming widespread. Fundamentally, technical details of each step of classical 
workflow in gel-based proteomics technology (Figure 11) will be thoroughly presented, 
involving sample preparation, protein separation, protein detection and image acquisition, 
protein quantification, and protein identification. Moreover, the challenges and room for 
technical improvement in the gel-based approach will also be discussed along with the 
applications of gel-based proteomics in modern biological science.   
 
 
 
Figure 11. A Classical Gel-based Proteomics Workflow. The gel-based proteomics workflow 
includes experimental design, sample preparation, protein concentration assessment, 2D gel 
protein separation, imaging acquisition and analysis, mass spectrometric protein identification 
along with data mining, and protein validation. Each of the steps in the workflow requires 
optimised and consistent procedures to attain accuracy and reproducibility of the results for 
individual gel-based proteomics experiments.  
 
 
 
Experimental Design 
 
Experimental design is generally the thought of formulating a hypothesis, selecting 
population study, and designing an unbiased experiment with certain experimental resources. 
Some scientists may find the subject of experimental design to be rather unexciting, but, in 
fact, it is the very first important tread of every single scientific experiment, including 
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proteome analysis. In particular, the quality control of the data from large-scale proteomic 
technologies is a vital issue which has an impact on all aspects of an investigation (171). The 
understanding of the sources of variation in individual experiment and knowing how to avoid 
those biological and analytical variations is of importance. In gel-based proteomics, bias and 
variation can occur during each step of experiment in the workflow. For example, if only one 
gel replicate form each population group is examined, the observed differential profile 
between this single case and control may not represent the true difference, but it could be an 
artifact of population sampling, or analytical error, or just values within normal biological 
variability (172). Furthermore, examples of technical noise in 2D gel electrophoresis consist 
of features of sample preparation, variation in running parameters, and artifact within the 
imaging process (172). Therefore, the knowledge of how to obtain an optimal number of gel 
replicates for an experiment and how to control an experimental procedure in consistent 
environments makes it possible to obtain accurate, reliable, and reproducible results from gel-
based proteomics. 
 
Sample Preparation 
                    
The composition of the sample has a great influence on the quality and reproducibility of 2D 
gel electrophoresis results, thus sample preparation is one of the most important experimental 
steps. It has been shown that this process has a profound effect on the final outcome of 
protein separation and its subsequence in proteomic analysis (173-175). In general, there are 
three fundamental steps of sample preparation for proteomics which are cell disruption or 
tissue extraction, interfering substances removal and protein solubilisation. Besides, pre-
fractionation of subproteomes is also suitable for particular experiments. Exact methods or 
protocols, however, are largely sample dependent. Generally, cells or tissues can either be 
lysed as a whole or fractionated into subcellular components such as cytosolic, membrane, 
organelle, nuclear, and cytoskeletal proteomes before lysis. The lysis procedure for individual 
type of cell or tissue needs to be optimised minimising proteolysis, loss, and modification of 
proteins. The whole or fractions of proteomes may then be cleaned up to remove non-protein 
components such as salt ions, nucleic acids, lipids, and cell debris (176, 177). After cell 
disruption and removal of interfering substances, a successful experiment also depends on 
efficient protein solubilisation process in order to disrupt molecular interactions and to ensure 
decent resolution (178, 179). The standard lysis solution contains 7M urea, 2M thiourea, 4% 
w/v CHAPS, dithiothreitol, and carrier ampholytes. Protease inhibitor cocktails and 
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phosphatase inhibitors are also added during protein extraction to prevent degradation and 
modification of proteins. With an exception, the lysis buffer for protein pre-labelling with 
fluorescent dyes must not contain dithiothreitol and carrier ampholytes at the condition where 
a pH value is above 8.0 for a proper labelling process (90). 
 
Protein Separation 
 
Two-dimensional gel electrophoresis (2-DE) has traditionally been used in the quantitative 
analysis of complex protein mixtures (82, 83).  It provides a high resolving power which is 
essential to separate complex protein samples prior to mass spectrometry protein 
identification. The principle of 2-DE is based on separation of proteins according to their 
charge or isoelectric point (pI) in the first dimension by isoelectric focusing (IEF) and size or 
molecular mass in the second dimension by sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). The advent of immobilised pH gradient (IPGs) for the first 
dimension separation has been described and generated valuable improvement in 2-DE 
separation in terms of higher resolution, better reproducibility, and improved loading capacity 
for preparative gels (179, 180). Other crucial technological advances in 2-DE include the 
development of sensitive protein stains and the use of difference in-gel electrophoresis 
(DIGE) (181, 182). 
 
First Dimension Electrophoresis: IEF with IPGs 
 
The first dimensional separation in 2-DE is normally IEF, which is a technique for separating 
different molecules by their electric charge differences (179, 183, 184). The underlying 
principle is that each protein migrates to its isoelectric point, the point that its pI value is 
equivalent to the surrounding pH and its net charge is zero, in the encompassing pH gradient. 
At a pH below their pI, proteins carry a net positive charge while, above their pI, they carry a 
negative charge. Positively charged molecules migrate through the pH gradient in the 
medium toward the negative electrode while negatively charged molecules move toward the 
positive electrode. Proteins focus at different positions in the pH gradient according to their 
different pI values, as determined by the composition of acidic and basic amino acid of the 
proteins. Currently, IPGs dominates the field of IEF and represents an ultimate revolution in 
the field of gel-based electrophoresis (185). In fact, it is generated by covalently corporating a 
gradient of acidic and basic buffering groups, immobilines, into a polyacrylamide gel. The 
30 
 
use of a pH gradient range depends on the required resolution for the particular protein 
sample. If the goal is to obtain all the proteins in the unknown samples, wide gradient such as 
pH 3-10, should be applied in order to get the distribution of protein samples. However, if the 
aim is to obtain resolution of maximal number of protein spots, either multiple overlapping 
narrow IPGs or wider gels should be utilised. Many buffer protocols have been attempted to 
improve the solubilisation process and enable compatibility with the first dimension 
separation, in particular, for basic, hydrophobic and large protein molecules (186, 187). 
Moreover, there are several commercial suppliers producing ready-made IPG dry strips 
which provide easier handling and better results for comparability and data exchange.  
 
Second Dimension Electrophoresis: SDS-PAGE 
 
In the second dimension, proteins are placed along with SDS and other reagents and are 
separated in accordance with their molecular mass when subjected to an electric field (179, 
184). Focused proteins are processed to get them ready for second dimensional 
electrophoresis run. This process is called equilibration. The equilibration process mainly 
consists of two steps in which a focused IPG strip is soaked in an SDS solution at first 
containing dithiothreitol and then with iodoacetamide. Each step takes about 15 minutes. 
Dithiothreitol works as a reducing agent while iodoacetamide alkylates sulfhydryls, 
preventing the reformation of disulfide bonds. After equilibration is complete, the second 
dimension step is then set up and run. While SDS-coated polypeptides are driven out of the 
IPGs into the SDS-PAGE gel, SDS binds with the proteins at the fixed ratio and gives them 
large negative charge within the gel. Therefore, the intrinsic electrical charges of the proteins 
can be disregarded owing to SDS binding effect and the relative mass difference between 
proteins are also still maintained in the protein-SDS complex. Size-dependent separation can 
occur as the proteins migrate according to sieving effect of the gel, due to the size of the pore 
inside the gel. Larger proteins are retained more in the gel and smaller proteins are able to 
pass through the gel (184, 188). Technically, variations often occur in three components of 
this step which are gel structure, buffer systems and detergent (185). Nowadays, several pre-
cast gels and buffer solution for second dimension are also commercially available, offering 
improved data interpretation and reproducibility.  
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Difference In-Gel Electrophoresis: DIGE 
 
One of the recent advances in 2-DE has been the advent of the multiplexing fluorescent 
DIGE technique (90), first described by Minden and co-workers, which involved pre-labeling 
of proteins with fluorescent cyanine dyes. DIGE technology allows running gel 
electrophoresis with quantitative capability and high sensitivity. Currently, two different 
CyDye DIGE Fluor dyes are available, including CyDye DIGE Fluor minimal dyes and 
CyDye DIGE Fluor saturation dyes (188). CyDye DIGE Fluor minimal dyes have an N-
hydroxysuccinimidyl (NHS) ester reactive group which forms a covalent bond with the 
epsilon amino group of lysine in proteins via an amide linkage. These minimal dyes will not 
provide the effect either in terms of charge or mass pattern detection of the labeled proteins. 
They will add approximately 500 Da to the mass of protein; nonetheless, this mass addition 
does not affect the pattern visible on the second dimension SDS-PAGE.  The minimal dye, its 
own, has a single positive charge. To replace the single positive charge of the lysine at neutral 
and acidic pH ensures that an alteration of the pI of the protein is minute(189). CyDye DIGE 
Fluor saturation dyes have a maleimide group which covalently reacts with cysteine residues 
in the proteins forming a thioether linkage. The charge and the mass of the labeled protein 
also will not significantly alter after labeling (190). Comprehensive technical details about 
DIGE and fluorescent technology for electrophoresis will be later shown in chapter 3 of this 
thesis. 
 
Combining this fluorescent technology, DIGE provides significant benefits over conventional 
2-DE by three major factors. Firstly, running multiple samples is carried on the same gel in 
order to reduce variation from running different samples on different gels. Secondly,  running 
an internal standard, comprising pooled equal amounts of protein from each sample, is 
achieved on all gels in the set of experiments to decrease erroneous results from biological 
variations (191). Lastly, using unique experimental design, a reciprocal labeling method, is 
conveyed to minimise potential dye artefacts and avoid preferential labeling (192). In 
summary, DIGE provides the capability to substantially reduce the effects of gel to gel 
variation on the quantitation of protein spots (193) and to increase the sensitivity of protein 
spot detection on the gel (181). 
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Detection and Analysis of Proteins Separated by 2-DE 
 
Following conventional 2-DE separation, the next key step is to make the separate spot 
detectable. The post-labeling of proteins has been by far the way for the visualisation of 2-DE 
gel-based separation. Generally, protein stains must be sensitive, have a broad linear range 
and be compatible with mass spectrometry (MS). Protein spots are visualised and taken an 
image, then the resulting image is anlysed by special software analysis. In particular, 
colloidal coomassie staining and silver staining are normally used because they are both 
sensitive and require less effort. With coomassie staining, the limit of detection (LOD) is 
around 25 to 50 ng of protein whereas with silver staining, LOD is about 5 ng of protein (194, 
195). In addition, fluorescence-based stains are characterised for having more sensitivity and 
linear ranges. Its LOD is as low as 0.25 ng of protein (196). The choice of staining method 
depends on many factors such as sensitivity of detection requirement and availability of 
instrumentation.  
 
After the imaging acquisition of the gel, recently, there are various analytical software 
programs to simply handle the detection and analysis of protein spots of the gel. Several 
software tools have been developed to enhance the precise alignment of multiple spots, to 
detect and localise the positions of spots, and to reduce the tediousness and frustration when 
manually performed. However, the software analysis technology currently still has a 
drawback in terms of software-to-software variations, signifying a variation up to 50% in the 
number of quantitative differential spots (197, 198). The crucial steps for software data pre-
processing and statistical inference are being continuously improved for spot detection and 
quantitation. 
 
Protein Identification by Mass Spectrometry 
 
Protein spots of interest can be identified and excised either manually or robotically from the 
2-DE gel. Then, typically gel spot is digested with the enzyme trypsin which cleaves at 
specific protein sequences and the peptide mixture is subjected to mass spectrometry. The 
fundamental operations of mass spectrometers are to measure the mass to charge ratio (m/z) 
of gas phase ions under vacuum. Mass spectrometers have three principal components: an 
ionisation source which volatises and ionises the analyte into gas phase ions under vacuum, a 
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mass analyser which separates the ions in accordance with their m/z, and an ion detector 
which registers the intensity of ions at each m/z value (199) (Figure 12).  
 
Two common ionisation methods are electrospray ionisation (ESI) and matrix-assisted laser 
desorption/ionisation (MALDI) and both are commonly used for protein sample analysis. 
These methods provide the generation of ions of intact macromolecules with high efficiency. 
The introduction of these two methods has revolutionised proteomics. In brief, ESI is a 
continuous ionisation method (71). The analyte molecules are eluted from a high voltage 
microcapillary. Principally, the field at the tip of the microcapillary charges the surface of the 
emerging droplet. While the droplet gets smaller by further evaporation, the repulsion 
between the surface charges increases causing further “explosion” of the droplet. This 
process continues until the ions are desorbed into the ambient gas, which can then pass into 
mass analyser. ESI is frequently coupled with reverse phase liquid chromatography (RPLC) 
for separation process and various mass analysers can be used with ESI. 
 
                                          
 
 
 
 
 
On the other hand, MALDI is a pulse ionisation method (72). Matrix substances which are 
normally used include dihydrobenzoic acid or α-cyano-4-hydroxycinnamic acid. A laser 
beam is radiated on marix-analyte crystals on a sample metal plate. Sputtering of the matrix 
molecules desorbs analyte ions into the ambient gas phase. The Time-of-flight mass analyser 
(TOF) is commonly coupled with MALDI ionisation method. 
Figure 12. A Schematic Picture of Mass Spectrometer Components. Sample 
molecules are introduced to ionization source. Analytes are ionized and a proportion of 
the molecular ions will be fragmented. The masses of the molecular ions and fragmented 
ions are analysed by mass analyser and visualised as mass spectra. (Adapted from (199)) 
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Several types of mass analysers are commonly used in protein identification such as time-of-
flight, quadrupole mass filter, ion traps, and Fourier transform  ion cyclotron resonance. Two 
or more mass analysers can be combined and used together such as quadrupole-time-of-flight 
(Q-TOF) or triple quadrupole in order to perform tandem MS/MS (200), where amino acid 
sequences of peptide could be determined. For peptide sequencing via tandem mass 
spectrometry, database searching is an essential component for successful identification. 
Several database search tools are currently available with shared similar core elements. 
Algorithms and computational modelling and various parameter settings have been reviewed 
in these articles (201, 202).  
 
1.3.3 Challenges of 2-DE in Gel-based Protemics 
 
Limitations and challenges of 2-DE have been excellently reviewed in the article by Gorg and 
colleagues (203). Briefly summarised, four different types of proteins, which are troublesome 
for 2-DE proteome analysis, include very acidic, very alkaline, low abundant and very 
hydrophobic proteins. For very acidic and alkaline proteins, different pH ranges of IPGs strip 
can be generated and used for particular pIs of proteins of interest. For instance, very acidic 
IPGs from 2.5-5 can be produced by using low pK acrylamide buffer and run without 
electroendosmotic flow. Recombinant proteins with very acidic pI’s can be presented with 
good resolution. But in the majority of complex protein samples from organisms, the acidic 
proteins with pIs lower than 3.0 do not normally present in the gel even with a compatible 
IPG strip. On the contrary, very alkaline proteins from organisms do present within the gel a 
lot more than very acidic ones. With high pH ranges of IPGs strip and modified IEF protocol, 
very alkaline proteins could be run with high reproducibility (204, 205). For low abundance 
proteins, due to the high dynamic range of complex proteins in organisms, the analysis of low 
abundance proteins in regard to detection and quantitation is a major challenge. The solution 
for this problem is to perform electrophoretic prefractionation or to obtain subproteome 
analysis. Several types of prefractionation methods have been described and applied for low 
abundance protein detection (206, 207). In addition to increased detection of low abundance 
proteins, a prefractionation strategy allows higher amount of protein loading without 
detrimental results (208). For hydrophobic proteins, particularly membrane proteins, they are 
underrepresented on 2-DE gels which may be attributed to several factors. Many membrane 
proteins posses alkaline pI’s and are expressed in low abundance. Furthermore, their low 
solubility and tendency to aggregate in aqueous solution altogether hinders the performance 
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of 2-DE gels for these proteins. Thus far, the protocol to solubilise and separate all membrane 
protein has not been well-established and is an active area of research.    
  
The quantitative capability of 2-DE is also an important issue to be addressed. A series of 
quantitative 2-DE methods have been developed. DIGE technology with using an internal 
standard is the most powerful technique in regard to quantitation in gel-based proteomics. 
This technique allows studies of differentially expressed proteins to be easier, more sensitive 
and reproducible. However, highly-performed DIGE technology still comes with high price; 
therefore, there is a need for cheaper or alternative fluorescent technology in 2-DE gels for 
broader accessibility. Importantly, another challenge in quantitative DIGE technology is gel 
image analytical tools which are crucial for accurate and reproducible results. 
 
As challenges in the field of cell biology increase, the trend for proteomics can be 
summarised rather easily as “the lower the complexity, the better the performance” (209). 
This approach has shown to be efficient on several cellular organelles, such as mitochondria 
and nuclear pore complex (210, 211). Additionally, 2D gels offer another advantageous way 
of detecting post-translational modifications of proteins by using a principle of the change in 
pI of protein induced by many modifications. The resolving power of 2D gels allows the 
visualisation of extra spot adjacent to the principal spot on 2D gels for further identification 
of modified proteins (212, 213). Interestingly, this unique ability of 2-DE to separate 
complete proteins with a high resolution can be used for studying protein degradation. In this 
frame, target proteins can be degraded by several proteases and the fragments of the target 
proteins after degradation process can be detected and located by immunoblotting on 2D gels 
for further characterisation (214, 215).  
 
In this thesis, the utility of the gel-based approach has been explained and emphasised. 
However, admittedly, the progress and ongoing success of MS technology seemingly allows 
researchers to use non-gel-based proteomics approach with increasing popularity. 
Comprehensive reviews of advanced non-gel-based proteomics technology have been 
excellently described in these several articles (200, 216-218). Each gel-based and non-gel-
based proteomic technology currently available provides distinctive technical advantages, but 
also limitations (219-221). In conclusion, altogether two approaches would give more robust 
and complementary results to each other to effectively address all proteome analysis 
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requirements and gel-based proteomics will remain the workhorse within the foreseeable 
future landscapes of biological and cellular proteome investigation. 
 
1.4 Gel-based Proteomics Applications in Stem Cells  
Currently, these are exciting times for stem cell biology. New emerging large-scale and high-
throughput proteomics technologies allow and enhance scientists to elucidate the mechanisms 
of stem cell-fate decisions with ever-increasing detail at the proteome level. Many 
applications of proteomics have been used for stem cell mechanistic insights, involving self-
renewal fate, growth and differentiation stages, and abnormalities in diseases. With the recent 
advanced technology to proliferate stem cells to numbers amenable to proteomic experiment 
and to induce stem cells with optimal constitutes into specific lineages, there has been an 
increase in the number of global protein studies of this important stem cell. Technically, gel-
based proteomics is normally performed by 2-D SDS-PAGE or DIGE coupled with MS or 
MS/MS, depending on the purposes of studies. Gel-based approach has been widely used to 
analyse the protein composition of different cellular states, the protein with up- or down-
regulation in certain differentiated fate, and the protein which supports growth and 
proliferation of stem cells. A summary of gel-based applications to stem cell proteomics is 
detailed in these three comprehensive reviews (222-224).  
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1.5 Aims and Outline of this Thesis  
The aims of studies in this thesis are to provide the technological enhancement of gel-based 
proteomics workflow and to employ gel-based proteomics in stem cell biology, decoding the 
relationship between the molecular phenotype of native and induced pluripotent stem cells. 
The information in each chapter is self-contained such that each chapter can be read 
separately from the others. As a consequence there is some duplication of information 
throughout the chapters. 
 
In chapter 2, the factors affecting the performance of 2-DE are discussed. Protein sample 
quality is one of the most critical compartments of successful gel-based proteomics results. 
Based on literatures, no instrumental tool or analytical device has been described to address 
this crucial issue. This study demonstrates a new approach for rapid 2-DE sample assessment 
using capillary gel electrophoresis combined with multi-pixel detection. Implementation of 
this technique in the proteomics workflow will improve the success rate of 2-DE and enhance 
the workflow efficiency. Furthermore, this technique also provides quantitation capability. 
This chapter has been published in Journal of Separation Science (225). 
 
In chapter 3, the quantitative aspects of gel-based proteomics are discussed, particularly 
DIGE technology. DIGE has proven the most powerful gel-based proteomics method for 
quantitative proteome comparison. Nonetheless, this excellence comes at the high cost, i.e. 
florescent CyDyes for pre-labelling proteins are costly. This barrier has made it barely 
feasible to use this approach routinely and to expand this excellent technique to a wider group 
of users. In this study, two alternative cyanine mono-functional NHS ester dyes are observed 
that their structural properties are quite similar to the CyDye minimal dyes with only slight 
difference. The results demonstrate that these alternative cyanine dyes produce practically 
identical results to CyDye, which allows sample multiplexing and accurate quantitation for 
differential proteome expression analysis. Hence these results will ultimately encourage a 
wide use of gel-based differential proteomic analysis by pre-labelling and 2D-PAGE with 
low cost. In addition, this study will enhance workflow efficiency by encouraging a training 
and experimental optimisation with cost-effective dyes allowing more experience. This 
chapter has been published in PROTEOMICS (226). 
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In chapter 4, the success of DIGE, in addition to technical skills, largely depends on the 
quality of the digital image captured after electrophoresis and software tools for image 
analysis. Various DIGE-compatible software packages have been established and widely 
used. Several literature papers have shown variations among those software programs, 
resulting in unreliable and inaccurate interpretation. No study has demonstrated which 
software tool is most suitable for DIGE image analysis in certain parameters. In this work, 
three commonly used software packages for DIGE analysis are used to analyse two set of gel 
images. The study includes quantitative tests as well as a general evaluation of the three 
software packages. The results show that generally all three software packages perform in a 
satisfactory manner, each with strengths and weaknesses. Based on matching accuracy, 
Progenesis SameSpots software performed best. This chapter has been published in Journal 
of Proteome Research (227). 
 
In chapter 5, applications of proteomics technology have been advanced to various biological 
and cellular investigations, including the emerging field of stem cell biology. In this work, 
the background of human embryonic stem cell and induced pluripotent stem cell generated by 
zinc finger nuclease technology are discussed. The iPSC technology is one of the biggest 
phenomena in the stem cell community and regenerative medicine. However, questions in 
stem cell biology are whether iPSC has the same properties as hESC exist and must be 
elucidated. This study will use gel-based proteomics to decipher how the iPSCs are different 
from hESCs in global protein expression levels. The results show that 22 protein spots from 
gel between two populations are differentially expressed more than two fold, being 20 down-
regulated and 2 up-regulated in iPSCs. Of those 22 spots, ATP dependent DNA helicase II 
(XRCC5) protein and heat shock 70kDa protein 9 protein (HSPA9) are identified by mass 
spectrometry and confirmed by q-PCR and western blot analysis, both being down-regulated 
in iPSC. Based on literature, these two proteins has not been reported or described in 
differential expression between iPSC and hESC. Their functions involve in the repair of DNA 
double-strand break and cell proliferation, respectively. Particularly, the XRCC5 protein, 
regulating the repair of DNA double-strand break, may be associated with tumour formation 
or cancer and worth for further investigation. This chapter is intended for publication in 
Journal of Cellular Biochemistry. 
 
In chapter 6, the results from the previous chapters are summarised and an outlook for further 
research and development is presented. 
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CHAPTER 2 
 
 
Multi-Pixel Detection Capillary Electrophoresis for Sample Quality 
Assessment prior to 2D Gel Electrophoresis 
 
 
 
Differential proteomics is an established field of importance in cell biology research 
and medical diagnosis. The traditional approach in proteomics work depends strongly 
on the quality of the two-dimensional gel electrophoresis (2-DE) separation. 
Reproducibility of 2-DE can be poor, in many cases because of the low quality of 
samples. Herein, a new approach to screen and quickly analyse the quality of samples 
before running 2-DE was developed to save valuable time and materials. Multi-pixel 
detection combined with capillary electrophoresis was used as a screening tool for 
analysing the quality of samples prior to 2-DE. The results showed high resolution 
and reproducibility, accurate molecular weight assignment, relative quantitation, and 
absolute quantification of known proteins. This work is an important step towards the 
standardisation of gel-based proteomics, providing a rapid and visual evaluation 
method for the quality assessment of 2-DE samples. Implementing this technique in 
the proteomics workflow will improve not only the reproducibility and high quality 2-
DE results, but also allow the relative quantification of proteins, which are then 
identified by 2D mass spectrometry.  
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2.1  Introduction 
 
 
2.1.1 Aims and Background 
 
Advances in proteomic method optimisation and technology development have catalysed the 
expansion of biological studies from single proteins to proteome-wide measurement. 2-DE 
remains the workhorse for proteomics research and is one of the most commonly used 
separation technique for complex protein samples. More than 5,000 distinct protein spots can 
be separated and visualised on one gel (179, 228). Furthermore, protein spots of interest can 
be easily selected and excised for proteolytic digestion and protein identification (229). 
Although 2-DE is a powerful tool given its versatile capacity, its limitations, such as 
solubility of membrane proteins, limited dynamic range, and poor reproducibility, are well 
known and still remain challenging, as previously stated in chapter 1. The Human Proteome 
Organization (HUPO) has set up the proteomics standards initiative (PSI) for the purpose of 
defining community standards for data representation in proteomics in order to facilitate data 
comparison, exchange and verification. Particularly for the 2-DE community, researchers go 
to great lengths to improve and develop reproducibility in 2-DE applications. Sample quality 
plays an important role in the reproducibility of 2-DE, in particular, non-completely-
denatured and salt-containing samples will drastically affect results. Herein an approach to 
resolve the problem of 2-DE reproducibility by using a method to rapidly verify the quality of 
2-DE samples was developed. This system uses the combination of capillary electrophoresis 
(CE) with multi-pixel detection system.  
 
2.1.2 Experimental Design 
 
Firstly, a solution and protocol which were suitable to characterize 2-DE samples in a multi-
pixel CE platform were developed and tested. The performances of the system were 
demonstrated in terms of resolution, reproducibility, sensitivity, mass assignment and 
quantification. Subsequently, the capability of this system to determine the quality of 2-DE 
samples was illustrated, showing rapid assessment of protein sample quality prior to gel 
separation. In addition, the quantitative capability of this system for 2-DE samples was 
demonstrated. As detailed in Figure 13, the high and low-quality protein samples for 2-DE 
were prepared. These samples were analysed by the proposed system, CE combined with 
multi-pixel detection, to obtain CE electropherograms. The results of electropherograms from 
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the high-quality sample should indicate good signals while those from the low-quality sample 
should signify poor signals from the system. These signals should correspond to the quality 
and reproducibility of 2-D gel results, providing the rapid tool for sample quality screening 
prior to 2-DE. 
 
       
 
 
Figure 13. A Conceptual Framework for Protein Sample Quality Assessment Prior to 2-DE. 
Capillary electrophoresis (CE) combined with multi-pixel detection could be used for protein 
sample quality assessment and quantitative validation complementary to two dimensional gel 
electrophoresis. Herein, the high and low-quality protein samples were prepared and used to 
obtain CE electropherograms. The signals indicated the quality of samples, corresponding to the 
quality and reproducibility of 2D gel results. In addition quantitative comparison was performed 
by matching similar molecular mass and fold change differences from both 2D-DIGE system and 
CE combined with multi-pixel detection.  
 
 
2.1.3 Capillary Electrophoresis for Protein Separation 
 
Capillary electrophoresis (CE) is an efficient separation method which is widely used in 
biochemical and pharmaceutical research. Its application in these fields stems from its speed, 
high sample throughput, ease of automation, high separation efficiency, high precision, low 
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sample volume. Principally, CE separates analytes from a complex mixture based on 
differential migration through a liquid-filled capillary column in a strong electric field. There 
are several types of CE analyses for protein studies such as capillary zone electrophoresis 
(CZE), capillary isoelectric focusing (CIEF), and sieving SDS capillary gel electrophoresis 
(SDS-CGE) (230). Typically in capillary electrophoresis, capillary tubes with internal 
diameters between 25-100 µm are used and high voltages are employed, allowing low sample 
volume use and shorter running times. Technically (231), the sample is injected into the 
capillary tube by using a pressure differential or applying a voltage across the capillary. The 
sample migration occurs when the capillary ends are placed in a buffer reservoir and an 
electrical field applied across it. The sample separates into its constituent components 
towards the outlet and detector, generating a signal. This signal then can be converted to a 
trace called an electropherogram. Peaks on electropherogram represent separated constituent 
components of a sample according to their mobility, a velocity of a charged particle under an 
applied electric field. Therefore, separated analyte components appear as peaks with different 
migration times in an electropherogram. 
 
Primarily, SDS-CGE is the mode of CE which has been employed in this study. It allows the 
separation of proteins coated with SDS based on their molecular mass. The SDS binds to the 
dissociated proteins in a constant ratio of 1.4 to 1 (g/g) of SDS to protein. This notion results 
in similar charge densities for the protein-SDS complexes (232-234). Under this condition, 
Takagi and Karim investigated migration of protein-SDS complexes in free solution 
electrophoresis (235). The results showed that each protein-SDS complexes migrate with the 
same mobility regardless of difference in molecular mass of each protein, making protein 
separation under free solution conditions unfeasible. Several types of polymer networks have 
been developed for treating capillary for molecular mass sieving of SDS-protein complexes 
(236, 237), allowing successful separation of SDS-protein complexes on the basis of 
molecular mass.  
 
2.1.4 Multi-Pixel Detection System  
 
Modes of protein detection in CE include conventional UV absorption, Laser-Induced 
Fluorescence (LIF) (238), and other methods such as chemiluminescence and amperometry 
(239). In addition, capillary electrophoresis can be directly coupled with mass spectrometers 
or surface enhanced Raman spectroscopy (SERS) to obtain the identity of analytes. Although 
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fluorescent and electrochemical detection methods have shown several advantages over UV 
absorbance detection system in terms of lower limits of detection and high resolution (240), 
UV absorbance remains the primary mode of detection in CE because of its wide 
applicability, easy handling, and minimal sample preparation. Nonetheless, a significant 
drawback for UV detection mode is poor limits of detection, typically in the range of mM to 
µM.  
 
Typically, detection limits in CE are assessed using the signal-to-noise (S/N) ratio. This S/N 
ratio is used as a measure of signal strength relative to background noise in an 
electropherogram. Several approaches have been established and demonstrated to increase 
the S/N ratio in UV detection mode, lowering limits of detection. To increase the path length 
of capillary window by creating the bubble cell or inserting additional tube will improve the 
sensitivity; however, this will decrease the resolution of the separation. Alternatively, 
sensitivity and limits of detection can be considerably improved by multiple measurements of 
an analyte following with signal averaging. Obviously, the simplest way to obtain multiple 
measurements of an analyte is to perform CE separation multiple times. Nevertheless, this CE 
repetitive run approach is impractical since the elution profile in a separated CE run is not 
sufficiently reproducible, prohibiting consistent multiple measurements, and the time 
required to repeat necessary number of runs is immense, hampering an efficient separation.   
 
In 1998, Culbertson and Jorgenson (241) demonstrated a system to improve the UV 
absorption detection limit by multiple measurements of an analyte with signal averaging in a 
single run. During one single run, multiple measurements could be achieved by using a single 
linear photodiode array detector, generating multiple detection points. The analyte signal 
from each detection point was then used for signal averaging to increase the S/N ratio. 
Theoretically, the maximal S/N enhancement of this method will vary according to the square 
root of the number of pixel detectors (241).  
 
In this chapter, a PEREGRINE CE system (deltaDOT, UK) used to perform CE experiments 
is described. The PEREGRINE CE instrument employs an automated single capillary system 
incorporating with a photodiode array detector. The light generator, filter wheel, separation 
phase and detector are linearly aligned on a common rail (Figure 14). UV light passes 
through a filter wheel allowing the selective detection wavelength.  As an analyte migrates 
along the capillary and passes the light beam, it adsorbs energy dependent on its spectral 
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properties, for example a λmax ~ 214 nm for peptide bond detection. The light beam is then 
focused on a photodiode array detector. As the analyte absorbs light energy, a reduction in 
signal occurs, representing a drop in signal from the baseline. Signals from the detector then 
can be transferred to computer analysis by proprietary software programs.  
 
Importantly, a photodiode array detector in PEREGRINE CE system comprises 512 pixel 
detectors configured linearly along the capillary. Each has a width of 25 µm and total 
produces a length of 1.28 cm. Each photodiode samples the signal at up to 30Hz, generating 
512 electropherograms for signal averaging, significantly improving the limit of detection for 
UV absorbance detection, theoretically 22 fold (225, 241).  
 
               
 
Figure 14. An Outer View and the Main Components of the PEREGRINE Capillary 
Electrophoresis Instrument. (Panel A) An outer view of the PEREGRINE instrument. (Panel B) 
Main components inside the main cover are demonstrated along with left hand side carousal. 
(Panel C) Top view of the main components is presented, comprising the lamp generator, filter 
wheel, capillary block and detector aligned to allow UV detection of analytes. 
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2.1.5 Data Processing Principles of PEREGRINE Capillary Electrophoresis   
 
Data obtained from the photodiode array detector in PEREGRINE system can be used to 
produce several data outputs. Special software program, named P3EVA, is used to perform 
computational analyses and generate traces from the signals. Generated forms of signals are 
presented in this study, including single pixel electropherograms, Generalised Separation 
Transform (GST) electropherograms, and Equiphase maps and signals.  
 
Basically, a single pixel electropherogram is the trace obtained from a single detector. The 
GST algorithm is the method to maximise S/N in such a way that the shape information of 
the analyte peak is retained. This GST-processed data allows all signals from array detection 
to be signal averaged and subsequently leads to a single complete signal averaged GST 
electropherogram. The equiphase algorithm is also used to achieve improved S/N by 
correlating information from multiple signals in a process called “vertexing”. This equiphase 
algorithm allows the reduction of noise and contaminant and to see the unlabelled molecules 
with more sensitivity and resolution. The output of equiphase-processed data can be 
illustrated in two patterns, being an electropherogram signal, so-called EVA signal, and an 
equiphase map. An equiphase map is a three dimensional view of the separation, where the 
axes are distance, time and absorbance. This equiphase map can be used to calculate the 
linear velocity of the analyte in the capillary.  
 
To be simply explained, forms of described data outputs from the analyses of the same 
analytes are provided in Figure 15, including single pixel electropherogram, GST-averaged 
data, and EVA signal. In addition, a schematic diagram of an eqiphase map is demonstrated 
in Figure 16, with the associated single pixel electropherogram which may be derived from 
any single pixel in the detector. 
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Figure 15. The Forms of Data Outputs of PEREGRINE Multi-pixel Detection Capillary 
Electrophoresis Instrument. (Panel A) Single pixel electropherogram. (Panel B) GST-averaged 
signal, an average of 512 single pixel electropherograms. (Panel C) EVA sigmal, improved S/N 
data output by correlating information from multiple signals in a process called vertexing. All 
data output was obtained from P3EVA software analysis. 
 
 
          
Figure 16. A Schematic of Equiphase (EVA) Map and Single Pixel Electropherogram and 
Enhanced Imaging due to the Vertexing Process. A protein relative molecular mass ladder 
consisting of seven components of Mr of 10000, 20000, 35000, 50000, 100000, 150000, and 
225000 was separated to illustratrate the enhanced imaging due to the vertexing process. The 
detector also measures the intensity of the signal. This is shown by the colour of the signal, 
changing from green through yellow to red at its most intense. (Reproduced from (225)) 
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In summary, a schematic workflow in using PEREGRINE instrument for CE with multi-pixel 
detection system is demonstrated in Figure 17. The figure recapitulates capillary 
electrophoresis steps incorporated with photodiode array. Then, signal from each detector 
will be used for data processing for the enhancement of S/N ratio. 
 
 
 
                         
 
 
Figure 17. A Schematic Workflow of the PEREGRINE Multi-Pixel Detection Capillary 
Electrophoresis Instrument. UV light passes through a filter wheel allowing the selective 
detection wavelength. As an analyte migrates along the capillary and passes the light beam, it 
adsorbs energy dependent on its spectral characteristics. The light beam is then focused on a 
photodiode array detector, generating 512 single pixel electropherograms. Signals from the 
detector then can be transferred for data analysis in GST and EVA forms of outputs, enhancing 
S/N ratio. 
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2.2     Materials and Methods 
 
 
2.2.1 Enhancement of S/N between Single Pixel and Multi-Pixel Data 
 
Protein molecular mass ladder, consisting of relative molecular mass (Mr) of 10000, 20000, 
35000, 50000, 100000, 150000, and 225000 was prepared. Sample was separated on a 22 cm 
effective length of capillary. Sample was loaded into the capillary through electrokinetic 
injection at 5kV (reverse polarity) for 20 s, and then separated under a field strength of ~450 
V/cm. 
 
2.2.2 Performance Assessment of the Multi-Pixel Detection CE System using 2-DE   
Protein Samples 
 
Standard 2-DE Sample Buffer Preparation                                   
 
Standard 2-DE sample buffer for protein samples was prepared and used unless otherwise 
stated. Briefly, 7 M urea (Bio-Rad, Hemel Haempstead, UK), 2 M thiourea (Sigma, 
Gillingham, UK), 4% w/v CHAPS (Calbiochem, Nottingham, UK) and 30 mM Tris (Sigma) 
was mixed and solubilised thoroughly. 
 
Optimised Operating Protocol for Multi-Pixel Detection CE System 
 
All protein samples (Sigma, unless otherwise stated) were prepared in standard 2-DE buffer 
for separation in the CE system. Prior to use the sample in CE system, optimised conditions 
was established for successful protein separation performance. 10 µL of the protein sample 
was added to 85 µL of CE sample buffer (SDS-MW Sample Buffer, Beckman Coulter, High 
Wycombe, UK) and 5 µL of β-mercaptoethanol (Sigma). This step needed to be gently 
performed to avoid making air bubbles. The samples were then gently mixed thoroughly and 
degassed in a vacuum chamber for 20 min. Separation was performed on the PEREGRINE 
CE platform (deltaDOT, London, UK) as previously mentioned in section 2.1.4. The machine 
was set up for the separation of protein using filter wheel setting to 214 nm. Samples were 
separated in a bare fused silica capillary of 50 µm internal diameter (Composite Metal 
Services, Charlestown, UK) with the total length and effective separation length of 34 and 22 
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cm, respectively. Prior to separation, the capillary was flushed with 0.1 M NaOH, 0.1 M HCl, 
and deionised water for 3 min each through pressure at 2.07 × 10
5
 Pa (30 p.s.i.) before every 
run. The CE run buffer (Bio-Rad) was flushed thoroughly through the capillary for 10 min 
through pressure at 4.14 × 10
5
 Pa (60 p.s.i.). After this step, a conductivity check was always 
performed to ensure that the capillary was filled completely and no air bubble was present. A 
linear voltage to current plot was generated with a successful conductivity check. Samples 
were loaded into the capillary through electrokinetic injection at 5kV (reverse polarity) for 25 
s, and then separated by applying a potential of 12-17 kV across the capillary for 25-35 min. 
Specific potential values and time duration of injection and separation for each experiment 
were provided in each test and in the results. 
 
Sensitivity and Repeatability Evaluation 
 
To test sensitivity performance of the system, α-lactalbumin in 2-DE sample buffer was used 
to prepare a stock of 2 mg/mL concentration. Twenty times dilution was performed to obtain 
a second stock of 100 µg/mL concentration. A dilution method was employed to produce a 
sample concentration of 10, 5, and 1 µg/mL. Three replicate runs were done at each 
concentration. To test repeatability performance of the system, a sample of ovalbumin protein 
in 2-DE sample buffer at 50 µg/mL concentration was used and twenty replicate runs were 
performed. Separation step in PEREGRINE CE was set a potential at 14 kV for 35 min for 
both sensitivity and repeatability performance tests. 
 
Resolution Evaluation 
 
A mixture of five proteins in 2-DE sample buffer was prepared and used: cytochrome c (12400 
Da) , α-lactalbumin (14200 Da), trypsin inhibitor (20100  Da), carbonic anhydrase (29000 Da), 
and ovalbumin (44300 Da), each at 100 µg/ml concentration. Separation step in PEREGRINE 
CE was set a potential at 12 kV for 35 min. 
 
Relative Molecular Mass Assignment Accuracy Evaluation 
 
A mixture of four proteins in 2-DE sample buffer was used to create a mass calibration. The 
proteins used were ovalbumin (44300 Da), albumin (67000 Da), phosphorylase b (97400 Da) 
and β-galactosidase (166000 Da), each at 125 µg/ml concentration. A protein sample of 
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glutamate dehydrogenase protein at 100 µg/ml concentration was used as an “unknown 
sample” to test the accuracy of the mass assignment. The separation step in PEREGRINE CE 
was set a potential at 17 kV for 35 min. 
 
Quantification Accuracy Evaluation 
 
Five samples of albumin in 2-DE sample buffer at concentrations of 100, 50, 25, 12.5, and 0 
µg/mL were used to create a concentration calibration curve. Five different concentrations of 
albumin were prepared and one sample was also selected randomly “blind” and analysed using 
the CE system for concentration determination. Separation step in PEREGRINE CE was set a 
potential at 14 kV for 35 min. To verify the accuracy of this blindly selected sample, 2D-Quant 
Kit (GE Healthcare, Buckinghamshire, UK) was used according to the instructed protocol. 
 
Relative Quantificaiton Validation Evaluation for 2-DE  
 
Two samples, “A” and “B”, containing different ratios of the proteins of ovalbumin and 
albumin were prepared in 2-DE sample buffer. Sample “A” consisted of 250 µg/mL ovalbumin 
and 50 µg/mL albumin. Sample “B” consisted of 50 µg/mL ovalbumin and 250 µg/mL 
albumin. Separation step in PEREGRINE CE was set a potential at 12 kV for 35 min. The 2-
DE system was also employed for sample “A” and “B” so that the relative quantification 
abilities of both systems could be compared. For the analytical 2-DE study for relative 
quantification, a fluorescent prelabeling 2-DE was utilised. 8 µL of sample “A” and “B” were 
used for 2-DE gel study. Therefore, Gel “A” consisted of 20 µg ovalbumin and 4 µg of 
albumin. Gel “B” consisted of 4 µg ovalbumin and 20 µg albumin. 
 
Protein Sample Labelling for 2-DE 
 
Protein samples were labeled with IC-OSu ethyl-Cy5 NHS ester cyanine (IC5) dye (NBS 
Biologicals, Cambridgeshire, UK) with a ratio of 50 µg of protein sample to 400 pmol of IC5 
dye. Briefly, the labelling mixture was incubated on ice in the dark for 30 min at pH 8.5 and 
the reaction was terminated by addition of 10 nmol of lysine for 15 min. Equal volumes of 
buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 2% v/v pH3-10 Pharmalyte (GE 
Healthcare), and 2% w/v DTT were added to each of the labelled protein samples. 
 
51 
 
2-DE and Image Acquisition and Analysis 
 
IPG strips (pH 3-11 nonlinear, 11cm, GE healthcare) were passively rehydrated overnight 
with buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 1% v/v pH3-10 Pharmalyte, and 
1% w/v DTT. Then, protein samples were subjected to IEF in IPGphor III machine (GE 
healthcare) using cup-loading technique. Protocol for each step of IEF is as follows: (i) 500 
V, 1 s, gradient; (ii) 500 V, 4 h, step and hold; (iii) 1000 V, 1 h, gradient; (iv) 1000 V, 1 h, 
step and hold; (v) 3500 v, 4 h, step and hold; (vi) 8000 V, 5 h, step and hold for a total of 64 
kVh. After the first dimension, IEF strip was removed from the manifold and equilibrated in 
5 ml of SDS equilibration buffer (50 mM Tris-HCl, 7M Urea, 2M thiourea, 30% v/v glycerol, 
2% w/v SDS, 20 mM DTT, and 0.01% w/v bromophenol blue dye) for 15 min, and 
subsequently alkylated with 4% w/v iodoacetamide instead of DTT for another 15 min. 
Subsequently, to perform the second dimensional electrophoresis, equilibrated strip was 
overlaid onto a precast Bis-Tris 4-12% polyacrylamide gel (11 cm, Bio-Rad, Hertfordshire, 
UK) and ran at 40 V initially for 15 min, then at 100 V until the bromophenol blue dye 
migrated to the bottom of the gel. Gel image acquisition was done immediately after the 
second dimension by using the Dyversity scanning system (Syngene, Cambride, UK) Gel was 
placed on a low-fluorescent glass plate and the thick edge was removed to enable LED side 
illumination. The selected exposure time combined with the lighting module for Cy5 was 
applied for optimised gel image production. Four replicate gel images were obtained and 
analysed by Progenesis SameSpots software package (Nonlinear Dynamics, UK). 
 
2.2.3 2-DE Sample Quality Assessment with Multi-Pixel Detection CE System 
 
Protein Sample Preparation 
 
Three different sample buffers were prepared to represent the satisfactory and poor 2-DE 
protein sample preparation. Three sample buffers used were standard 2-DE sample buffer, 
standard 2-DE sample buffer containing 50 mM NaCl, and standard 2-DE sample buffer 
without denaturants (urea and thiourea). A mixture of five proteins, including cytochrome c 
(12400 Da), α-latalbumin (14200 Da), carbonic anhydrase (29000 Da), ovalbumin (44300 
Da), and glutamate dehydrogenase (55000) was prepared in three different sample buffers. 
Three different qualities of samples, prepared in three different sample buffers, were used to 
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perform the quality assessment on the multi-pixel detection CE system complementary to the 
2D gel electrophoresis system. 
 
Cell Protein Lysate Preparation 
 
Human type II pneumocyte tumour cell line (A549) was obtained from ATCC number CCL-
183. F12K medium (Invitrogen, Paisley, UK) supplemented with 10% foetal bovine serum 
(PAA, Yeovil, UK) and 2 mM L-glutamine (Invitrogen) was used to culture A549 cell line. 
Cell culture was established in 75 cm
2 
T-flask (Orange, Scientific, Brainel’Alleud, Belgium) 
and maintained in a gas-jacket incubator equilibrated with 5% CO2 at 37°C during the 
required time of culture. To harvest the cells, A549 cells were then removed from the flask 
using a cell scraper (Orange Scientific). Cell pellets were solubilised in 2-DE sample buffer 
with complete protease inhibitor (Roche, Hertfordshire, UK). The samples were alternately 
vortexed and put on ice every 2 min until a clear solution was obtained. The samples were 
harvested by centrifugation for 30 min at 4°C at 14000×g. The supernatant were collected to 
perform further procedures.  Protein concentration was determined by using the 2D-Quant 
Kit (GE healthcare). The 2D Clean-Up Kit (GE heathcare) was also used to precipitate 
protein pellets, ensuring non-protein contaminant removal. After using Clean-Up Kit, protein 
pellets were then resolubilised with three different sample buffers and sample quality 
assessment was performed on the multi-pixel detection CE system complementary to the 2D 
gel electrophoresis system as described previously. 
 
Sample Labelling, 2-DE gel electrophoresis, and Image Acquisition and Analysis 
 
An analytical 2-DE gel study was performed to determine sample quality corresponding to 
the result from CE system. Protein samples from cell lysate were labeled with IC5 as 
previously described in section 2.2.2. 2-DE and image acquisition were also performed 
according to the protocol stated in section 2.2.2. 
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2.3 Results and Discussion 
 
 
 
2.3.1 Enhancement of S/N between Single Pixel and Multi-Pixel Data  
 
The improvement of S/N between single pixel and multi-pixel data was obtained and shown 
in Figure 18 and summarised in Table 3. In Figure 18, single pixel results were obtained from 
the 256th pixel at the centre of the detector. GST-averaged signal data output was obtained 
from software analysis to enhance S/N ratio. From Table 2, comparatively, an enhancement 
of between 10 and 21 times S/N was observed for the multi-pixel GST- processed data. 
 
 
              
 
Figure 18. Enhancement of S/N between Single Pixel and Multi-Pixel Data. Single pixel and 
GST-processed data for protein molecular mass ladder were shown where peaks 1 – 7 represented 
relative molecular masses of 10,000, 20,000, 35,000, 50,000, 100,000, 150,000 and 225,000 
respectively. Sample was separated on a 22 cm effective length capillary of 50 μm i.d. Sample 
was injected at 5 kV for 20 s and separated under field strength of ~450 V/cm. The enhancements 
in signal to noise were clearly illustrated. (Reproduced from (225))  
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Table 3. List of the Improvement in Signal to Noise between Each Relative Molecular Mass. 
S/N values for single pixel and GST-processed data for protein molecular ladder of Figure 18. 
 
 
          M r     10000        20000        35000        50000       100000     150000      225000 
S/N for  
single pixel 
      74           42           22           24           10            3            4  
 
S/N for GST-
processed data 
    1296        795         446         486         154          35          41  
 
 
 
2.3.2 Performance Assessment of the Multi-Pixel Detection CE System using 2-DE   
Protein Samples 
 
 
Sensitivity and Repeatability Evaluation 
 
Sensitivity test was evaluated by running α-lactalbumin protein in 2-DE sample buffer. α-
lactalbumin was prepared at concentrations of 10, 2, and 1 µg/mL. Separation step in 
PEREGRINE CE was set a potential at 14 kV for 35 min. Figure 19 showed an overlay GST-
processed data for 10, 2, and 1 µg/mL α-lactalbumin.  
 
 
 
                          
   
 
 
Figure 19. An Overlay of GST-processed Data for 10, 2, and 1 
µg/mL α-lactalbumin. Separation step in PEREGRINE CE was set 
a potential at 14 kV for 35 min and filter was used at 214 nm. 
(Reproduced from (225)) 
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The relationship between peak height or peak area and protein concentration for unlabelled 
proteins depended on the amino acid sequence of the protein. The filter was selected at 214 
nm where the peptide bond was the main absorbing moiety, thus absorbance was a function 
of protein composition. The observed limit of detection (LOD) from Figure 19 was 1 µg/mL 
for α-lactalbumin with an S/N of 5. Good linearity was also observed over the concentration 
range, R
2
 values being above 0.997.  
 
For repeatability test, ovalbumin protein was prepared in 2-DE sample buffer at 50 µg/mL 
concentration. Separation step in PEREGRINE CE was set a potential at 14 kV for 35 min. The 
respective peak times, proportional to protein relative molecular mass, and peak areas, 
proportional to protein concentration, were recorded for 20 replicate injections. High 
repeatability was observed in terms of peak time and peak area with RSD values less than 2% 
in both parameters. 
 
 
 
Resolution Evaluation 
 
Resolution efficiency of separations was performed using a mixture of protein ladder 
consisting of five proteins of cytochrome c (Mr 12400), α-latalbumin (Mr 14200), trypsin 
inhibitor (Mr 20100), carbonic anhydrase (Mr 29000), and ovalbumin (Mr 44300) (Figure 20). 
Separation step in PEREGRINE CE was set a potential at 12 kV for 35 min. The separation 
by relative molecular mass was demonstrated to have a resolution of at least 1800.  
 
 
                    
   
 
 
 
Figure 20. An EVA Signal of Resolution Evaluation. Five proteins of 
cytochrome c (Mr 12400), α-latalbumin (Mr 14200), trypsin inhibitor (Mr 
20100), carbonic anhydrase (Mr 29000), and ovalbumin (Mr 44300) were 
separated under optimised conditions for resolution performance test. 
(Reproduced from (225)) 
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Results were also observed to have wider base of the peaks when relative molecular mass 
was higher. When a wide range of relative molecular masses needed to be covered, it was 
useful to select the optimal running conditions over a narrower range of relative molecular 
masses in multiple separate runs. In addition, resolution could be improved by adapting 
separation matrices to attain a range of more appropriate pore sizes. 
 
 
 
Relative Molecular Mass Assignment Accuracy Evaluation 
 
A mixture of four proteins in 2-DE sample buffer was used to generate a mass calibration. The 
proteins used were ovalbumin (Mr 44300), albumin (Mr 67000), phosphorylase b (Mr 97400) 
and β-galactosidase (Mr 166000). The mobility value of each protein was used to create a mass 
calibration curve. A protein sample of glutamate dehydrogenase protein was used as an 
“unknown sample” to test the accuracy of the mass assignment. Separation step in 
PEREGRINE CE was set a potential at 17 kV for 35 min. 
 
 
 
  
 
 
Figure 21. An Evaluation of 
Relative Molecular Mass 
Assignment Accuracy. (Top) 
GST-processed data overlay 
of four known proteins in 
black and an “unknown 
sample” in red. (Bottom) The 
mass calibration curve 
generated using the four 
known proteins in black dots 
and an “unknown sample” 
mass assignment in red dots. 
(Reproduced from (225)) 
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Figure 21represented GST-processed data for four peaks of known separated proteins in 
black colour. An “unknown sample” was run in separate experiment and was overlay in red 
colour. Mobility of each protein from the four known proteins was used for mass calibration 
curve generation. The results of “unknown sample” showed two peaks whose relative 
molecular mass was estimated at 54800 and 66300 using the generated mass calibration 
curve. The 55000 peak corresponded to the “unknown sample” protein which was glutamate 
dehydrogenase. Another peak at 66300 was also identified corresponding to the relative 
molecular mass of bovine serum albumin, which was used as a stabilising protein for the 
glutamate dehydrogenase sample. 
 
 
Quantification Accuracy Evaluation 
 
Absolute quantification accuracy was tested under optimised conditions. Ovalbumin protein 
in 2-DE sample buffer at five different concentrations of 100, 50, 25, 12.5, and 0 µg/mL was 
used to create a concentration calibration curve. Separation step in PEREGRINE CE was set 
a potential at 14 kV for 35 min. The concentration curve was used to determine a 
concentration of “blind” ovalbumin sample (notional concentration of 50 µg/mL). 2D-Quant 
Kit for protein concentration determination was also performed to verify the accuracy. 
 
 
     
Figure 22. An Evaluation of 
Quantification Accuracy.  
(Top) GST-processed data overlay 
of known concentration of 
ovalbumin protein, including 100, 
50, 25, and 12.5 µg/mL in black, 
red, green and blue, respectively. 
(Bottom) The concentration 
calibration curve generated using 
the known proteins was used to 
perform quantification evaluation 
of “blind” ovalbumin sample. 
(Reproduced from (225)) 
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Figure 22 showed GST-processed data of known concentrations of ovalbumin protein in 
different colours. Black, red, green, and blue electropherograms represented concentrations of 
100, 50, 25, and 12.5 µg/mL, respectively. As peak area was in proportion to protein 
concentration, it allowed the concentration calibration curve could be generated from the 
known concentration proteins. The “blind” concentration ovalbumin sample was quantified 
using the calibration curve. The estimated protein concentration of the “blind” ovalbumin 
sample was 49.3 ± 2.3 µg/mL. In addition, another method, 2D-Quant Kit, to verify the 
concentration of “blind” sample was applied and the results were obtained at 48.7 ± 2.0 
µg/mL High accuracy of protein quantification was achieved in this muti-pixel detection CE 
system. 
 
 
Relative Quantificaiton Validation Evaluation for 2-DE  
 
Relative quantification accuracy is another important performance parameter for the 
characterisation of 2-DE samples. To test the performance for relative quantification of 
proteins using this muti-pixel detection CE system, two different samples were prepared in 2-
DE sample buffer, sample A and sample B. Sample A consisted of 250 µg/mL ovalbumin and 
50 µg/mL albumin. Sample B consisted of 50 µg/mL ovalbumin and 250 µg/mL albumin. 
Separation step in PEREGRINE CE was set a potential at 12 kV for 35 min. The 2-DE system 
was also employed for sample A and B so that the relative quantification abilities of both 
systems could be compared. For the analytical 2-DE study for relative quantification, a 
fluorescent prelabeling 2-DE was utilised. 8 µL of sample A and B were used for 2-DE gel 
study. Therefore, Gel A consisted of 20 µg ovalbumin and 4 µg of albumin. Gel B consisted of 
4 µg ovalbumin and 20 µg albumin. Theoretically, 5-fold differences of ovalbumin and 
albumin in both sample A and sample B, and gel A and gel B should be observed. Results in 
Figure 23 demonstrated an electropherogram mirror plot of sample A and sample B in red and 
blue, respectively. The relative differences of ovalbumin and albumin were calculated and 
obtained at 4.8-fold and 5.1-fold, respectively. Results of 2-DE comparison between Gel A and 
Gel B were also obtained. A fluorescent prelabeling 2-DE comparison showed that the 
differences of ovalbumin and albumin were 4.8-fold and 4.7-fold, respectively. Therefore, a 
good agreement between results from multi-pixel detection CE platform and 2-DE system was 
observed. The high accuracy of relative quantification of such CE system could provide an 
alternative method for 2-DE results validation for the comparative analysis. 
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Figure 23. An Evaluation of Relative Quantification Capability. (Left) GST-processed mirror 
data of fivefold mixture of ovalbumin and albumin of sample A and sample B in red and blue, 
respectively. (Right) A fluorescent prelabelling 2-DE separation of fivefold mixture of ovalbumin 
and albumin in gel A and gel B. CE peak area gave an accurate relative quantification 
corresponding to the 2-D image analysis software. (Reproduced from (225)) 
 
 
 
2.3.3 2-DE Sample Quality Assessment with Multi-Pixel Detection CE System 
 
Two most common factors, which cause poor resolution and reproducibility in 2-D gels, are 
the amount of salt in the sample and the extent of denaturation of proteins. CE separation was 
also adversely affected by salt concentration  and nondenatured proteins (242). Three 
different sample buffers were prepared to represent the satisfactory and poor 2-DE protein 
sample preparation. Three sample buffers used were standard 2-DE sample buffer, standard 
2-DE sample buffer containing 50 mM NaCl, and standard 2-DE sample buffer without 
denaturants (urea and thiourea). 
 
Proof-of-Concept for Sample Quality Analysis using Five Standard Proteins 
 
 
A mixture of five proteins, including cytochrome c (Mr 12400), α-latalbumin (Mr 14200), 
carbonic anhydrase (Mr 29000), ovalbumin (Mr 44300), and glutamate dehydrogenase (Mr 
55000) was prepared in three different sample buffers as described above. Figure 24 showed 
the GST-processed electropherograms of each sample under three different conditions 
combined with the corresponding 2-DE gel results from each sample. 
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Figure 24. Proof of Concept for Sample Quality Assessment using Five Standard Proteins. 
The image illustrated the GST processed data on the left and the 2-DE results on the right. The 
top panel: separation under standard buffer conditions, middle panel: sample buffers contained an 
additional 50 mM NaCl and the bottom panel: sample buffer without denaturants. The 2-DE gels 
were stained with Coomassie blue. In standard panel, electropherograms showed six peaks of 
proteins: 1 cytochrome c (12,400), 2 α-lactalbumin (14,200), 3 carbonic anhydrase (29,000), 4 
ovalbumin (44,300) and 5 glutamate dehydrogenase (55,000), including one extra protein, 
albumin, 6, which was a stabiliser for glutamate dehydrogenase according to product information 
sheet. Gel result from standard panel also showed clearly separated proteins with good resolution 
and no streaking. (Reproduced from (225)) 
 
 
The electropherogram of protein mixtures in standard 2-DE sample buffer showed six peaks 
with good resolution and reproducibility (Top panel in Figure 24). Six peaks comprised 
cytochrome c (Mr 12,400), α-lactalbumin (Mr 14,200), carbonic anhydrase (Mr 29,000), 
ovalbumin (Mr 44,300) and glutamate dehydrogenase (Mr 55,000), including one extra 
protein, albumin, which was a stabiliser for glutamate dehydrogenase according to product 
information sheet. In the presence of 50 mM salt, all six peaks were observed with a drop in 
signal intensity due to preferential injection of highly charged salt ions. Signal intensity 
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decreased when salt content of the sample increased and the current during the separation was 
unstable with high salt-contained sample. An explanation for this event was that when 
samples were loaded in SDS-CGE mode, typically by electrokinetic injections, the smaller 
charged salt ions competed with proteins during the introduction process. The 
disproportionate level of salt in the sample and separation matrices resulted in unstable 
current or current stoppage and Joule heating. Taken together, this caused inefficient and 
broad electropherogram peaks with irregular baselines. Furthermore, the mixture of five 
proteins was also analysed in the absence of denaturing reagents. The absence of denaturing 
reagents also caused a drop in signal intensity in electropherogram as well as a loss in 
resolution as illustrated in the bottom panel of Figure 24. All expected peaks were observed 
but with a loss of resolution and a drop in intensity. Current instability was not noticed during 
the separation, indicating that SDS in the sample buffer might be sufficient to help 
denaturing, but not completely, the protein.  
 
Following the sample quality screening by multi-pixel detection CE system, each of the 
samples was used to perform 2-DE gel studies. 2-DE gel images were obtained by Coomassie 
blue staining as shown in Figure 24 (Right panels). Gel image obtained from standard sample 
preparation (Top, Right panel) showed clearly separated proteins on the gel with good 
resolution and no streaking, corresponding to a good quality of sample when screening by 
multi-pixel detection CE system. Gel images obtained from samples in the presence of salt 
and in the absence of denaturants (Middle and Bottom, Right panels) showed vague 
separation with a loss of resolution in some proteins, as expected to the bad qualities of 
samples from electropherograms. In total, a poorly resolved CE run could predict poorly 
resolved 2-DE of the same sample. 
 
 
Sample Quality Analysis using Whole Cell Lysates 
 
 
Whole cell lysate was prepared from A549 lung cancer cells to be a representative of 
complex protein mixtures for mammalian cells. Protein pellets from A549 whole cell lysates 
were resolubilised with three different sample buffers, including  standard 2-DE sample 
buffer, standard 2-DE sample buffer containing 50 mM NaCl, and standard 2-DE sample 
buffer without denaturants as previously stated.   Sample quality assessment was performed 
on the multi-pixel detection CE system complementary to the 2D gel electrophoresis system.  
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Figure 25. Sample Quality Assessment using Whole Cell Lysates. Quality analysis of A549 
whole cell lysates was performed. The image illustrated the GST-processed data on the left and 
the 2-DE results on the right. The top panel: separation under standard conditions, middle panel: 
sample buffers contained an additional 50 mM NaCl and the bottom panel: sample buffer without 
denaturants. (Reproduced from (225)) 
 
 
(Figure 25) In standard sample buffer, GST-processed electropherogram showed multiple 
peaks of complex proteins with high signal intensity. Good resolution and reproducibility was 
also obtained when performing 2-DE with the same sample (Top panel). In the presence of 
salt in the sample (Middle panel), results were observed with a drop in signal intensity and a 
loss in resolution from both the electropherograms and 2-DE experiments, similar to the 
results from the previous section. This was further proved that salty samples produced low 
quality results both by the CE and 2-DE systems. (Bottom panel) In the absence of denaturing 
reagents, electropherogram showed only a few peaks of whole lysate complex proteins, with 
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the expected loss of signal intensity and resolution. The current instability was observed in 
most runs of the sample without denaturants, resulting in experimental stoppage. This current 
instability may be due to blockage of the gel by nondenatured proteins and protein 
aggregates. In addition, 2-DE images were poorly resolved as expected from the screening 
result with CE. 
 
In summary, the suitabiltity of sample for 2-D gel electrophoresis could be presented by the 
multi-pixel detection CE system as represented in Figures 24 and 25. This approach could be 
a rapid tool to predict the suitability and quality of the 2-DE samples, which is a significant 
step towards the standardisation of gel-based proteomics, enabling complementary use of this 
multi-pixel detection CE platform approach with established and canonical 2-DE techniques. 
. 
 
2.4     Conclusion 
 
Gel-based proteomics has been widely used for the scope of various applications ranging 
from molecular cell biology understanding, signaling pathway and mechanism determination, 
and biomarker and drug discovery. Capillary electrophoresis (CE) and 2D gel electrophoresis 
(2-DE) are two typical methods used for the efficient separation and analysis of complex 
protein mixtures. The strengths of each technique complement the other; however, both 
methods place high demands on sample quality.  
 
Herein, the multi-pixel detection CE platform was presented and analysed. This study 
described the performance of a multi-pixel detection system built into a CE platform using 
protein samples prepared for 2-DE. The results showed a detection of sensitivity 1 µg/ml, a 
mass resolution of at least Mr of 1800 and high reproducibility (RSD ≤2%). The system also 
allowed accurate molecular weight assignment and importantly absolute and relative 
quantification of proteins.  
 
Importantly, a rapid screening of 2-DE sample quality by this system was performed and 
achieved with good agreement of results wtih the 2-DE gel studies. The use of this method 
will provide the ability to rapidly screen the quality of samples before running 2-DE. This CE 
platform will also support other high-throughput proteomic technologies, standardising 
protein quality assessment across different methods. This technique proved to be a 
satisfactory method for the quality assessment of 2-DE samples, and also saving time, 
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lowering the consumable costs, and saving precious samples. Implementation of this 
technique in the proteomics workflow will not only improve the success rate of 2-DE results, 
but will also allow relative molecular mass assignment and relative quantification. This 
method can be further developed for CE-MS-based platform and for other separations such as 
peptides and monitoring of post-translational modifications using other modes of CE. 
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CHAPTER 3 
 
 
An Alternative Cost-Effective Cyanine Dyes for Gel-based Differential 
Proteome Expression Analysis 
 
 
Comparative proteomics is widely used to analyse differential expression at the 
protein level due to disease, or treatment of cells with various stimuli. While the 
labelling or label-free comparative quantitation using a direct LC and MS/MS 
approach has been introduced, 2-D gel electrophoresis in conjunction with 
multiplexed fluorescence pre-labelling retains its merit and is the method of choice for 
protein separation and quantitation on account of its high resolution and parallel 
processing. Differential In-gel electrophoresis (DIGE) offers improved reproducibility 
and confidence in spot matching and quantitation compared to traditional 
approaches. However, this comes at a high price, i.e. fluorescent cyanine dyes are 
exceptionally costly, and it is expensive to use this approach routinely, not to mention 
the costs of training and testing required prior to undertaking the “real” experiment.  
This has limited the wider use of this technique. In this study, the use of a set of 
cyanine dyes, which have similar chemical properties and a price much lower than the 
DIGE CyDyes, was investigated for comparative quantitation capability.   
Importantly, through multiple sample analyses these dyes were demonstrated to 
produce practically identical results to DIGE CyDyes, which allow sample 
multiplexing and accurate quantitation for differential proteome expression analysis. 
This alternative set of cyanine dyes provides useful approach for staff training, 
optimisation of experimental methods, and for preliminary results. In time, allowing 
more access to staff training and proof-of-principles studies will encourage the use of 
DIGE approach and enhance technique development. 
 
 
 
 
 
66 
 
3.1  Introduction 
 
 
3.1.1 Aims and Background 
 
The comprehensive analysis of complex biological system has demanded the establishment 
of new technologies to study the cell proteome. The comparison of distinct proteomes is of 
paramount importance, for example, between normal and diseased cells or diseased and 
treated cells. The advent of 2D differential in-gel electrophoresis (DIGE) (90), using 
fluorescent dyes for pre-labelling of proteins, has overcome various limitations of traditional 
2-DE, including low reproducibility, low sensitivity of detection, low linear range of 
visualisation procedures, and inaccurate quantitative analysis. DIGE technology allows 
multiplexing distinct protein mixtures to be separated on one single gel and also enables 
differences between the abundance levels of proteins to be compared. Nonetheless, the cost 
of fluorescent dyes using in DIGE is high, approximately £1,610 for running up to 12 gels in 
standard experiment. Furthermore, this price also excludes the cost of technique training and 
adjusted protocol for optimal conditions. Several other pre-electrophoresis-labelling and 
multiplexing strategies have been described, such as using Alexa Fluor (243) and BODIPY 
dyes (244), yet the use of DIGE CyDyes is well established and familiar.  
 
In this study, two cyanine mono-functional NHS ester dyes were used whose structures are 
very similar to the DIGE CyDyes, Cy3 and Cy5. These cyanine dyes were named IC3 and 
IC5 and are available for antibody labelling. The only slight difference between these IC dyes 
and CyDyes is the aliphatic chain at the R group, being ethyl- for both dyes as a replacement 
for propyl- or methyl- in Cy3 or Cy5 dyes. (Figure 26) Therefore all chemical properties 
should remain nearly equivalent, such as molar extinction coefficients, quantum yields, and 
fluorescent spectra. Even with theoretically similar identity between these two sets of dyes, 
IC3 and IC5 were investigated to see their performance in sample multiplexing and accurate 
quantitation for difference in-gel electrophoresis minimal labelling technique. Hence the 
ultimate aims of this study are to encourage a wide use of gel-based differential proteomics, 
and to highlight that the use of these cost-effective cyanine dyes in training and protocol 
optimisation to encourage an extensive use of pre-labelling and 2D-PAGE and enhance 
understanding of biological complexes. 
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Figure 26. Chemical Structures of IC3, IC5, Cy3, and Cy5 Dyes. (Left) Structural properties 
of IC3 and IC5 were presented. The aliphatic chains at the R group of IC3 and IC5 were 
ethyl- for both dyes. (Right) Structural properties of Cy3 and Cy5 were presented. The 
aliphatic chains at the R group of Cy3 and Cy5 were propyl- and methyl-, respectively. Only 
slight structural differences between these two sets of dyes were observed. Quantitative 
ability for differential proteome expression of IC3 and IC5 dyes required experimental data to 
support equivalent results compared to Cy3 and Cy5 dyes.  
 
 
3.1.2 DIGE Technology 
 
The primary prerequisite for DIGE technology is that the pre-labelling fluorescent dyes must 
not perturb the relative electrophoretic mobility of protein. This was accomplished by the 
establishment of dyes which are satisfied the following criteria: (i) The dyes must match the 
charge of protein residues that they modified, ensuring that the pI of the protein does not 
significantly alter. (ii) The dyes must be migration matched, thus the same labelled-protein 
samples with any of the dyes will migrate towards the same position on the gel. (iii) The dyes 
must have different excitation and emission wavelengths. The cyanine dyes (Cy2, Cy3 and 
Cy5) used for DIGE experiment are all charge-matched and molecular mass-matched to 
prevent alteration of isoelectric point, and minimise dye-induced shifting of labelled proteins 
during electrophoresis. These dyes are all satisfied these criteria (245).  
 
DIGE CyDye minimal dyes are N-hydroxy succinimidyl ester derivatives and undergo 
nucleophilic substitution reactions with lysine epsilon amine groups to form an amide. The 
68 
 
dyes carry a +1 charge in which when coupled to the lysine residue, it replaces the lysine’s 
+1 charge with its own charge, ensuring no change in protein electronegativity. For the 
molecular mass shift, each dye evenly adds estimated 450 Da to the labelled protein so that 
the molecular mass shift does not pose a problem where all the protein is labelled to the same 
extent. However, due to the hydrophobicity of the dyes, labelling process could cause 
perturbation in the solubility of the proteins. Moreover, 1-2% of all the lysine residues in the 
whole protein extract are found to be optimal, minimal labelling process for CyDyes occurs 
where each labelled protein carries only one dye molecule and is visualised as a single 
protein spot. (188) 
 
CyDye fluor minimal dyes provide good sensitivity, as low as 250 pg of protein can be 
detected, and offer a linear response to protein concentration up to four orders of magnitude 
(181). The dyes also possess narrowly distinctive excitation and emission fluorescence 
spectra suitable for multi-colour discrimination (188). (Figure 27) The properties of the 
CyDye fluor minimal dyes make them ideal for multiplexing different protein samples within 
the same 2D gel. 
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Figure 27. A Representation of Excitation and Emission Spectra of Each CyDye Dye. Black 
and blue curves represent excitation and emission spectra for each of the dyes, respectively. The 
numbers at the top of each curve indicate the maximal values. Purple, green, and red lines show 
excitation wavelengths of Cy2, Cy3, and Cy5, orderly. Shaded yellow, red, and blue colours  
illustrate emission filters of Cy2, Cy3, and Cy5, correspondingly. (Taken from (188)) 
 
 
 
Another important advantage of DIGE technology includes the use of “internal standard” 
created by pooling equal amounts of protein from each biological sample in the experiment 
and labelling it with one of the CyDye fluor minimal dyes, indicating that every protein from 
all samples will be represented in the internal standard. The internal standard is run on every 
single gel along with each individual labelled sample. This pooled internal standard is used to 
normalise protein abundance measurements across multiple gel experiments. Variations in 
spot intensities due to experimental variation, for example protein loss during sample entry 
into the strip or fluorophor loss during gel image acquisition procedures, will be the same for 
each sample within one single gel. The inclusion of an internal standard within each gel limits 
experimental variation and ensures accurate intra- and inter-gel matching (191, 193).  
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In Figure 28 (246), the details of how pooled internal standard enhances an accuracy of 
quantitation across experimental gels are presented. 
 
 
           
 
 
Figure 28. An Illustration of the Benefits of an Internal Standard in Comparative 
Quantitation between Samples. Sample 1 and 3 are labelled with Cy3 while sample 2 and 4 are 
labelled with Cy5. The right panel shows the different results achieved of the volumes of the 
protein spots without and with an internal standard. (Taken from (246)) 
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Two general approaches for DIGE system with using pooled internal standard have been 
described, being two-dye labelling (245) and three-dye labelling (191) technique, and applied 
in a wide range of biological areas. Examples of experimental designs for two-dye and three-
dye labelling of protein samples are presented in Figure 29 (188). Basically, in two-dye 
labelling system, pooled internal standard is labelled with either Cy3 or Cy5 dye. The other 
dye is used for labelling both control and treated protein samples. Then, the labelled pooled 
standard sample is mixed with either labelled control or labelled treated sample before 
together being separated on one 2-D gel. On the other hand, in three-dye labelling system, 
pooled internal standard is labelled with Cy2 dye. Control and treated samples are 
reciprocally labelled with Cy3 and Cy5 dyes. Then, the labelled pooled standard sample is 
mixed with both labelled and treated samples for further separation on one single gel. 
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Figure 29. A Design of Experiment for Two-Dye and Three-Dye Labelling System. By having pooled internal standard samples being labelled 
with one Cy dye, multiplexing of gel separation can be achieved by either two-dye (Left) or three-dye labelling (Right) approach. (Adapted from 
(188))
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3.1.3 Experimental Design 
 
To derive statistical and meaningful data on capability of IC3 and IC5 in multiplexing and 
accurate quantitation for difference in-gel electrophoresis minimal labelling technique, the 
following experimental design was applied (Figure 30). Three cell lines were used in this 
study, including murine white blood cells, Neisseria meningitides cells, and human fibroblast 
cells. Equal amount of lysate proteins from each cell line was labelled with either DIGE Cy3, 
DIGE Cy5, IC3, or IC5. Samples labelled with DIGE Cy3 and DIGE Cy5, or IC3 and IC5 
were mixed prior to simultaneous running on the same 2D gel. Gel images of samples 
labelled with either (i) DIGE Cy3 and DIGE Cy5, or (ii) IC3 and IC5 in a single gel were 
analysed using two software packages to determine comparable competence of these 
alternative cyanine dyes. When 2-fold and 5-fold changes in volume ratios (increased or 
decreased) were specified, % similarity was calculated in two sets of dyes individually. With 
equal amount of similarly labelled proteins applied to the single gel, intensity differences in 
spots indicate variation in spot migration or shape arising from the dyes used in this 
experiment. Triplicate or quadruplet gels were done for each cell line sample with each set of 
dyes as described below.  
 
 
        
 
 
 
Figure 30. A Design of Experiment. 
 
(Top) Samples were labeled with 
DIGE Cy3 and Cy5 and were mixed 
and run on the same gel. Software 
packages for quantitative analysis 
were used to determine percentages of 
spot similarity between two images 
from the same gel. (Bottom) Samples 
were labeled with IC3 and IC5 and 
were mixed and run on the same gel. 
Software packages for quantitative 
analysis were used to determine 
percentages of spot similarity between 
two images from the same gel. 
Finally, comparable competence of 
these alternative IC dyes was 
examined and described. 
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Neisseria meningitides cells 
Gel number 1 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 2 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 3 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 4 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 5 50 µg labelled with IC3 + 50 µg labelled with IC5 
Gel number 6 50 µg labelled with IC3 + 50 µg labelled with IC5 
Gel number 7 50 µg labelled with IC3 + 50 µg labelled with IC5 
Gel number 8 50 µg labelled with IC3 + 50 µg labelled with IC5 
 
Murine white blood cells 
Gel number 1 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 2 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 3 50 µg labelled with DIGE Cy3 + 50 µg labelled with DIGE Cy5 
Gel number 4 50 µg labelled with IC3 + 50 µg labelled with IC5 
Gel number 5 50 µg labelled with IC3 + 50 µg labelled with IC5 
Gel number 6 50 µg labelled with IC3 + 50 µg labelled with IC5 
Gel number 7 50 µg labelled with IC3 + 50 µg labelled with IC5 
 
Human Fibroblast Cells 
Gel number 1 10 µg labelled with DIGE Cy3 + 10 µg labelled with DIGE Cy5 
Gel number 2 10 µg labelled with DIGE Cy3 + 10 µg labelled with DIGE Cy5 
Gel number 3 10 µg labelled with DIGE Cy3 + 10 µg labelled with DIGE Cy5 
Gel number 4 10 µg labelled with IC3 + 10 µg labelled with IC5 
Gel number 5 10 µg labelled with IC3 + 10 µg labelled with IC5 
Gel number 6 10 µg labelled with IC3 + 10 µg labelled with IC5 
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3.2 Materials and Methods 
 
 
3.2.1 Sample Preparation 
 
Human fibroblast cell line (HFF-1) was obtained from ATCC number SCRC-1041. 
Dulbecco’s modified eagle’s medium (DMEM) (Gibco) supplemented with 10% foetal 
bovine serum and 1% penicillin/streptomycin (Gibco) was used to culture human fibroblast 
cell line. Cell culture was established in 175 cm
2 
T-flask (NUNC) and maintained in a gas-
jacket incubator equilibrated with 5% CO2 at 37°C during the required time of culture. To 
harvest the cells, HFF-1 cells were treated with 5 ml per 175 cm
2 
T-flask of 0.25% trypsin 
ethylenediaminetetraacetic acid (EDTA) in phosphate buffered saline (PBS) and maintained 
in a gas-jacket incubator equilibrated with 5% CO2 at 37°C for 5 min. Afterwards trypsin was 
neutralised with 10 ml (double amount of trypsin) of DMEM supplemented medium, then 
centrifuged to gain the cell pellet at 1400×g for 5 min. The supernatant was discarded and the 
pellet was washed twice with PBS. Murine white blood cells (three week-old CD-1(BR)) and 
Neisseria meningitides (serogroup B) MC-58 ΔsiaD mutant cells were obtained from 
National Institute for Biological Standard and Control (NIBSC). 
 
Cell pellets of three cell lines were suspended in lysis buffer containing 30 mM Tris, 7 M 
urea, 2 M thiourea, and 4% CHAPS at pH 8.5. The samples were alternately vortexed and put 
on ice every 2 min until a clear solution was obtained. The samples were harvested by 
centrifugation for 20 min at 4°C at 12000×g. The supernatant were collected to perform 
further analysis. 
 
3.2.2 Protein Concentration Determination 
 
Total protein concentration was determined by using detergent-compatible Bradford assay 
(Bio-Rad, Cat No. 500-0006). Triplicates were done for the standard curve and lysate 
samples. Standard curve and lysate samples were prepared according to the following 
protocol, then 1 mL of diluted Bio-Rad protein assay dye reagent (1:5 in water) was added. 
250 µL of each sample was taken and loaded onto 96 well plate. Plate was covered and 
incubated at room temperature for 15 min and then read on the microplate reader at a 
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wavelength of 570 nm. Protein concentration in each sample was quantified against the BSA 
standard curve.  
 
Mass BSA (µg) 
 
Vol. BSA stock 
(1 mg/mL) (µL) 
Lysis buffer 
(µL) 
0.1M HCl 
(µL) 
Water 
(µL) 
0 0 50 10 40 
2 2 48 10 40 
4 4 46 10 40 
8 8 42 10 40 
12 12 38 10 40 
16 16 34 10 40 
20 20 30 10 40 
25 25 25 10 40 
30 30 20 10 40 
40 40 10 10 40 
50 50 0 10 40 
Sample 2* 48 10 40 
 
* The dilution factor for the final concentration of sample is 2 because of the volume added.  
If 5 L is added, the dilution factor is 5. 
 
 
3.2.3 Cyanine Dyes Preparation 
 
GE Healthcare CyDye DIGE Fluor minimal dyes, propyl-Cy3 and methyl-Cy5 N-
hydroxysuccinamide (NHS) ester cyanine dyes (named as DIGE Cy3 and DIGE Cy5 here) 
containing 5 nmol per tube were freshly reconstituted in anhydrous DMF at 100 pmol/µl. 
 
Dojindo IC-Osu ethyl-Cy3 and ethyl-Cy5 NHS ester cyanine dyes (named as IC3 and IC5 
here) containing 1 mg, equivalent to approximately 1.5 µmol per tube (Dojindo Laboratories, 
Kumamoto, Japan, distributed by NBS Biologicals, Huntingdon, UK) were first made in fresh 
100% methanol at 100 nmol/tube. The dyes were immediately dried using vacuum centrifuge 
and packed in aluminium foil and store at -20°C. Secondary stocks were prepared at 5 nmol 
per tube as previous when needed. The 5 nmol dyes were prepared prior to labelling as 
described above for DIGE CyDyes.  
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3.2.4 Protein-Cyanine Dye Labelling 
 
Samples of three different cell lines were solubilised in lysis buffer to give a final 
concentration of 2 mg/mL, 2 mg/mL, and 0.4 mg/mL for murine white blood cells, Neisseria 
meningitides cells, and HFF-1 cells respectively. A minimal labelling approach was used with 
a ratio of 50 µg total proteins and 400 pmol dyes. 50 µg of proteins from murine white blood 
cells and were labelled with 400 pmol of amine reactive cyanine dyes, including DIGE Cy3, 
DIGE Cy5, IC3, and IC5. 10 µg of protein from HFF-1 cells was labelled with 80 pmol of 
dyes as previously stated. The labelling mixture was incubated on ice in the dark for 30 min 
and the reaction was terminated by addition of 10 nmol of lysine for 15 min. Equal volumes 
of 2×sample buffer containing 7M urea, 2M thiourea, 4% CHAPS, 1% pH3-10 Pharmalyte, 
and 2 mg/mL DTT were added to each of the labelled protein samples. Samples labelled with 
DIGE Cy3 and DIGE Cy5, or IC3 and IC5 were mixed prior to IEF on Immobiline IPG 24 
cm strips (GE Healthcare) 
 
3.2.5 2D Gel Electrophoresis 
 
Samples labeled with DIGE Cy3 and DIGE Cy5, or IC3 and IC5 were mixed prior to IEF and 
carried out in IPGphor II with the total focusing of 60-100KVhr. The second dimensional 
SDS-PAGE was run on 12% Tris SDS gels (26×20×0.1 cm), prepared in-house at NIBSC 
using an automatic gel casting system (NextGen Sciences, Huntingdon, UK) in conjunction 
with low fluorescence glass plates. Running conditions were carried out at 8 mA/1W/gel for 
120 min and continuously at 18 mA/1W/gel until the tracking dye has run off the bottom of 
the gel in 2×Laemmli SDS buffer.  
 
3.2.6 First Dimension Electrophoresis: IEF 
 
Immobiline IPG DryStrip gel (24 cm pH 3-11 NL) (GE healthcare) was passively rehydrated 
in rehydration solution containing a matching IPG buffer (7M Urea, 2M Thiourea, 2% w/v 
CHAPS, 0.5% v/v IPG buffer pH 3-11 NL, 0.3% v/v 1M DTT, and trace Bromophenol blue) 
with the labelled protein as mentioned above. Rehydration buffer was added into each 
labelled sample up to 650 µL and placed into each lane of the immobiline drystrip reswelling 
tray. The protective plastic cover of the Immobiline DryStrip strip was gently removed and 
then the strip was placed face down into the mixture solution. To ensure that the entire length 
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of the strip is in contact with the solution, the strip should float freely and large bubbles 
should be removed. The strip was covered in the lane with 5 ml of Mineral Oil (GE 
healthcare) to prevent evaporation. The reswelling tray was covered with the lid and 
aluminium foil, and the strip was left to be in-gel rehydrated overnight at room temperature. 
 
Following in-gel rehydration step, the strip was transferred to the Ettan IPGphor II Manifold 
(GE Healthcare). The strip was applied face up in the tray with the anode end starting at the 
mark for the length of the strip and Mineral Oil was used to fill the lane. Soaked filter wick 
(GE Healthcare) was lined one upon a small part of the strips both at the anode and cathode 
ends. The electrodes were firmly located onto the wicks and the electrode clamps were turned 
to fix the electrodes to the manifold sides. The strip was focused in the first dimension with 
the following steps: (1) 300V, gradient, 15 min; (2) 500V, step, 3 hrs ; (3) 1000V, gradient, 1 
hr ; (4) 1000V, step, 1 hr; (5) 10000V, step, 4 hrs; (6) 500V, step, 5 hrs, to achieve the 
approximate total focussing of 100 kVhr. The temperature was maintained at 20°C and the 
setting was covered to prevent the photo bleaching from light. 
 
3.2.7 Second Dimension Electrophoresis: SDS-PAGE 
After the first dimension, IEF strip was removed from the manifold and equilibrated in 5 ml 
of SDS equilibration buffer (50 mM Tris-HCl, 7M Urea, 2M thiourea, 30% v/v glycerol, 2% 
w/v SDS, 100 mM DTT, and trace Bromophenol blue) for 15 min, and subsequently 
alkylated with 240 mM iodoacetamide for another 15 min. The second dimensional SDS-
PAGE was performed on vertical system. Each equilibrated strip was immediately applied to 
the top of 12% T SDS-PAGE gel. 1 % agarose (Sigma) containing bromophenol blue were 
used to seal the strip to the gel. Gel was run using 2× Laemmli SDS buffer at 8mA/1W/gel 
for 120 min and then increased to 18 mA/1W/gel until the bromophenol blue dye migrated 
off the bottom of the gel. 
 
3.2.8 Gel Image Acquisition 
 
The gels were scanned using a Typhoon 9410 scanner. The first step was to perform a quick 
pre-scan at 500 µm resolution to figure out an optimal photomultiplier tube (PMT) value. 
Once the PMT value was noted for each channel, which gave the desired pixel intensity, the 
gel were subsequently scanned at 100 µm resolution. The DIGE Cy3 and IC3 images were 
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obtained using green laser at the excitation/emission values of 532/580 nm BP30 while the 
DIGE Cy5 and IC5 were obtained using red laser at the values of 633/670 nm BP30. The 
same PMT of 520 V and 540 V were applied for either DIGE Cy3 and IC3, or DIGE Cy5 and 
IC5, respectively.  
 
3.2.9 Image Analysis 
 
The images were analysed using two commonly-used software packages for DIGE 
experimental analysis, DeCyder
TM 
V6.5 (GE Healthcare) and Progenesis SameSpots V3.0 
(Non-linear Dynamics, Newcastle upon Tyne, UK). Identical cropped images for both DIGE 
Cy3 and Cy5, and IC3 and IC5 were analysed using default detection parameters. No manual 
editing was used, to eliminate bias.  
 
Gel images of labelled samples within a single gel were divided into two groups, DIGE CY3 
and DIGE CY5, and IC3 and IC5. The images were analysed using DeCyder
TM
 and 
Progenesis SameSpots software, which are designed for DIGE-type experiments. When 2-
fold and 5-fold changes in volume ratios (increased or decreased) were specified, % of 
similarity was calculated (number of spots with change in volume ratio < 2 or < 5 fold 
divided by the total detected and matched spots).  
 
For DeCyder
TM
, the image loader module was used to import sets of gel images within the 
DeCyder 2D database. The Differential In-gel Analysis (DIA) module was employed to 
process sets of images labelled with different fluors. The DIA algorithms detect spots on a 
combined image derived from merging individual images from an in-gel set of images. This 
co-detection ensures that all the spots are represented in all images. DIA then quantitates spot 
protein abundance for each image, thereby indicating changes in expression levels by direct 
comparison of corresponding spots. For Progenesis SameSpots V3.0, the experiment was 
created in DIGE experiment without internal standard mode. The images were loaded and 
checked through a process of quality assessment, and then automatically aligned without 
manually input. On the basis of the analysis, all of the images were looked together, 
determined a single representative spot pattern and applied the same outline for each spot to 
the corresponding spot on every image in the experiment. With highly accurate pixel-level 
image alignment algorithms, the images were ensured that each pixel on an image 
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corresponded to the same pixel at that location on every other image in the experiment, 
providing the avoidance of missing values and any match editing.   
 
 
3.3     Results and Discussion 
 
 
3.3.1 Gel Images 
 
Gels for each cell line sample with each set of dyes as previously described in section 3.1.3 
were imaged and provided in Figure 31, 32, and 33, respectively. These gels have been 
performed by collaborator at NIBSC. 
 
 
Figure 31. Separation and Detection of Protein Spots on 2-D Gels from Neisseria 
meningitides Cell Lysates. Separation was performed on the 2-D gels using IPG 3-11 NL, 24 cm 
strips with an in-gel rehydration technique. Each gel provided two images, being DIGE CY3 and 
DIGE CY5 group, and IC3 and IC5 group. 
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Figure 32. Separation and Detection of Protein Spots on 2-D Gels from Murine White Blood 
Cell Lysates. Separation was performed on the 2-D gels using IPG 3-11 NL, 24 cm strips with an 
in-gel rehydration technique. Each gel provided two images, being DIGE CY3 and DIGE CY5 
group, and IC3 and IC5 group. These gels have been performed by collaborator at NIBSC. 
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Figure 33. Separation and Detection of Protein Spots on 2-D Gels from Human Fibroblast 
Cell Lysates. Separation was performed on the 2-D gels using IPG 3-11 NL, 24 cm strips with an 
in-gel rehydration technique. Each gel provided two images, being DIGE CY3 and DIGE CY5 
group, and IC3 and IC5 group. These gels have been performed by collaborator at NIBSC. 
 
 
3.3.2 Images Analyses 
 
All gel images from Figures 31, 32, and 33 were used to analyse comparative quantitation 
competence by two software programs designed specifically for fluorescent stains, being 
DeCyder V6.5 and Progenesis SameSpots V3.0. DIA module was employed for DeCyder 
analysis while multiple stains without internal standard mode was applied for Progenesis 
SameSpots analysis.  
 
From two software analyses, Tables 4 and 5 represented the total numbers of spots from each 
gel, total numbers of different spots (>2 fold), and total numbers of different spots (>5 fold). 
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Table 4. Image Analyses from DeCyderTM. From individual gel analysis, total spot numbers, 
different spot numbers (>2 fold change), and different spot numbers (>5 fold change) were 
analysed and presented. 
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Table 5. Image Analyses from Progenesis SameSpots. From individual gel analysis, total spot 
numbers, different spot numbers (>2 fold change), and different spot numbers (>5 fold change) 
were analysed and presented. 
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In addition, examples of spot detection histograms from DeCyder were shown in Figure 34. 
 
 
 
Figure 34. Spot Detection Histograms from DeCyderTM Analyses. Gel images from all cell 
lines were analysed using DeCyder software program. 2-fold and 5-fold cut-off threshold were 
used to detect spot difference from both DIGE and IC dyes. Histograms showed groups of spots, 
including ones within the threshold and outside the threshold. Spots with Green, Red, and Blue 
represented ones being in the threshold, decreased fold change outside the threshold, and 
increased fold change outside the threshold, respectively. 
 
 
3.3.3 Spot Matching and Comparison 
 
A multiplexing approach for difference in-gel electrophoresis analysis was applied on equal 
quantities of biological extracts from three cell lines as described in section 3.1.3. With equal 
amounts of labelled proteins applied to the gel, intensity differences in spots indicate 
variation in spot migration or shape arising from the dyes used. Results of gel images 
analyses were represented in Table 6, showing closely comparable results in terms of % 
similarity between the well-established DIGE CyDye and IC dyes. 
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DeCyder
TM
 V6.5 – DIA mode 
 
Cell lysates 
% similarity between DIGE dyes % similarity between IC dyes 
2-fold change 
(No. of gels) 
5-fold change 
(No. of gels) 
2-fold change 
(No. of gels) 
5-fold change 
(No. of gels) 
Mouse 
white blood 
91.3 ± 1.5 
(n = 3) 
96.0 ± 1.1 
(n = 3) 
91.7 ± 1.3 
(n = 4) 
98.6 ± 0.5 
(n = 4) 
MenB MC-
58 ΔsiaD 
mutant 
94.1 ± 2.6 
(n = 4) 
98.3 ± 1.2 
(n = 4) 
91.6 ± 0.7 
(n = 4) 
98.5 ± 0.7 
(n = 4) 
Human 
fibroblast 
75.8 ± 5.1 
(n = 3) 
98.2 ± 1.4 
(n = 3) 
83.7 ± 4.4 
(n = 3) 
98.2 ± 1.3 
(n = 3) 
 
Progenesis SameSpots V3.0 – multiple stains without internal standard mode 
 
Cell lysates 
% similarity between DIGE dyes % similarity between IC dyes 
2-fold change 
(No. of gels) 
5-fold change 
(No. of gels) 
2-fold change 
(No. of gels) 
5-fold change 
(No. of gels) 
Mouse 
white blood 
92.3 ± 2.1 
(n = 3) 
98.5 ± 0.9 
(n = 3) 
92.8 ± 1.5 
(n = 4) 
98.8 ± 0.8 
(n = 4) 
MenB MC-
58 ΔsiaD 
mutant 
94.6 ± 1.5 
(n = 4) 
98.7 ± 0.4 
(n = 4) 
94.9 ± 0.8 
(n = 4) 
98.9 ± 1.0 
(n = 4) 
Human 
fibroblast 
82.6 ± 3.6 
(n = 3) 
90.0 ± 2.1 
(n = 3) 
89.2 ± 1.5 
(n = 3) 
93.5 ± 1.8 
(n = 3) 
 
 
Table 6. Spot Matching and Comparison using Two Different 2-D Gel Analysis Software 
Packages. % similarity was calculated between either (i) DIGE dyes or (ii) IC dyes. This was 
determined by number of spots with change in volume ratio <2 or <5 divided by total detected 
and matched spots. (Reproduced from (226)) 
 
 
In addition, the overall chemistry of IC dyes and DIGE CyDye dyes are very similar. The net 
charge of all dyes is positive, thus when labelling the NH+ on the lysine residue, the overall 
pI of protein molecule remains the same. However, there is a mass difference of 26 Da 
between IC3 and IC5 dyes which is not represented in the case of DIGE CyDye which have 
matched molecular masses. In the fluorescent minimal labelling technique, each labelled 
protein carries only one dye molecule as previously explained. Therefore, the 26 Da mass 
difference in the dyes produces a difference of less than 0.3% over the total mass of a protein, 
such as for a low molecular mass protein of 10 kDa. The difference in protein migration 
between IC3 and IC5 labelled proteins should not be detectable on 2-D gels and was not 
experimentally observed in the study by examining their 3-D views, particularly in the 
regions of low molecular mass. 
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Besides, another supportive reason why the difference in migration should be undetectable is 
that in the three-colour CyDye DIGE minimal labelling when using Cy2 as the internal 
standard, although Cy3 and Cy5 have matched molecular masses but Cy2 has a mass 
difference of 30 Da from Cy3 and Cy5. No problematic apprehension in mass shift has been 
reported for the three-colour CyDye DIGE Fluor minimal labelling process. 
 
It was clear that the performance of these two combinations of the dyes between IC dyes and 
DIGE Cydyes was highly comparable. IC3 and IC5 dyes were suitable for minimal pre-
electrophoresis-labelling, multiplexing and differential quantitative analysis. Furthermore, the 
low concentration of human fibroblast cell lines, out of recommended concentration range for 
fluorescent pre-labelling process, was also prepared to test the comparative performance of 
two sets of dyes. The % similarity of gel images from human fibroblast cells was relatively 
low compared to the other two cell lines due to low protein concentration of samples but still 
showed a good agreement between two sets of dyes. In addition, spot volume ratios between 
two images (Cy3 and Cy5 images) of identical samples run on a single gel and ideally should 
all equal 1.00, resulting in % similarity of 100. However, even the experiment led by the 
Amersham (company first produced Cy3 and Cy5 dyes but now owned by GE healthcare) 
showed ratios ranged from 1.13 to 4.27, in order of decreasing spot volume, due to 
experimental variability (181). Overall, the trend was smaller volume spots giving rise to 
larger ratios, resulting in % similarity of < 100%. 
 
The use of DIGE approach is subject to patent protection in many countries (DIGE patent 
numbers: US6043025, US6127134, US6426190, WO9633406, EP0821787, JP2006023314 
and associated patent family). Precisely, the patent protection covers both the dyes and the 
methods. One of the reasons why the price of such CyDye is costly could be that the dyes and 
the methods are undertaking patent protection. The patent expiry date is estimated to be in 
2015, calculating by adding 20 years from the earliest filed date of patent application. 
Therefore, the use of IC3 and IC5 in combination with the processes claimed under such 
patent protection should ensure that such use does not infringe or, where necessary, an 
appropriate licensing arrangement concluded with the patent holder for the proposed use.  
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3.4     Conclusion 
 
 
The results demonstrated that these cyanine dyes, IC3 and IC5, produced practically identical 
results to DIGE CyDye, which allowed sample multiplexing and accurate quantitation for 
differential proteome expression analysis.  
 
The DIGE CyDyes are costly (approximately £100/sample in standard use) but of course this 
price comes with a guaranteed high specification and quality control. The IC dyes are not 
manufactured for such application and their pack size is high for proteomic labelling but 
theirs cost is small (approximately 5p/sample). However, extreme care must be taken when 
aliquoting the dyes, as the reactive group, being NHS-ester, is extremely labile and 
hydrolyses rapidly in aqueous solution at a half-life time of 60 min at pH 8 and 25°C (247).  
 
In a DIGE experiment design with two-dye labelling system, DIGE Cy3 is used to label 
pooled internal standard and DIGE Cy5 to label individual biological variants. Subsequent to 
steps of image spot matching and normalisation are completed with DIGE Cy3 images, 
accurately quantitative comparison among biological variants is performed through DIGE 
Cy5 images, allowing no interference or variation due to the difference in dye structure. The 
same approach for DIGE experiment with two-dye labelling system could be used for these 
IC3 and IC5 dyes with more cost-effective manner, allowing more access to skill training, 
experimental optimisation and pilot studies.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
CHAPTER 4 
 
 
A Comparison of Three DIGE Analysis Software Packages Suitable for 
Minimal User Intervention in Gel-based Proteomics 
 
 
Image analysis is viewed as a major bottleneck in gel-based proteomics, where the 
time spent on the analysis is largely dependent on user variability. Particularly, the 
success of high-performance DIGE analysis is down to the software tool chosen for 
highlighting the differences, and the statistical analysis. Several commercial software 
packages are currently available for analysing DIGE experiments. Three commonly 
available DIGE enabled software packages were chosen for comparison of their 
performance in this study, including Progenesis SameSpots V3.0, DeCyderTM V6.5, 
and Dymension 3. Two sets of DIGE gel images were used to evaluate the software 
packages both quantitatively and subjectively, considering ease of use with minimal 
user intervention. Quantitative assessment was performed by comparing: the number 
of detected spots, the cross-matched spots, and the expression differences of selected 
spots. The comparison of spot matching consistency across the three software 
packages was performed, focusing on the top fifty spots ranked statistically by each 
package. Results showed that all three software packages provide fully automated 
image analysis with minimal user intervention. The results also demonstrated the 
same behaviour in both set of images. All three software packages performed in a 
generally satisfactory manner, each with strengths and weaknesses. Based on 
matching accuracy, Progenesis SameSpots outperformed the other two software 
packages, possibly benefiting from its unique algorithm by outlining identical spot 
across all the gels. Furthermore, results of protein fold changes were different in each 
package, indicating that despite of using internal standards, quantification is also 
software dependent.  
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4.1  Introduction 
 
 
4.1.1 Aims and Background 
 
One important stage in gel-based proteomics is the acquisition of digital images as well as the 
analysis of gel images by software packages. Particularly, a 2D-DIGE comparative study is 
largely dependent on software tools specifically written for DIGE analysis. Several 
commercial software packages are currently available such as DeCyder
TM
 and Progenesis 
SameSpots. The evaluation of the software packages is essential in order to allow users 
achieve valuable data with high quality software tool.  
 
Each software package contains its own basic workflows and alignment algorithms. The 
workflow for 2D gel image analysis varies according to the package. The difference largely 
depends on whether spot alignment or spot detection is performed first (248). Several 
investigations have addressed comparative assessment among commercially available 2-DE 
software packages (249-252). For instance, Raman et al. (250) performed two software 
packages comparison (Z3 and Melanie) based on three criteria including spot detection, gel 
matching, and spot quantitation. Their result showed that Z3 performed better in spot 
detection whereas Melanie outperformed in spot quantitation. 
 
DIGE is a powerful method in gel-based proteomics as previously discussed in section 3.1.2. 
To obtain the best results from DIGE applications it is necessary that an appropriate software 
tool be used which could affect the most reliable and accurate data analysis for the sample 
type. The software packages which have been developed for DIGE-based experiments 
include DeCyder
TM
 (GE healthcare), ImageMaster (GE healthcare), Progenesis SameSpots 
(Nonlinear Dynamics), Dymension (Syngene), and PDQuest (Bio-Rad). In this study, the 
three commercially used DIGE analysis software tools were evaluated for comparative 
performance including DeCyder
TM
 V6.5, Progenesis SameSpots V3.0, and Dymension 3. The 
samples used in this study were secreted proteins (secretomes) by two cell lines, being 
HepG2 (human hepatocellular carcinoma cell line) and END2 cells (mouse endoderm-like 
P19 embryonal carcinoma sub-cell line). The samples were labelled with three-colour DIGE 
CyDyes with internal standards and the separation was performed. The gel images were then 
used to perform software package evaluation. A summary figure is shown in Figure 35.  
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Figure 35. Comparison of three software packages for DIGE experiments. Fluorescence 
2-D difference gel electrophoresis (2D-DIGE) can be used for direct differential protein 
expression analysis. Here, the complex secretomes of HepG2 and END2 cell lines were used 
to compare three commonly available DIGE analysis software packages. Yellow, red and blue 
colours represented labelled polled protein standard, END2 and HepG2 secretomes, orderly, 
therefore, the images were analysed by using Progenesis SameSpots, Dymension and 
DeCyderTM programs to perform comparison among three software. 
 
4.1.2 Experimental Design 
 
Gel images obtained from DIGE experiments of HepG2 and END2 secretomes were analysed 
by three different software packages as mentioned. The results were obtained from the 
perspective of proteomics user. A general evaluation as well as quantitative assessment was 
performed for the comparison of the three software packages. The general workflow of each 
package was compared among the three packages including spot detection, alignment, and 
statistical analysis of spots. Quantitative evaluation was performed by comparing the number 
of detected spots, the cross-matched spots, and the expression differences of selected spots. In 
all analysis, the user intervention was kept to a minimum considering an ease of use. In 
addition to the set of images from secretomes, a different set of images obtained from breast 
cancer cell lines was used to compare the results of the performance of the three software 
packages. 
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4.2     Materials and Methods 
 
4.2.1 Sample Preparation 
 
HepG2 (ATCC HB-8605, UK) and END2 (obtained from Professor Mummery, Hubrecht 
Laboratory, Netherlands) cells were cultured in serum-free DMEM media (Invitrogen, UK) 
for four days. 50 ml of each conditioned media (CM) was collected and filter-sterilised 
through a 0.22 µm filtration unit. The samples were then 1000-fold concentrated to the final 
volume of 50 µl, and stored at -80°C till used. Brest cancer cell line, MCF-7, were cultured in 
RPMI-1640 containing 10% FCS and 2mM GlutaMAX
TM
 under the condition either with or 
without antimycotics, Amphotericin B 2.5 µg/mL (Breast cancer cell culture was performed 
by Dr. William Mathieson). The breast cancer cells from both conditions were harvested and 
washed. Conditioned media protein concentrate and breast cancer cell pellets were 
resolubilised in lysis buffer containing 30mM Tris, 7M urea, 2M thiourea, and 4% CHAPS at 
pH 8.5. The amount of proteins was then quantified using 2D Quant Kit (GE healthcare). 
 
 
4.2.2 Minimal CyDye Labelling 
 
The proteins were labelled with DIGE CyDye (GE Healthcare) according to the 
manufacturer’s instruction. Briefly, 50 µg of each HepG2-CM and END2-CM and 50 µg of 
each of breast cancer cell line in standard medium and in anti-fungal treated medium were 
labelled with 400 pmol of Cy3 or Cy5 dyes respectively in a reciprocal manner. The internal 
standard pooled from the aliquots of all the samples of each set was labelled with Cy2. The 
labelling reaction was carried out by incubation on ice in dark environment for 30 min and 
the reaction was stopped by the addition of 10 nmol of lysine. 
 
4.2.3 2D Gel Electrophoresis and Gel Image Acquisition 
 
The first dimension IEF was carried out in IPGphor III using 11cm IPG strips with the total 
focusing of 70KVhr. The second dimension SDS-PAGE was run on 4-12% Bis-Tris Criterion 
XT gels (Bio-Rads), then carried out at a constant voltage of 40 V for 15 min and 
continuously of 150V until the samples has almost run off the bottom of the gel. DIGE gels 
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were imaged using the Dyversity (Syngene, Cambridge, UK) imaging system immediately to 
prevent diffusion of protein spots and subsequent signal loss. 
 
 
4.2.4 Image Analysis 
 
Gel images were aligned and analyzed using three different software packages; DeCyder
TM
 
V6.5 (GE-Healthcare, Buckinghamshire, UK), Progenesis SameSpots V3.0 (Nonlinear 
Dynamics, Newcastle, UK), and Dymension 3 (Syngene, Cambridge, UK). In each software 
package, the top fifty spots were ranked statistically based on p-values (p<0.05) from 
ANOVA and maximum fold change. These ranked fifty spots from each software package 
were selected to perform comparison among three software packages. Among the selected 
fifty spots, mis-matched spots were counted by manual screening under two conditions: 1) 
aligned without landmark* and 2) aligned with five landmarks.  
 
*
Definition of landmark: Spots determined by users to represent same proteins across 
replicate gels.  
 
 
4.2.5 Spot Detection and Analysis by DeCyder
TM
 
 
In each gel set, protein spots were co-detected using Differential In-Gel Analysis (DIA) 
mode. The exclusive criteria of the spots to eliminate biological variation were slope >1.1, 
area <100, volume < 100,000, peak height <100 and > 64000. The estimated number of spots 
for each gel was set to default at 2000. Background subtraction and normalisation was 
performed on the images using default settings. Each sample was grouped in Biological 
Variation Analysis (BVA) mode and gel images were automatically aligned in two ways, 
with no user intervention or with minimal user intervention based on five landmarks on each 
gel. Gels were then matched and the spots were compared. 
 
 
4.2.6 Spot Detection and Analysis by Progenesis SameSpots 
 
In each gel set, gel images were aligned by automated calculation with no user intervention or 
with minimal user intervention using five landmarks vectors. The multiple stains with 
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internal standard mode was used to perform analysis. The aligned images were grouped to 
represent the biological grouping and then were analysed. In the review stage of the software 
package, list of spots with significantly statistical changes were ranked for evaluation. 
Moreover, a total spot number of each gel was also calculated in a separate analysis.  
 
4.2.7 Spot Detection and Analysis by Dymension  
Spots were detected automatically with default spot detection settings as follows: blur radius: 
1.2, peak limit threshold: 0.01, splitting threshold: 0.001. Detection confidence ratio and 
separation confidence ratio was set at 20 according to the manufacture’s instruction. Noise 
filtering and background correction was performed automatically under the default setting 
parameters which were raw volume/height > 10, and height > 5. Pool matching was carried 
out by automatic gel alignment. Statistical analysis was automatically performed when pool 
matching was carried out. 
 
4.3     Results and Discussion 
 
 
4.3.1 General Evaluation and Comparison among Three Software Packages 
 
General evaluation of the three software packages is shown in Tables 7 and 8.  This general 
evaluation was carried out in terms of visualisation interfaces, normalisation method and 
workflow.  
 
For visualised interfaces, all three packages provided good graphical user interfaces. 
Alignment, spot detection and analysis processes could be performed automatically in all 
three packages. Spot visualisation was seen on 2D and 3D views. Generally, all three 
packages provided a user-friendly system for efficient DIGE gel image analysis. 
 
In DIGE experiments, an internal standard sample is labeled with a separate dye to use as an 
in-gel normalisation method. The ratiometric normalisation process was provided in all three 
packages. To obtain accurate results of DIGE experiments, several statistical analysis tools 
were available in each software package, for instance, t-test and ANOVA. 
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Table 7. General Evaluation on three software packages; DeCyderTM, Progenesis 
SameSpots and Dymension. Alignment, spot detection, spot analysis, normalisation method, 
and data export process of each package were described. 
 
 
 DeCyder
TM 
Progenesis 
SameSpots 
Dymension 
Alignment -Gels aligned in BVA 
mode 
-User intervention 
possible in spot detection 
and alignmen. 
-No averaged gel created. 
-Automatic vector 
calculation 
-User intervention 
possible in 
alignment 
-One averaged gel 
created. 
-Automated alignment 
in pool matching step 
-User intervention 
possible in alignment 
and spot detection 
-One averaged gel 
created 
Spot Detection Automatic detection in 
each gel set in DIA mode 
Automatic 
detection among 
aligned groups 
Automatic detection in 
each gel set 
Analysis Automated Automated Automated 
Visualisation  2D, 3D montage 2D, 3D montage 2D, 3D montage 
Normalisation 
Method 
Ratiometric 
Total volume 
Ratiometric 
Total volume 
Ratiometric 
Statistics t-test, ANOVA t-test, ANOVA t-test, ANOVA 
General User 
Intervention 
-Alignment stage 
-Spot detection 
-Protein filter 
-Alignment stage 
-Spots of interest 
selection 
-Spot detection 
-Alignment 
 
Data Export Image, Table exported to 
XML 
Image, Table 
exported to Excel 
or Word 
Image, Table exported 
to Excel or Word 
 
 
 
The general workflow of each software package was compared and presented in Table 8. 
Principally, three main steps comprised the analysis of all three packages, including spot 
detection, alignment, and statistical analysis of spots. Progenesis SameSpots had a different 
approach from the other two software packages in terms of the order of alignment and spot 
detection step. It performed alignment at the beginning of the analysis and spots were 
subsequently detected with same spot outlines across the experiment while the others carried 
out the spot detection before the alignment or matching process. Another different point in 
the workflow was shown in the Dymension. Only the spots that were present in all the 
internal standard sample gels were accepted and matched for the analysis. 
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Table 8. A Comparison of the Workflow of the Three Software Packages. Each package 
generally obtains basic features in common such as alignment, spot detection, and statistical 
analysis. The workflow of each package showed slight difference in terms of the order of 
performing alignment and spot detection. 
 
      
 
 
 
 
4.3.2 Spot Detection and Alignment 
 
The aligned DIGE gel images were shown in Figure 36. The set of images were used to 
perform DIGE software analysis in all three packages. END2-CM, HepG2-CM, and internal 
standard sample were labelled with Cy3, Cy5, and Cy2, respectively. The representative gel 
image of the DIGE gels was demonstrated in Panel (a) of Figure 36. In Panel (b), (c), and (d), 
aligned gel images from DeCyder
TM
, Progenesis SameSpots, and Dymension software 
package were shown orderly. The circled spots in the aligned images represented results of 
the highly ranked top 50 spots from individual software analysis. 
 
 
 
 
Set up the DIA-batch 
 
Process each gel in the 
DIA batch; 
Spot detection  
 
Set up the BVA batch 
Assign groups 
 
Process the group data 
in BVA batch; 
Gel matching 
Statistical analysis  
 
Alignment; 
Assigning vectors 
 
Explore; 
Assigning group 
details  
Statistical analysis: 
Spot selection 
 
Review; 
Further analysis on the 
selected spots 
Set experimental 
details 
 
Spot detection 
 
Pool registration 
Alignment 
 
Pool matching 
 
Spot matching 
Analysis 
 
 
Progenesis SameSpots Dymension DeCyder
TM 
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Figure 36. Aligned DIGE Gels Images. (a) The representative image of the DIGE gels. Red – 
Cy3 labelled END2-CM, Blue - Cy5 labelled HepG2-CM, Green - Cy2 labelled internal standard. 
Aligned gel image by (b) DeCyderTM, (c) Progenesis SameSpots, (d) Dymension. The circled 
spots are statistically highly ranked top 50 spots. (Reproduced from (227)) 
These gels have been performed by collaborator at Chemical Engineering. 
 
To assess spot detection performance of each software package, total spot number and 
matched spot number were analysed and compared from individual package. Furthermore, 
the assessment was performed in two experiments, being the alignment without setting any 
landmark vectors and the alignment with five landmarks selected manually. Table 9 shows 
the results of spot detection performance from each package. 
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Table 9. Detected and Matched Spot Numbers in Each Gel Seta (Reproduced from (227)) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a w/o.l., without landmark; w.l., with five landmarks. 
b Separate experiment was done for each gel in order to calculate total spot number per gel. 
c “Spot No. in gel set” represents spots from each image that includes all three Cy-dyes.  
d Matched spot No. was analyzed by four gel sets together. 
 
 
Overall for total spot number, DeCyder
TM
 detected more spots than the other two software 
packages, mainly due to the default detection settings at 2000 spots. Moreover, the higher 
total spot numbers found in DeCyder
TM
 resulted from false spot splitting. As an example 
shown in Figure 37, a spot was detected as multiple spots in DeCyder
TM
 whereas it was 
identified as a single spot in Progenesis SameSpots. In sum, spot splitting at inflection points 
tends to be more liberal in DeCyder
TM
, often resulting in spot oversplits leading to over 
counted spot numbers. Progenesis SameSpots and Dymension are more conservative at spot 
splitting and seem to obtain fewer over counted spot numbers. 
 
 
 
 
 DeCyder
TM Progenesis 
SameSpots
b
 
Dymension 
Spot No. in gel
c
   set1 979 610 479 
Spot No. in gel     set2 984 593 524 
Spot No. in gel     set3 661 654 482 
Spot No. in gel     set4 1019 648 383 
  w/o.l. w.l. w/o.l.
d
 w.l.
d
 w/o.l.
d
 w.l.
d
 
Matched spot No. 
Gel set1 
Gel set2 
Gel set3 
Gel set4 
443 
489 
405 
1019 
495 
544 
415 
1019 
 
620 
 
548 
 
73 
 
73 
99 
 
 
 
 
 
 
 
Figure 37. An Example of Different 
Spot Splits at Inflexion Points in 
Three Software Packages. Spot splits 
in (a,d) Progenesis SameSpots, (b,e) 
DeCyderTM, and (c,f) Dymension. 
(Reproduced from (227)) 
  
  
 
A matched spot is defined as the spot which appears in the images and is used for statistical 
analysis for significant changes in intensity. Matched spot numbers were assessed using two 
experiments. The first setting was the alignment of all images without any manual landmark 
vectors and the second one was those with the five manually selected landmarks. The 
analysis was performed to evaluate matching performance in each case. 
 
Since each software package contains its unique matching algorithm, the results were not 
directly comparable. For DeCyder
TM
, a master gel with the greatest number of spots was 
chosen and each gel was subsequently matched to this gel for statistical analysis. For 
Progenesis SameSpots, it creates one averaged gel which contains all the spots from each gel 
set, including both the matched and unmatched spots. It also generates the boundary of each 
spot across the experiment where unmatched spots are matched to the virtual boundary 
generated. Matched spot numbers in DeCyder
TM 
and Progenesis SameSpots showed a similar 
pattern in results in both the experiment with and without manually selected landmarks 
(Table 9). For Dymension, only spots which appear in all the internal standard sample gel are 
accepted and used for matching process. This explains the relatively low matched spot 
numbers, 73 in both of the settings, found in Dymension analysis as compared to those in the 
other two packages (Table 9) 
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4.3.3 Cross-matching of the Top 50 Highly Ranked Spots 
 
After image alignment and spot detection by all three software packages had been carried out, 
statistical analysis was performed to achieve a differential expression comparison between 
two groups of samples (END2-CM and HepG2-CM). As a result for each software analysis, 
the greatest fold changes across groups at 95% confidence level (p<0.05) were ranked. The 
top fifty spots with statistically significant changes resulted from each software package were 
selected for well-matched spot comparison. The well-matched spot defines as the matched 
spot which shows a true match when confirmed manually.  
 
Among the matched spot numbers from DeCyder
TM
 and Progenesis SameSpots software 
packages shown in Table 9, approximately 150 spots were significantly different at the p< 
0.05 level (Table 10). The top fifty spots were able to be selected from those statistically 
different spots for well-matched spot comparison. However, in Dymension, out of those 73 
matched spots (Table 9), only 3 spots showed differences with statistical significance (Table 
10). Thus, the top ranked fifty spots from Dymension were basically selected, independent of 
the p value, to perform indirect comparison against the other two software packages. 
 
Among the three sets of fifty top ranked spots selected by the three software packages, only 5 
spots were found in common (Figure 38). DeCyder
TM
 and Progenesis SameSpots results 
shared the greatest number of cross-matched spot, 19. The explanation for this variation seen 
in cross-matched spot results may partially due to the different matching algorithms of each 
software package. Furthermore, since Dymension contains more restricted criteria for 
matching, the top fifty spots which were used to analyse were independent of the statistical 
significance, possibly leading to the greater variation in cross-matched analysis when 
compared to the other two packages. 
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Table 10. Number of Spots which were Significantly Different at p<0.05% Level by 
ANOVA. Spots with statistically significant changes and well-matched spots among the top 50 
highly ranked spots by fold change are included. (Reproduced from (227)) 
 
 
  DeCyder
TM Progenesis  
SameSpots 
Dymension* 
No. of significantly 
different spots at 0.05% 
level (Without landmark) 
157 146 3 
No. of significantly 
different spots at 0.05% 
level (With landmarks) 
139 132 3 
No. of well-matched spots 
from top fifty spots 
(Without landmark) 
29 33 12 
No. of well-matched spots 
from top fifty spots 
(With landmark) 
36 46 22 
 
 
 
 
 
  
 
* Due to Dymension’s different algorithm, the number of significantly different spots was not 
exactly comparable. In Dymension the top 50 spots were chosen, independent of the p value, to 
carry out comparisons with other packages.  
 
 
 
  
                                 
 
Figure 38. Diagram of Number of Cross-Matched Spots among Top 50 Spots. Top ranked 50 
spots which showed the greatest fold changes in three software analyses were represented in vein 
diagram. Only 5 spots were found commonly in all the three sets of results. (Reproduced from 
(227)) 
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The accuracy of each software package in matching process was determined by manual 
confirmation whether the top ranked fifty spots were well-matched or mis-matched. As 
defined previously for the well-matched spot, the more number of well-matched spots are 
found, the more accuracy of the matching process is suggested in each software package. 
 
The results in Table 10 demonstrated that when manual landmark vectors were not applied, 
all the three software packages gave poor matching accuracy. DeCyder
TM
 and Progenesis 
SameSpots correctly matched 29 and 33 spots, respectively, out of the top 50 spots (58% and 
66% accuracy), while Dymension well matched only 12 out of 50 spots (24% accuracy). 
When the analyses were performed by putting five manual landmark vectors before automatic 
alignment, all three software packages improved their accuracy in matching performance. 
With the landmarks, matching accuracy increased to 72%, 92%, and 44% for DeCyder
TM
, 
Progenesis SameSpots, and Dymension, respectively.  
 
Overall, Progenesis SameSpots outperformed the other two software packages in matching 
performance. The poor accuracy in the matching process in all three packages when 
performed without using any landmarks may be due to the images used for the analysis. 
Because the samples used in the study were conditioned media from cell lines which 
contained highly abundant proteins resulting in unresolved protein spot chains. The results 
from matching analysis suggested that without user intervention high-quality matching 
cannot be achieved for these types of samples, conditioned media. Therefore, the analysis 
was also performed with the different set of images that included more discrete spots and the 
results will be provided in section 4.3.5. 
 
4.3.4 Quantitative analysis 
 
Spot quantitation is one of the most important and useful process of gathering information in 
gel-based proteomics from the biologists’ point of view. The performance of the spot 
quantitation reflected the accuracy of the differential proteome studies (248, 250, 253). 
Herein, quantitative analysis was compared among the three software packages. The five 
spots commonly found in cross-matched analysis by all three packages were used to evaluate 
quantitative performance. Out of the five cross-matched spots, three spots were well-matched 
in all three packages and were selected for quantitative performance assessment (Figure 39, 
panel (b)). 
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Figure 39, panel (a) showed the fold changes of the three spots calculated by each software 
package. Fold change between the three cross-matched spots in the three packages reported 
considerable discrepancies ranging from 4 to 90 fold.  DeCyder
TM
 calculated a much higher 
differential expression ratio ranging from 60 to 90 in all three spots. Progenesis SameSpots 
gave a range from 15 to 40 in all three spots. In both analyses the fold change values were 
much greater that those reported in most gel-based proteomics experiment. These results 
reflected on-off differences between conditioned media samples which happened in these 
three spots. 
 
Therefore, four other well-resolved spots, which appeared in both groups of conditioned 
media samples, were selected to evaluate quantitative differences among the three software 
packages (Figure 40, panel (b)). Nonetheless, fold changes between the three packages of 
these well-resolved spots were still significantly different as depicted in Figure 40, panel (a). 
The most obvious explanation of the observed differences was the way spot boundaries were 
defined by each software package as an example in Figure 40, panel (c), (d), and (e). The spot 
boundary for one of analyses spot varied depending on the software package, leading to 
different results in quantitation performance.   
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Figure 39. Quantitative Analysis of Cross-Matched Spots Found in the Three Software 
Packages. (a) Comparison of quantitative analysis on the completely cross-matched spots in three 
software packages (b) 2D images of the three cross-matched spots. (Reproduced from (227)) 
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Figure 40. Quantitative Analysis of Four Well-Resolved Spots in the Three Software 
Packages. (a) Comparison of quantitative analysis on four well-resolved spots (b) 2D image of 
four well-resolved spots, and 3D images of spot 4 in (c) Progenesis SameSpots, (d) DeCyderTM, 
and (e) Dymension (Reproduced from (227)) 
 
 
4.3.5 Spot Detection, Alignment and Cross-matching of the Top 50 Highly Ranked Spots 
using Different Sets of Images 
 
In addition to the set of images from conditioned media samples, another set of images was 
used to perform the three software packages comparison. The Breast cancer cell line, MCF-7, 
was cultured under two different conditions, MCF-7 with or without antimycotics. The cell 
complex proteome from both conditioned cells, allowing more resolved protein spots when 
compared to conditioned media proteome, were used for the comparison of the three 
commercially available DIGE analysis software packages.  
 
Spot detection and alignment steps were carried out as in section 4.3.3. Results were showed 
in Table 11. The results demonstrated the similar trend in DeCyder
TM
 and Progenesis 
SameSpots as when using conditioned media samples. Dymension reported much higher spot 
detection number and also reflected in higher matched spot number when compared to the 
results with conditioned media samples. The reason may be due to the more resolved spot 
pattern in breast cancer proteome provided more suitable images for Dymension’s 
algorithms. 
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Table 11. Detected and Matched Spot Numbers in Each Gel Set from Breast Cancer Cell 
Proteomesa.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a w/o.l., without landmark; w.l., with five landmarks. 
b Separate experiment was done for each gel in order to calculate total spot number per gel. 
c “Spot No. in gel set” represents spots from each image that includes all three Cy-dyes.  
d Matched spot No. was analyzed by four gel sets together. 
 
 
Table 12. Number of Spots which were Significantly Different at p<0.05% Level by 
ANOVA from Breast Cancer Proteome Images. Spots with statistically significant changes 
and well-matched spots among the top 50 highly ranked spots by fold change were included.  
 
 
 DeCyder
TM Progenesis 
SameSpots 
Dymension 
No. of significantly different 
spots at 0.05% level     
(Without landmark) 
65 51 69 
No. of significantly different 
spots at 0.05% level          
(With landmarks) 
74 71 66 
No. of well-matched spots 
(Without landmark) 
33 38 29 
No. of well-matched spots 
(With landmark) 
39 47 32 
  
 
 
 DeCyder
TM Progenesis 
SameSpots
b
 
Dymension 
Spot No. in gel  c   set1 922 655 880 
Spot No. in gel     set2 943 553 895 
Spot No. in gel     set3 989 612 887 
  w/o.l. w.l. w/o.l.
 d
 w.l.
 d
 w/o.l.
 d
 w.l.
 d
 
Matched spot No. 
Gel set1 
Gel set2 
Gel set3 
 
523 
512 
508 
 
560 
546 
516 
 
578 499 393 407 
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The accuracy of each software package in matching process was also determined by this set 
of more resolved images.  
 
The results in Table 12 demonstrated that without manual landmarks, all the three software 
packages gave better matching accuracy when compared to using conditioned media images.  
A similar tendency of the result as when using conditioned media samples was also observed 
when five manual landmark vectors were applied in which the improvement in matching 
accuracy was achieved in all three packages to 78%, 94%, and 64% for DeCyder
TM
, 
Progenesis SameSpots, and Dymension, respectively. 
 
Taken together, these results evidently showed that Progenesis SameSpots outperformed the 
other two software packages in matching performance. In fact, a more discrete spot pattern in 
DIGE images provided better performance in matching accuracy in all three software 
packages. 
 
 
4.4     Conclusion 
 
DIGE is the most powerful technology in gel-based proteomics, which overcomes the 
drawbacks of conventional 2-DE. Software analysis is a key part of DIGE experiments 
reflecting in accurate and reliable results of matching accuracy and spot quantitation. To 
extract the best information from DIGE applications, it is essential that appropriate software 
be used for the sample type to obtain the most accuracy in data analysis. 
 
Results showed that all three software packages provided fully automated image analysis 
with minimal user intervention. Two sets of samples were used for the experiment, including 
conditioned media sample and breast cancer cell line samples. The results from both groups 
of samples showed the same tendency. All the three software packages performed in a 
generally satisfactory manner, each with strengths and weaknesses. Based on matching 
accuracy, Progenesis SameSpots performed best. The mis-matching process found in 
DeCyder
TM
 and Dymension were mainly caused by errors in spot detection and alignment. 
By optimising detection settings and making manual vector corrections, the accuracy of 
analysis can be significantly increased as shown by increased matching accuracy after 
inclusion of five manual landmarks. Therefore, user intervention is essential in order to 
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achieve the best analysis results; even in fully automated and apparently sound software 
analysis. Spot quantitation performance was highly various in all three packages. The 
observable justification was that the spot boundary created by each software package was 
different, reflecting in a diverse spot volume. As a result, users should be cautious when 
drawing inferences based on the magnitude of differences between samples as calculated by 
software packages; statistical analysis must be validated by alternative methods such as 
western blot. 
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CHAPTER 5 
 
 
2D-DIGE Comparative Proteome Profile of Human Induced   
Pluripotent Stem Cells Generated by Zinc Finger Nuclease Technology  
and Human Embryonic Stem Cells 
 
Reprogramming technology by using OCT4, SOX2, c-MYC and KLF4, i.e. 
Yamanaka’s factors, has recently been a major breakthrough in the field stem cell 
biology. The ability of reprogrammed induced pluripotent stem cells (iPSCs) to 
express similar characteristics and to obtain comparable developmental potential as 
embryonic stem cells (ESCs) has created powerful new opportunities for modelling 
human diseases, drug discovery, and personalised regenerative cellular therapies. 
While the field is catapulting forward, key concerns have been raised for scientists 
regarding whether iPSCs are indeed the true equivalents of ESCs and whether 
complex genetic manipulations in the process of iPSC generation, such as those 
derived from viral reprogramming or other random-integration methods, leads to 
increased risks of tumourigenicity. In this work subtle differences between these two 
types of cells were investigated using a global differential proteomics approach. 
Difference in-gel electrophoresis (2D-DIGE) method was performed for differential 
proteomic comparison between these two cell types. The proteomic results showed 
that 24 protein spots from the gel between two cell populations differentially 
expressed more than two-fold change, being relatively 22 down-regulated and 2 up-
regulated in iPSC population. Of those 24 spots, two identified proteins, being ATP 
dependent DNA helicase II protein (Ku80 protein) and heat shock 70kDa protein 9 
protein (mortalin protein), were selected for further validation by q-PCR and western 
blotting. Functions of Ku80 and mortalin protein are involved in the repair of DNA 
double-strand break and cell proliferation, respectively, hence potentially associating 
with tumour formation or cancer in iPSCs and worthing for further investigation 
towards a closer clinical therapeutic application of iPSC technology. This work 
provides an important insight and a highlighted application of gel-based proteomics 
in stem cell biology. 
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5.1  Introduction 
 
 
5.1.1 Aims and Background 
 
Applications of proteomics technology have been advanced to various biomedical and 
clinical investigations (70, 254-256). Proteomics can be used to obtain global, comprehensive 
and high-throughput information in order to better understand biochemical and biological 
mechanisms, pathways and networks involving in various physiological states at protein 
levels. Advanced proteomic technologies have been increasingly used in stem cell biology in 
the past decade (257-259). Particularly in ESCs, there has been a great amount of data using 
proteomics in characterising ESCs (260-262), identifying self-renewal, proliferation and 
differentiation markers (263-265), and studying post-translational modifications and 
epigenetic processes which control ESC biology (266, 267).        
 
Human embryonic stem cells (hESCs) are derived from the inner cell mass of blastocyst-
stage embryo (130). They contain capability of self-renewal and potential to differentiate into 
all three germ layers, therefore they hold a great promise as a renewable source for 
developmental biology research, drug development and regenerative medicine. Several well-
established methods and protocols have been widely used to derive and maintain hESCs 
across various genotypic populations (268-271). For clinical use and therapeutic applications, 
large-scale expansion of undifferentiated hESCs is required but still limited. A number of 
efforts to develop more robust and scalable culture technologies for hESCs have been 
established since its derivation, including the development of feeder-free system, defined 
animal-free media and substrates, biomaterial-based scaffolds, suspension culture system, and 
bioreactor.  
 
Although a vast potential of hESCs; however, to use human embryo in ESCs derivation faces 
ethical concern among many communities. Furthermore, to generate patient-specific or 
disease-specific ESCs is far difficult which hinders the effective applications of hESCs. In 
2006, Yamanaka and colleagues reported that mouse embryonic fibroblasts (MEFs) could be 
reprogrammed to a pluripotent state by introducing four defined transcription factors, 
including Oct3/4, Sox2, c-Myc, and Klf4, via retroviral delivery (145). The finding has 
demonstrated that this approach may eventually allow the creation of limitless pluripotent 
cells directly from somatic cells. Subsequently, two separate research teams have proved and 
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reported that iPSCs could be generated with human cells (146, 147).  These human induced 
pluripotent stem cells (hiPSCs) have normal karyotypes, become morphologically and 
biochemically similar to human ES cells, and maintain the developmental potential to 
differentiate into derivatives of three germ layers. 
 
Due to potential of hiPSCs for generating specific cell types whenever necessary, the 
anticipated benefits of hiPSCs go beyond research to clinical medicine in disease modeling, 
drug discovery and cell therapy. Challenges to hiPSC-based disease modeling and drug 
discovery have been largely investigated under the expectation of using hiPSCs to assess 
safety and efficacy of candidate compounds in human cells and tissues differentiated from 
hiPSCs rather than conventionally used animal tissues or cells (272, 273). Moreover, an 
application to use patient-specific hiPSCs in intractable and congenital diseases and in 
regenerative medicine would be an intriguing promise in future personalised medicine (274-
276).  
 
However, there is a certain drawback in conventional method used for generating hiPSCs via 
integrating retroviral or lentiviral system which might be prone to form tumours. To 
overcome this potential problem in therapeutic applications, many methods have been newly 
developed to reduce or eliminate the risk of potential tumour formation such as using 
nonintegrating adenoviral system to transport the requisite genes for induced pluripotency 
(277) and, interestingly, using non-viral techniques to generate iPSCs (151, 152). 
Nevertheless, the efficiency of non-viral techniques to generate hiPSCs is still limited.  
 
In this study, hiPSCs produced by a Zinc Finger Nuclease Technology was compared with 
hESCs. This technology was established at the Centre for Stem Cell Biology, University of 
Sheffield, to generate hiPSCs by using Zinc Finger Nuclease Technology combined with a 
plasmid transfer to introduce four key transcription factors into human somatic cells. This 
technique allows the removal of four introduced transcription factors after hiPSCs has been 
generated, preventing contamination of the host genome with residual non-human sequences. 
In this chapter, the hiPSC line generated by the Zinc Finger Nuclease Technology is called 
ZFNiPSCs. 
 
Herein, the characterisation and optimisation of ZFNiPSCs were evaluated by common 
assays of pluripotent stem cells for stem cell and differentiation markers. However, one 
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important question in stem cell biology is whether hiPSCs have the same properties as 
hESCs. To elucidate this key question, a genome-wide study has been investigated between 
these two populations of cells (278). The ultimate aim of this study is to reveal this important 
information on the protein levels by using a proteome-wide study. In this study, gel-based 
proteomics approach was employed as an application to study stem cell biology. 2D-DIGE 
approach was applied for the comparative global proteome profiles between ZFNiPSCs and 
hESCs. This comparative proteomics information may disclose key biological differences, 
constituting a crucially novel insight in hESCs and hiPSCs biology, and may reveal a closer 
technology in therapeutic applications of human iPSCs. 
 
 
5.1.2 A Brief Description of hiPSCs Production by Zinc Finger Nuclease Technology 
 
Zinc finger iPS cells were generated using human primary foreskin fibroblasts. The plasmid 
was linearised and, together with mRNAs encoding two zinc finger endonucleases specific to 
5' and 3' end of the linearised plasmid (Sangamo Biosciences), was utilised to transfect into 
the human somatic cells by electroporation. After 30 days of transfection, ES-like colonies 
were picked up and were expanded. 
 
 
5.1.3 Experimental Design 
 
To clarify whether ZFNiPSCs and hESCs used in this study maintain the pluripotent 
properties, varieties of assays were used to characterise both ZFNiPSCs and hESCs. Those 
include phase contrast microscopy, flow cytometry analysis, and immunofluorescent staining 
studies. Phase contrast microscopy was used to observe cell morphology. Flow cytometry and 
immunofluorescent staining analysis were performed for stem cell and differentiation 
markers to determine both ZFNiPSC and hESC characteristics. Once characterisation was 
evaluated, ZFNiPSCs and hESCs were collected for whole cell lysate preparation. Protein 
samples from both cell types were employed for 2D-DIGE proteomics application, allowing 
differential comparison of proteome profiles between ZFNiPSCs and hESCs. Further protein 
identification along with validation is also achieved by mass spectrometry as well as western 
blotting analysis. (Figure 41)  
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Figure 41. Quantitative Proteomics Comparison between ZFNiPSCs and hESCs. 
Characterisation for stem cell and differentiation properties of ZFNiPSCs and hESCs is 
performed to ensure the suitable use of both cells for proteome comparison. 2D-DIGE method is 
used to investigate differential comparative proteome profiles between both cell types. Further 
protein identification and validation are done to reveal key biological differences and novel 
insight in stem cell biology. The highlighted advantages and concerns of ZFNiPSCs and hESCs 
are also provided in green and red contexts, respectively.    
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5.2 Materials and Methods 
 
5.2.1 Culture and Maintenance of hESCs and ZFNiPSCs 
 
hESC line used in this study was H7. ZFNiPSC line used in this study was generated by the 
Centre for Stem Cell Biology, University of Sheffield, as in brief description above.  Both 
types of cells were grown in culture media (Knockout-DMEM supplemented with 20% 
Knockout-Serum Replacement, 1X non-essential amino acids, 1mM glutamine, 0.1mM β-
mercaptoethanol and 4 ng/ml basic fibroblast growth factor (bFGF) (Invitrogen)). They were 
seeded on 6 x 10
3
 cells/cm
2
 mitomycin C-treated MF-1 mouse embryonic fibroblasts (MEFs).  
Cells were maintained in a gas-jacket incubator equilibrated with 5% CO2 at 37°C and 
passaged every 5-7 day during the required time of culture. To passage the cells, collagenase 
type IV (Invitrogen) with glass-bead scraping technique (Sigma) was applied. 
 
 
5.2.2 Antibody Preparation, Sources and Concentration for Analyses 
 
 
Primary antibody for immunostaining References Dilution 
Anti-P3X  (Kohler and Milstein (279)) 1 in 10 
Anti-SSEA3 (Shevinsky, Knowles et al. (280)) 1 in 10 
Anti-SSEA4 (Kannagi, Cochran et al. (281)) 1 in 10 
Anti-TRA-1-60 (Andrews, Banting et al. (282)) 1 in 10 
 
 
Secondary antibody for immunostaining Supplier Dilution 
Goat anti-mouse FITC  Abcam (ab6785-1) 1 in 200 
Goat anti-rabbit Texas Red Abcam (ab6719-1) 1 in 200 
 
 
Primary antibody for flow cytometry References Dilution 
Anti-P3X  (Kohler and Milstein (279)) 1 in 10 
Anti-SSEA3 (Shevinsky, Knowles et al. (280)) 1 in 10 
Anti-SSEA4 (Kannagi, Cochran et al. (281)) 1 in 10 
Anti-TRA-1-60 (Andrews, Banting et al. (282)) 1 in 10 
Anti-A2B5 (Eisenbarth, Walsh et al. (283)) 1 in 10 
 
 
Secondary antibody for flow cytometry Supplier Dilution 
Goat anti-mouse FITC  Abcam (ab6785-1) 1 in 200 
IgM secondary antibody Jackson Laboratory 1 in 200 
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Primary antibody for western blotting Supplier Dilution 
Anti-GAPDH  Abcam (ab9483) 1 in 1000 
Anti-OCT4-A mouse monoclonal Santa Cruz (sc-101534) 1 in 1000 
Anti-Ku80 rabbit monoclonal Abcam (ab79391) 1 in 500 
Anti-Grp75 mouse monoclonal Abcam (ab82591) 1 in 500 
 
 
Secondary antibody for western blotting Supplier Dilution 
Bovine anti-mouse HRP conjugated Santa Cruz (sc-2371) 1 in 10000 
Chicken anti-rabbit HRP conjugated Santa Cruz (sc-2955) 1 in 10000 
 
 
 
5.2.3 Immunofluorescence Staining Studies 
 
 
Both hESCs and ZFNiPSCs were grown on a 24 well-plate at 1 × 10
4
 approximately to obtain 
sub-confluence at 70-80%. The cells were washed with PBS (Ca
2+
/Mg
2+
-free) twice and then 
fixed using 4% paraformaldehyde solution in PBS for 15 min. After fixation, cells were 
washed three times for 5 min each with PBS. For immunofluorescence, the fixed cells were 
blocked with 20% fetal calf serum (FCS) in PBS for 30 min followed by incubation with 
primary antibody diluted in 200 µL of blocking solution for 1 hour at 4 °C. Once the primary 
antibody incubation was finished, cells were washed with PBS three times for 5 min each. 
Secondary antibodies were used at a dilution of 1:200 in blocking solution. The secondary 
antibody staining was performed for 1 hour at 4 °C. Cells were then again washed with PBS 
three times for 5 min each. The well containing the immunostained cells were finally 
mounted with 200 µL of 10 µg/mL Hoechst 33258 in PBS and incubated for 5 min at room 
temperature. Once finished, the solution was removed and 0.5 mL of PBS was added to the 
well. The plate was then subjected to fluorescence microscope (Olympus IX70).  
 
5.2.4 Flow Cytometry Studies 
 
Both hESCs and ZFNiPSCs were grown on T-flask and washed with PBS twice. Cells were 
dissociated at single cell level using 1 mL of 0.25% trypsin for 5 min in gas-jacket incubator 
equilibrated with 5% CO2 at 37°C. Afterwards trypsin was neutralised with 10% FCS in PBS. 
Cells were counted using a haemocytometer, and were taken at 10
5
 cells per staining reaction 
into a new 15 mL tube. Cells then were centrifuged at 1200 rpm for 3 min and the 
supernatant was carefully removed. 100 µL per staining reaction of 10% FCS in PBS was 
115 
 
added into the 15 mL tube containing 10
5
 cells. Cells were resuspended and were alliquotted 
at 100 µL volume into FACS tube. Primary antibody incubation was performed on live cells 
and incubated for 30 min at 4 °C. Once the primary antibody incubation was finished, cells 
were washed with 3 mL of 10% FCS in PBS by centrifugation at 1200 rpm for 3 min. The 
supernatant was then carefully removed just about the line at the bottom of the FACS tube, 
which obtained the volume of 200 µL. Secondary antibody incubation was performed by 
adding 1 µL of  the goat anti-mouse FITC-conjugated IgG + IgM secondary antibody to the 
cell suspension. The incubation was done for 30 min at 4 °C. After secondary antibody 
staining, cells were washed with 10% FCS in PBS by centrifugation at 1200 rpm for 3 min. 
The supernatant was again carefully removed just about the line at the bottom of the FACS 
tube. The cell suspension was gently flicked and 0.5 mL of 10% FCS in PBS was finally 
added to the FACS tube. Flow cytometry acquisition analysed 10
4
 independent events using a 
bench-top flow cytometer (Cyan, Dako). The Summit software (Dako) was employed for 
analysing flow cytometry data. 
 
 
5.2.5 RNA Extraction, Quantification, and Quality Control  
 
 
Total RNA was extracted from cells using the TRIZOL reagent (Invitrogen). The TRIZOL 
reagent consists of a mixture of guanidine thiocyanate and phenol in a monophase solution 
and is able to separate DNA, RNA, and protein following lysis of cells. After adding 
chloroform, the mixture separates into an aqueous phase conataining RNA, an interphase 
containing DNA, and an organic phase containing proteins.. To extract RNA from cells, cell 
pellets were collected, washed, and then were resuspended in 1 mL of TRIZOL reagent. Cells 
were thoroughly lysed by repeated pipetting and vortexing to form a homogeneous lysate and 
were incubated on ice for 30 min. After the incubation, the solution was centrifuged at 12000 
rpm for 10 min at 4
o
C. The supernatant was then transferred into a new 1.5 ml tube. 0.2 mL 
of iced-cold chloroform was then added per mL of TRIZOL reagent used. The resulting 
mixture was incubated on ice for another 30 min and centrifuged at 14000 rpm for 15 min at 
4 °C. The centrifugation separates the mixture into 3 phases. The colourless upper aqueous 
phase which contains the RNA was carefully transferred into a fresh tube to which 0.5 mL of 
iced-cold isopropanolol is added per mL of TRIZOL reagent used. The mixture was then 
allowed to stand overnight at -20 °C, followed by centrifugation at 14000 rpm for 20 min at 4 
°C to pellet RNA. The RNA precipitates as a pellet on the side and bottom of the tube. The 
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supernatant was then removed and the RNA pellet was washed with 1 mL of iced-cold 75% 
ethanol. The sample was subsequently centrifuged at 14000 rpm for 10 min. The supernatant 
was removed and the RNA pellet was air-dried for 20 min at room temperature, prior to 
dissolution in 0.01% DEPC-treated sdH2O. 
 
RNA concentration was determined using a UV spectrophotometer (Beckman). The 
absorbance of each sample at 260 and 280 nm was also assessed using the same instrument. 
Only samples exhibiting 260:280 ratios above 1.5, which is acceptable purity of RNA 
samples, were utilised for subsequent experiments. 
 
5.2.6 First Strand cDNA Synthesis 
 
 
First strand cDNA synthesis was performed using the following reagents and protocol: 
 
5 µL of 0.2 µg/µL RNA sample 
1 µL of 0.5 µg/µL random hexaprimers (MWG Eurofins) 
1 µL of 1 µg/µL 18-nucleotide oligo-dT (MWG Eurofins) 
3 µL of DEPC-treated sdH2O to adjust a final volume to 10 µL 
 
The mixture was heated to 70 °C for 5 min for annealing of the primers to RNA and then 
cooled down at 4 °C in a PCR machine (Applied Biosystems). 
 
The sample was mixed with following cocktail reagents: 
 
4 µL of 5X RT buffer (Invitrogen) 
2 µL of 0.1 M DTT (Invitrogen) 
1 µL of 10 mM dNTPs (Invitrogen) 
2 µL of DEPC-treated sdH2O to adjust a final volume to 10 µL 
 
The contents in the tube were mixed gently and incubated at 25 °C for 5 min. 1 µL (200 
units) of MMLV reverse transcriptase (Invitrogen) was added and mixed by gentle pipetting, 
followed by a further incubation at 25 °C for 5 min. The mixture was then heated to 42 °C for 
60 min, after which the reaction was inactivated by heating at 70 °C for 10 min and placing at 
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4 °C on hold. The completed reaction mixture was diluted 1 in 2 with sdH2O and was directly 
used for PCR or stored at -20 °C. 
 
 
5.2.7 Quantitative Reverse Transcriptase Polymerase Chain Reaction 
 
 
Primers were designed using the Primer Premier software. Only primer pairs yielding a PCR 
product with the size between 150 to 400 base pairs were chosen for synthesis. Details of 
primers used are shown below. 
 
Gene Forward Primer Reverse Primer 
HSPA9 TCTGGACTGAATGTGCTTCG ATCCCCATTTGTGGATTTCA 
XRCC5 CCCCAATTCAGCAGCATATT CCTTCAGCCAGACTGGAGAC 
ACTB AAACTGGAACGGTGAAGGTG AGAGAAGTGGGGTGGCTTTT 
 
 
Quantitative RT-PCR was performed in a 96-well plate (Cell Projects) using the following 
reagents and protocol:    
 
1 µL of cDNA template 
2 µL of 10 µM forward and reverse primer mixture (MWG Eurofins) 
10 µL of 2X SYBR Green JumpStart Taq ReadyMix (Sigma) 
7 µL of sdH2O to adjust a final volume to 20 µL  
 
Polymerase chain reaction was performed under the following conditions for 49 cycles using 
iQ5 machine (Bio-Rad): 
 
94 °C for 2 min 
94 °C for 15 s; 60 °C for 30s; 72 °C for 1 min 
 
After the PCR process was done, the reaction was continued for a melting curve analysis 
using the following conditions: 
 
94 °C for 1 min 
55 °C for 1 min 
Repeat for 80 cycles with an increase of 0.5 °C per 10 s for every cycle 
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In order to ensure accuracy, a housekeeping gene (ACTB) was simultaneously performed to 
normalise the expression of genes of interest. Three technical triplicates were performed in 
every quantitative RT-PCR reaction. 
 
5.2.8 Protein Extraction and Quantification 
 
 
Protein Extraction and Quantification for 2D-DIGE 
 
Both hESCs and ZFNiPSCs were washed twice with PBS and were collected by using cell 
scrapers. Cell pellets were solubilised in 2-DE sample buffer containing 7 M urea, 2 M 
thiourea, 4% w/v CHAPS, and 30 mM Tris-base with complete protease inhibitor (Roche). 
The samples were alternately vortexed and put on ice every 2 min until a clear solution was 
obtained. The samples were harvested by centrifugation at 14000 rpm for 30 min at 4°C. The 
supernatant was collected for further analysis and were stored at -80 °C. Protein 
concentration was determined by using detergent-compatible Bradford assay (Bio-Rad) as 
previously described in section 3.2. 
 
Protein Extraction and Quantification for Western Blotting Analysis 
 
 
Both hESCs and ZFNiPSCs were washed twice with PBS and were collected by using cell 
scrapers. Cell pellets were resuspended in 100 µL of RIPA buffer. The samples were 
disrupted by a sonicator using 14% of amplitude for 10 s with intervals of 10 s each for 3 
min. Then the samples were subsequently centrifuged at 14000 rpm for 10 min at 4 °C.  The 
supernatant was collected into a new 1.5 mL tube for further analysis and were stored at -80 
°C. 
 
Protein concentration was performed using the bicinchoninic acid protein assay (BCA) kit 
(Thermo Scientific). The BCA assay relies on the formation of a Cu
2+
-protein complex under 
alkaline conditions, followed by the reduction of Cu
2+
 to Cu
1+
. The amount of reduction is 
proportional to the protein present. BCA forms a purple-blue complex with Cu
1+
 in alkaline 
environments, thus providing a basis for monitoring the reduction of alkaline Cu
2+
 by 
proteins. The procedure made use of 50 µL of a prepared protein sample and 1 mL of the 
prepared BCS working solution. A standard curve was first generated using bovine serum 
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albumin (BSA) protein standards of different concentrations in triplicates. Once the BCA 
working solution was added to the prepared protein sample and standards, the mixture was 
incubated for 30 min at 37 °C, followed by cooled down for 5 min at room temperature. The 
absorbance of the solution was then measured at 562 nm using a spectrophotometer 
(Unicam). The protein concentrations of the protein samples were subsequently determined 
by comparing the absorbance of the unknown samples to the generated standard curve. 
 
5.2.9 2D Difference in-gel Electrophoresis (2D-DIGE) 
 
 
Protein-Cyanine Dye Labelling 
 
 
CyDye Flour Dyes (Cy3 and Cy5, GE Healthcare) were used for fluorescent pre-labelling of 
the protein samples. The dye preparation and labelling process was done as previously 
described in section 3.1.2 and 3.2. Two-dye labelling approach was employed in this study as 
shown in the following ratio of amount of protein to dye used in each gel. 
 
Gel number 1 50 µg pooled sample * with 400 pmol Cy3 + 50 µg hESC with 400 pmol Cy5 
Gel number 2 50 µg pooled sample with 400 pmol Cy3 + 50 µg hESC with 400 pmol Cy5 
Gel number 3 50 µg pooled sample with 400 pmol Cy3 + 50 µg hESC with 400 pmol Cy5 
Gel number 4 50 µg pooled sample with 400 pmol Cy3 + 50 µg ZFNiPSC with 400 pmol Cy5 
Gel number 5 50 µg pooled sample with 400 pmol Cy3 + 50 µg ZFNiPSC with 400 pmol Cy5 
Gel number 6 50 µg pooled sample with 400 pmol Cy3 + 50 µg ZFNiPSC with 400 pmol Cy5 
 
* Pooled sample contained 25 µg of hESC and 25 µg of ZFNiPSC protein sample 
 
2D Gel Electrophoresis and Gel Image Acquisition 
 
 
First and second dimensional electrophoresis was performed with Immobiline IPG DryStrip 
gel (24 cm pH 4-7, GE Healthcare) and 12% Tris SDS gels (26×20×0.1 cm), respectively. 
The running conditions for first and second dimension was employed as previously stated in 
section 3.2. Typhoon 9410 scanner was used to obtain images after protein separation. The 
Cy3 images were obtained using laser at the excitation/emission values of 532/580 nm BP30 
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while the Cy5 images were obtained using the laser at the values of 633/670 nm BP30. The 
same PMT of 520 V or 540 V was applied for either Cy3 or Cy5 image, respectively.  
 Image Analysis 
 
The images were analysed using two software packages for DIGE experimental analysis, 
including DeCyder
TM 
V6.5 (GE Healthcare) and Progenesis SameSpots V3.0 (Non-linear 
Dynamics). Identical cropped images for both Cy3 and Cy5 images were analysed using 
default detection parameters. For DeCyder, DIA (Differential In-Gel Analysis)and BVA 
(Biological Variation Analysis) modes were used for analysis. For Progenesis SameSpots, the 
experiment was created in multiple stains experiment with internal standard mode. 
 
 
Post-Stain and Spot picking  
 
 
A total-protein stain with Coomassie Blue was applied after DIGE quantitation analysis. This 
post-stain gel was used as the basis for spot picking. Spots of interest were picked from the 
central of spots in two replicates. 
 
5.2.10 Protein Identification by Mass Spectrometry (LC-MS/MS) 
 
 
This identification process was performed by a collaborator, Dr. Jun Wheeler at the National 
Institute of Biological Standards and Control. Briefly described, protein spots of interests 
were excised from the preparative gels, and digested with trypsin. LC-MS/MS was carried 
out using a mass spectrometry system equipped with a nano-electrospray ion source and two 
mass detectors i.e. linear trap (LTQ) and orbitrap (Thermo Electron, UK), coupled with an 
Ultimate 3000 nano-LC system, comprising a solvent degasser, a loading pump, a nano-
pump, and a thermostated autosampler (Dionex, UK). After an automated injection, the 
extracted peptides from each digestion was desalted in a trapping cartridge (PepMap reversed 
phase C18, 5 mm 100 Ǻ, 300m id x 5 mm length) (Dionex) and eluted on to a C18 reversed 
phase nano-column (3 mm, 100Ǻ, 5 cm length) (Dionex), and followed by a 20 min 
separation under a column flow rate of 0.3 µL/min using linear gradient from 5–70% 
acetonitrile and 0.1% formic acid. 
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Mass spectra were processed and database searched using Proteome Discoverer v.1.0 with 
built-in Sequest (Thermo Electron) and Swiss-Prot database 56.4. Initial mass tolerances for 
protein identification by MS were set to 10 ppm. Up to two missed tryptic cleavages were 
considered and methionine oxidation and cysteine carboxyamidomethyl were set as dynamic 
and static modifications, respectively. Peptide sequences by MS/MS were only included 
when Xcorrelation scores were greater than 1.5, 2 or 2.2 for charge states 1, 2 and 3, 
respectively. An unambiguous identification was considered when at least two peptides 
matched to the human protein, and the peptide must be in the rank 1 and only present in the 
top scored protein. 
 
5.2.11 Western Blotting 
 
Protein samples were prepare at 2 µg/µL with a protein loading buffer (250 mM Tris-Cl pH 
6.8, 10% w/v SDS, 50% v/v glycerol, 5% v/v 2-mercaptoethanol, and 0.5% bromophenol 
blue). The mixture was then incubated at 95 °C for 5 min. 20 µg of protein samples was 
loaded in each well of the gel. The first well of the gel was loaded with 2.5 µL of pre-stained 
protein ladder (GE Healthcare), which upon separation allows the detection of protein sizes 
between 12 to 225 kDa. The electrophoresis was performed using 100 Volt set on a power 
supply (Bio-Rad) until the front dye reached at above the bottom of the gel. 
The separated proteins were then transferred on to polyvinylidine fluoride (PVDF) 
membranes (Bio-Rad). A wet-transfer blotting system (GE Healthcare) was employed for 
protein transfer. When assembling a cassette, a fibre pad, 2 Whatman filter papers, SDS-
PAGE gel, a PVDF membrane, 2 Whatman filter papers, and a fibre pad were gathered in the 
following order. Importantly, the cassette was inserted into the chamber with the PVDF 
membrane side facing toward the positive end of the electrode, followed by putting the 
cassette in a foam box covering with plenty of ice to maintain temperature during the 
transferring process. A constant electric current of 300 mA was applied for 2 hours 
 
The electrotransferred PVDF membrane was washed with blotting TBST buffer (10 mM 
Tris-Cl pH 7.6, 136 mM NaCl and 0.1% v/v Tween-20) and blocked in 5% non-fat milk 
diluted in TBST solution for 1 hour. The membrane was then incubated with primary 
antibody diluted in blocking solution overnight at 4 °C. Bovine anti-mouse or chicken anti-
rabbit HRP-conjugated IgG antibody was used as secondary antibody in the same diluents as 
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for the primary antibody. The membrane was incubated with secondary antibody for 1 hour at 
room temperature. Finally, the membrane was washed 3 times for 5 min each with TBST 
buffer and visualisation of protein bands was achieved with ECL Western Blotting detection 
reagent (Thermo Scientific). Then a developing process was performed in a dark room with 
an X-ray film (GE Healthcare) and developing machine (Kodak). 
 
 
5.3 Results and Discussion 
 
 
5.3.1 Characterisation of hESCs and ZFNiPSCs 
 
Both hESCs and ZFNiPSCs were characterised for stem cell state and differentiation. As 
shown in Figure 42, the cells were observed under phase contrast and fluorescent microscope. 
The detected markers used to show stem cell properties of both cell populations were SSEA-
3, SSEA-4 and TRA-1-60. P3X was used as a negative control study for the experiment. 
Results showed positive staining of all stem cell markers in both hESCs and ZFNiPSCs. 
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Figure 42. Immunofluorescent Staining Studies of Pluripotent Markers for both hESCs and 
ZFNiPSCs. Characterisation for pluripotent properties of ZFNiPSCs and hESCs is performed to 
ensure the suitable use of both cells for proteome comparison. Both cell populations showed 
positive staining for SSEA-3, SSEA-4 and TRA-1-60 markers (Green), representing pluripotent 
characteristics in both hESCs and ZFNiPSCs. P3X used as a negative control. Hoechst dye used 
for nuclear staining (Blue).   
 
 
 
Further characterisation of pluripotency for both hESCs and ZFNiPSCS were performed 
using flow cytometry studies (Figure 43). The same stem cell markers were used for 
detection, including SSEA-3, SSEA-4, and TRA-1-60. P3X was also used as a negative 
control for the studies. A2B5 marker is a cell surface antigen, representing neuronal property, 
was used to observe differentiated cell population in both hESCs and ZFNiPSCs. Results 
showed similarly quantitative percentage of stem cell properties in both cell groups and some 
of the cell population in both groups were differentiated as representing in positive A2B5 
markers. 
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Figure 43. Flow Cytometry Studies of Pluripotent and Differentiated Surface Markers for 
both hESCs and ZFNiPSCs. Characterisation for pluripotent properties of ZFNiPSCs and 
hESCs is performed to ensure the suitable use of both cells for proteome comparison. Both cell 
populations showed positive staining for SSEA-3, SSEA-4 and TRA-1-60 markers in relatively 
similar percentage of positive staining in each pluipotent markers. P3X used as a negative 
control. A2B5 used as a differentiated marker and the results showed some of the cell population 
in both groups were differentiated. 
 
 
 
5.3.2 Optimisation for 2D Gel Electrophoresis Conditions for hESCs and ZFNiPSCs  
 
The strip was focused in the first dimension with the following steps: (1) 300V, step, 3 hrs; 
(2) 300V-1000V, gradient, 9 hrs ; (3) 1000V-3500V, gradient, 4 hr ; (4) 3500V-10000V, 
gradient, 4 hr; (5) 10000V, step, 3 hrs; (6) 10000V-1000V, gradient, 3.6 hrs; (7) 1000V-
300V, gradient, 30 min, to achieve the approximate total focussing of 75 kVhrs. 
 
Both cell lysates from hESCs and ZFNiPSCs were used to test for optimal conditions for 2D 
gel electrophoresis. The strips used in the optimisation step were pH 3-11 NL and pH 4-7. 
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Figure 44. Optimisation for 2D Gel Electrophoresis Conditions suitable for hESCs and 
ZFNiPSCs Lysates. 24 cm Immobiline strips (pH 3-11 NL, top, and pH 4-7, bottom) were used 
to assess optimal conditions for 2D gel electrophoresis with total focussing of 75 kVhrs during 
IEF step. 
 
 
Results from the optimisation for 2D gel electrophoresis conditions were shown in Figure 44. 
Immobiline strips with pH 3-11 NL demonstrated more comprehensive global protein 
expression as seen in both of the gels in top panel of Figure 44. As expected, protein lysate 
from both of the cell types showed narrow range of protein expression where Immobiline 
strips with pH 4-7 were applied (Figure 44 bottom panel). However, the pattern of protein 
spots where strips with pH 4-7 were used indicated more resolved spots with round shape and 
better resolution, comparing to the ones from pH 3-11 NL. Therefore, the strips with pH 4-7 
were selected to perform comparative study with the optimal conditions tested. However, it 
would be best to use another strip with narrow pH range to cover basic proteins in cell lysates 
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but as seen in top panel of Figure 44 the more basic proteins towards the right positions of the 
gel showed protein pattern with difficulty to get resolved. Therefore, to perform an additional 
narrow range pH strip covering basic proteins in this study might not be practical. 
 
5.3.3 2D-DIGE for hESCs and ZFNiPSCs 
 
2D-DIGE experiment was performed according to the protocol provided in section 5.2.9. Gel 
results from pooled internal standard sample labelled with Cy3 dye were shown in green 
colour in Figure 45. Gel results in red colour represented protein samples of hESCs and 
ZFNiPSCs labelled with Cy5 dyes in three replicates for each cell population. 
    
 
 
 
Figure 45. Gel Results of hESCs and ZFNiPSCs from 2D-DIGE Experiments. Each gel 
produced two images, being one from pooled internal standard sample labelled with Cy3 dye 
(green) and the other from either hESC or ZFNiPSC lysate labelled with Cy5 dye (red). Three 
replicates were achieved for each cell population. 
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To observe the gel images clearer, gel 1 and gel 4 from Figure 45 were selected to be 
demonstrated in larger size (Figure 46). 
 
 
 
 
 
Figure 46. Gel 1 and Gel 4 of hESCs and ZFNiPSCs from 2D-DIGE Experiments in Larger 
Size. Each gel produced two images, being one from pooled protein lysate labelled with Cy3 dye 
and the other from either hESC or ZFNiPSC lysate labelled with Cy5 dye. When performing 
comparatively quantitative analysis, intensity of each spot from sample lysate (Cy5 image) was 
normalised against intensity of that from pooled protein lysate (Cy3 image) to provide accurate 
quantitative comparison across the gels. 
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5.3.4 Software Analysis for Quantitative Comparison 
 
By using DeCyder software program to analyse gels for quantitative changes between hESC 
and ZFNiPSC population, master images for both groups were shown in Figure 47. Analysis 
data was shown in Table 13, representing fold change, ANOVA score, number of spot 
appearance across experiment, and spot intensity. In Table 13, only spots with statistically 
significant change in expression level between hESCs and ZFNiPSCs were included and spot 
number was orderly presented according to the intensity of individual spot from maximal to 
minimal intensity. 
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Figure 47. Master Images for hESCs and ZFNiPSCs. Equal amount of protein from hESCs 
and ZFNiPSCs was used for differential expression study using 24 cm strip with pH 4-7. 
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Table 13. Analysis Data from DeCyderTM software program. Fold change, ANOVA score, 
number of spot appearance across experiment, and spot intensity were presented in the table. 
Spot number was orderly shown from maximal to minimal intensity. 
 
Spot 
number 
Master 
Number Appearance 
Fold change 
(ZFNiPS:hES) ANOVA 
Spot 
Intensity 
1 718 12 -8.05 0.022 137480 
2 1314 12 -1.6 0.00066 99021 
3 325 12 -1.58 0.022 86404 
4 707 12 -6.32 0.011 76882 
5 699 12 -7.36 0.028 73642 
6 1058 12 -2.09 0.0014 58354 
7 674 12 -2.16 0.046 49883 
8 969 12 1.23 0.0063 44386 
9 596 12 -1.7 0.022 38595 
10 694 12 -5.36 0.03 36955 
11 1243 12 -1.54 0.012 36813 
12 700 12 -6.34 0.016 34462 
13 660 12 -1.45 0.012 32050 
14 1124 12 -1.5 0.047 29219 
15 594 10 -1.35 0.043 22570 
16 691 12 -2.43 0.035 22408 
17 703 12 -4.45 0.0044 20683 
18 701 12 -5.52 0.008 15595 
19 1869 12 -1.39 0.046 12030 
20 1044 12 -1.32 0.03 11499 
21 656 10 -1.89 0.0012 11322 
22 1050 12 -1.64 0.019 11226 
23 1347 12 -5.41 0.00061 10177 
24 1048 12 -1.34 0.037 9379 
25 1917 12 2.21 0.00026 9048 
26 1345 12 -2.17 0.017 8345 
27 1182 12 -1.59 0.037 7014 
28 1245 12 -1.41 0.0059 6651 
29 1036 12 -1.25 0.028 6590 
30 1291 12 -1.65 0.0047 6363 
31 1298 12 1.16 0.028 6062 
32 711 10 -1.89 0.00077 6057 
33 1142 12 -1.26 0.021 5752 
34 1216 12 -1.93 0.035 5749 
35 1359 12 -3.93 0.03 5496 
36 666 10 -2.23 0.0042 5394 
37 704 12 -3.37 0.0028 5207 
38 686 12 -1.36 0.05 5072 
39 1147 12 -1.91 0.0097 4924 
40 465 12 -1.79 0.0058 4911 
41 637 12 -1.95 0.021 4810 
42 1272 12 -1.63 0.0086 4315 
43 1915 12 2.14 0.0042 4246 
44 1180 12 -3.31 0.032 4024 
45 1122 12 -1.87 0.032 3938 
46 1809 10 -2.03 0.031 3710 
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Spot 
number 
Master 
Number Appearance 
Fold change 
(ZFNiPS:hES) ANOVA 
Spot 
Intensity 
47 1222 12 -2.81 0.0015 3593 
48 154 12 -1.72 0.026 3583 
49 1120 12 -1.86 0.035 3512 
50 355 8 -2.3 0.0011 3441 
51 1455 12 -3.9 0.047 3349 
52 461 12 -2.05 0.015 3096 
53 349 12 -1.81 0.023 3069 
54 258 12 -1.59 0.0037 2752 
55 633 12 -1.7 0.0049 2585 
56 261 12 -2.06 0.0054 2512 
57 710 12 -1.98 0.015 2512 
58 157 10 -1.49 0.039 2299 
59 1742 8 1.3 0.019 2033 
60 356 8 -1.68 0.021 1979 
61 943 12 1.42 0.0007 1921 
62 585 10 -1.42 0.022 1344 
63 303 12 -1.81 0.0073 1117 
 
 
From data presented in the Table, in total, 63 spots showed differential expression between 
two population of cells with statistical significance (ANOAVA<0.05). Those spots were 
orderly demonstrated by using spot intensity from high to low intensity. The reason for this 
was that when performing spot picking for further protein identification, gels were post-
stained with Coomassie Blue in order to obtain spot visualisation. The more the intensity of 
individual spot represented within the gel, the more the blue-stained colour could be 
visualised after post-staining. Therefore, the gel spot picking was performed on the basis of 
spot intensity. However, this may limit the identification of some proteins with significant 
changes because those protein spots could not be stained and visualised easily on the gel due 
to their low intensity. 
 
Out of 63 spots shown in the table, the following spots could be visualised after Coomassie 
staining at least more than two gel replicates and excised with accuracy, including spot 
number 1-26, 30, 34, 35, 39, 43, 44, 46, 47, and 52. Thus, these spots were manually excised 
with precision and further used for protein identification by mass spectrometry. Figure 48 
represented all individual spot position which could be cut on the master gel. 
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Figure 48. Protein Spot Positions on the Gel. (Blue circle) Spot number of individual protein 
which was excised for mass spectrometry protein identification. 
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5.3.5 Mass Spectrometry Protein Identification 
 
Subsequently, the gel pieces of interest were prepared for tryptic digestion and then subjected 
to mass spectrometry for protein identification. Table 14 demonstrates the results of protein 
identification. 
 
Table 14. Protein Identification of Individual Protein Spot of Interest. Spot number, Fold 
change, ANOVA score, and Protein ID were provided in the table. (N/A=Not able to be 
identified, negative sign (-) means down regulation) 
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Individual mass spectrum and peptide sequence for each identified protein will be provided in 
the CD version of this thesis. From mass spectrum data, one single gel spot could generate 
multiple protein identifications. This is due to the statistical analysis of the identifications. 
The nature of the statistics provides the possible identifications which could possibly match 
to the peptide database. This also could lead to misidentification of the protein of interest. 
Careful consideration to interpret the results of the analyses should be applied. The process of 
the selection of the proteins for further study is another important step to obtain accurate 
information. Herein, all identified proteins with significant changes of expression levels more 
than two-fold were thoroughly looked for details of their functions in literatures. The proteins 
which might provide insight into metabolic pathways, cancer formation network, and 
pluripotency mechanism are of much interest. Subsequently, individual of the identified 
proteins from the mass spectrometry was checked for the accuracy of predicted pI and Mr 
with the experimental ones. Afterward, individual mass spectrum of the protein of interest 
was thoroughly looked. For instance, ratio of the fold change of spot 52 was -2.05. The mass 
spectral from spot 52 provided multiple protein hits, including trypsin, ATP dependent DNA 
helicase II protein, keratin, and other non-human proteins. The protein list of trypsin could be 
from the process of trypsin digestion of the identification. Keratin was possibly from the 
process of epithelial human contact from any process of the study including cell culture, 
protein collection and protein identification. Other non-human proteins hits may be due to the 
similar in some of the peptide sequences of these proteins with the mass spectra of this 
protein spot according to statistical analysis. This process of selection and exclusion of 
individual identified protein is vital in the accuracy of the results. Therefore individual mass 
spectrum need to be examined thoroughly in this process. 
 
As a result, two proteins including ATP dependent DNA helicase II protein and stress-70 
protein were selected for further investigation and validation. These two proteins 
demonstrated 2.05- and 2.43-fold down-regulated expression in ZFNiPSCs, respectively, 
from 2D-DIGE results. The ATP dependent DNA helicase II protein (Ku80 protein) involves 
in DNA double-strand break. This Ku80 protein is a product of XRCC5 gene. There have 
been several reports showing that Ku80 protein facilitates DNA repair and also involves in 
nonhomologous end-joining or homologous recombination (284-287). This, therefore, should 
result in an association between Ku80 DNA repairing function with predicted cancer 
suppression potential. However, one report demonstrated that Ku80 facilitated tumour 
growth, contrary to its assumed role as a caretaker tumour suppressor (288). In sum, the Ku80 
135 
 
protein plays a role in DNA repairing mechanism but the precise understanding how it 
suppresses or facilitates tumour formation and cancer must be further elucidated. In addition, 
the role of Ku80 protein in embryonic stem cell has been investigated. There were a few 
publications reporting the role of this protein related to embryonic stem cell. Ku80 deficiency 
in mouse embryonic stem cell have increased ionising radiosensitivity and defective DNA 
end-binding activity(289). These results also have been shown in Ku80-deficient mice (290). 
Based on literatures, no any publication of Ku80 protein function in iPSC has been described. 
In addition, this Ku80 protein has not been reported showing differential expression level 
between ESC and iPSC.  
 
Another protein of interest, being stress-70 protein (Mortalin protein), is the product of 
HSPA9 gene. This mortalin protein involves in cell cycle regulation with important roles in 
cellular senescence and immortalisation pathways (291, 292). It is differentially expressed in 
normal and cancerous cells. In cancer biology, malignant transformation of normal cells 
could be occurred by overexpression of mortalin protein (293). Elevated levels of mortalin 
expression also have been detected in association with cancerous tissue such as brain tumour, 
colorectal adenocarcinoma, liver cancer metastasis (294-296). However, the knowledge of 
the role of mortalin protein in embryonic stem cell as well as iPSC is still limited. Potentially 
its functions might be important and relevant to cell survival, control of proliferation and 
differentiation in embryonic stem cell. Therefore, the differential expression level of this 
protein between ESC and iPSC would also be worth for further investigation. 
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5.3.6 Quantitative PCR and Western Blotting 
 
 
 
 
 
Figure 49. Quantitative PCR and Western Blotting Results of Mortalin and Ku80 Proteins. 
(Panel A) q-PCR results of HSPA9 and XRCC5 genes, encoding mortalin and Ku80 protein, 
respectively. Relative RNA expression level of HSPA9 was decreased in ZFNiPSC population 
(2.7 fold). Level of RNA expression of XRCC5 showed slightly different between ESC and 
ZFNiPSC population. (Panel B) Western blotting results of mortalin (HSPA9 gene) and Ku80 
(XRCC5 gene) proteins. Both of the proteins demonstrated decreased levels of protein expression 
in ZFNiPSC population, corresponding to the results from 2D-DIGE analysis. OCT4 and 
GAPDH proteins were used as a pluripotent and housekeeping protein markers, respectively. 
 
 
Next, q-PCR and western blotting were employed to validate the differential expression of 
Ku80 and mortalin proteins between hESCs and ZFNiPSCs. The results of RNA and protein 
expression levels of mortalin protein (HSPA9 gene) showed a similar pattern of down 
regulation in ZFNiPSC when comparing to ESC population (Figure 49). This result also 
matched with the 2D-DIGE analysis, showing 2.43 decreased level of protein expression in 
137 
 
ZFNiPSC population (Table 14). For Ku80 protein (XRCC5 gene), the level of XRCC5 gene 
expression (Figure 49) was not differential expressed between hESC and ZFNiPSC groups. 
However, western blotting results for Ku80 protein showed significant difference of protein 
expression level between two cell populations (Figure 49). The result demonstrated a 
decrease expression level of Ku80 protein in ZFNiPSC, also corresponding to the 2D-DIGE 
results (2.05 down regulation, Table 14). Principally, it is not necessary that the abundance of 
the transcript always represent the abundance of the protein. In this finding, the expression 
level of XRCC5 gene did not represent significant change between these two cell groups, but 
the abundance of XRCC5 protein product which is the actual functional molecule within the 
cells showed a decreased level of expression in ZFNiPSC population. In summary, the levels 
of mortalin and Ku80 protein expression were both down-regulated in ZFNiPSC population 
in correspondence to the results of 2D-DIGE combined with mass spectrometry results as 
previously demonstrated. These two proteins have not been reported in differential profiles 
between ESC and iPSC population and may play an important role in the control of 
maintenance and differentiation processes of pluripotent stem cells along with the potential of 
tumourigenicity of these cells. These findings might pave the way for further investigation 
and elucidate the better insight into the mechanisms and pathways of stem cell biology.  
 
 
5.4 Conclusion  
 
In this study, reprogramming technology to generate iPSCs by the Zine Finger Nuclease 
Technology was applied. The utmost advantage of this technique in the generation of iPSCs 
over other techniques is that this method allows site-specific integration of the transgene and 
the removal of four introduced transcription factors after iPSCs has been generated, avoiding 
the risks of the host genome contamination with residual non-human sequences. To assess 
relevant molecular differences between ESCs and iPSCs is vital, given that even such subtle 
differences may impact their potential of clinically therapeutic use.  
 
Comparative proteomics analysis of hESCs and ZFNiPSCs was performed with 2D-DIGE 
technology combined with mass spectrometry. Thus far, three reports have been described 
direct proteomic differential comparison between hESC and iPSC generated by conventional 
methods (297-299). However, two proteins, demonstrating for differential expression in this 
study, are the novel proteins showing decreased levels of protein expression in iPSCs. These 
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two proteins are mortalin and Ku80 proteins which their functions involve in cell 
proliferation and DNA double-strand break repairing system, respectively. The roles of these 
two proteins have not been clearly elucidated in pluripotent stem cells and must be further 
investigated. These results may provide valuable insight into the factors which contribute to 
the control of pluripotent stem cells and the mechanisms of reprogramming. 
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CHAPTER 6 
 
 
SUMMARISATION 
 
 
General Discussion, Summary and Future Directions 
 
 
One of the most commonly used protein separation techniques in proteomics is 2D gel 
electrophoresis. Despite having been used extensively, 2-DE still has a number of technical 
challenges associated with its application to facing proteomics problems. DIGE technique has 
been developed to set up and give a better visual profile of complex protein mixtures in terms 
of quantitation, sensitivity and reproducibility. However, it still can be laborious and 
expensive. Furthermore, complete protein separation could be difficult to achieve and the 
reproducibility is still variable in gel-based proteomics. All these factors result in increased 
sample replicates needed in the discovery of biologically relevant protein expression changes. 
Among these challenges, the low-quality of protein samples prior to embarking on 2-DE, the 
cost of performing DIGE experiment, and the variations in software-based spot analysis are 
the primary technical issues in gel-based proteomics and limited the full potential of 2-DE 
performance. In this thesis, the technology implemented along with the currently available 
systems was investigated to overcome these challenges to enhance the gel-based proteomics 
workflow and achieve better outcomes. Finally, the use of gel-based proteomics in a 
differential proteome comparison was performed to investigate the differences between 
hESCs and iPSCs. The comparison of these stem cells by using global proteomics approach 
not only allows subtle differences observed to be used as potential protein markers for stem 
cell characterisation but also potentially provides a better understanding of the mechanistic 
pathways in stem cell biology from their protein differences. 
 
The second chapter discussed how the low quality of samples can affect the separation 
performance in 2D gel electrophoresis. To avoid running low quality samples on 2D gels and 
wasting valuable materials and time, samples were first analysed and quality checked using a 
multi-pixel capillary electrophoresis detection system. 
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Protein detection in multi-pixel capillary electrophoresis detection system is based on Label 
Free Intrinsic Imaging (LFII™) developed by deltaDOT. This sample screening step allows 
speeding up and improving the 2-DE gel outputs. Moreover, it also gives the opportunity to 
verify and relatively quantify protein expression. In the future, the validation of relative 
quantification potentially can be automated by a capillary electrophoresis-mass spectrometry 
platform, which provides the capability to characterise, identify, and quantitate 
simultaneously, in addition to sample quality screening. This will be a step towards the 
standardisation of gel-based proteomics. 
The third chapter discussed alternative cost-effective cyanine dyes for pre-labelling in 2D gel 
electrophoresis. As DIGE provides a very powerful method in proteomics, it has been widely 
used in several applications. In this chapter, to enhance wider user of this DIGE technique 
and further method development in gel-based proteomics, alternative cost-effective cyanine 
dyes with close structural properties to the DIGE CyDyes were used to perform a comparitive 
study between two sets of dyes. 
 
The results demonstrated that these cyanine dyes produce practically identical results to 
DIGE CyDyes, which allows sample multiplexing and accurate quantitation for differential 
proteome expression analysis. Future direction for this work is to use these alternative 
cyanine dyes in a practical experiment to determine the relevant differential proteome 
between biological samples. The use of this set of dyes was carried out, but not yet 
completed, to make a proteomics comparison between lung cancer cells cultured in 2D 
(Dimension) and 3D environments. An initial assessment of this set of dyes in this 
investigation suggested useful and reliable results of differential proteome profiles from these 
alternative cyanine dyes. 
 
The fourth chapter discussed software used for DIGE image analysis. The image analysis is 
one of the most important steps in gel-based proteomics. To obtain accurate and reliable 
information from gel-based proteomic experiments is largely dependent on data analysis by 
software packages. In this chapter, a comparison of the performance of three software 
packages designed for DIGE was performed.  
 
Each software package contained its own unique algorithms and provided different strengths 
and weaknesses. Sample type highly affected the results of the data analysis by each software 
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package. Based on the spot matching accuracy, Progenesis SameSpots outperformed the 
other two software packages. Even though all three software packages allowed automated 
analysis, with minimal user intervention the accuracy of the analysis was significantly 
increased. This leads to the future direction of this work which is to establish a standardised 
2D based proteomics workflow with emerging algorithms in providing fully automated 
system for data analysis with more accuracy and reliability. This will reduce the bias and 
keep the errors to minimum by user intervention. 
 
The fifth chapter discussed the use of gel-based proteomics as an application to stem cell 
proteomics. Stem cells, particularly embryonic stem cells, hold a great promise in the 
therapeutic use in clinical settings. The advent of human embryonic stem cells and induced 
pluripotent stem cells hugely drives ongoing research in the stem cell field. The best 
approach to characterise the properties of stem cells is to perform experiments in a global 
aspect, obtaining considerable amount of information in a single experiment. At the proteome 
level, the comparison between human embryonic stem cells and induced pluripotent stem 
cells was carried out by using 2D-DIGE and the results suggested only minor difference 
between these two cell populations.  
 
Furthermore, the results provided two intriguing protein candidates that were differentially 
expressed more than 2 fold between these two cell types. The two proteins are mortalin and 
Ku80 protein which are involved in cell proliferation and DNA double-strand break 
repairing. In future experiment, functional analyses of these two proteins are worth 
investigating for the roles of these two proteins in the reprogramming process and 
pluripotency maintenance. Furthermore, the gel-based experiment performed herein, even 
though more than a thousand proteins were compared, is rather limited to a certain protein 
range due to pI of the proteins compatible with the separation process. To study the 
comparison of these two cell types by using alternative expressional proteomic tools such as 
SILAC combined with powerful mass spectrometry may be useful in finding differential 
proteome expression in acidic or basic protein and obtaining more insight into the 
mechanisms of stem cell regulation. 
 
In sum, the results from this thesis comprised major parts, including the development of new 
technologies to enhance the efficiency of the gel-based proteomics workflow and the use of 
gel-based technologies to answer biological questions of stem cell biology. The new 
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screening method of sample quality for proteomics in chapter 2 could potentially be 
implemented in the proteomics workflow for quality control of the protein samples. The 
system could be used easily providing an opportunity to quickly check the quality of sample, 
however; the current method still needs at least one corresponding 2D gel result of each 
sample to compare with the quality of the eletropherogram signal from the screening process. 
The process could be improved. By adding known protein maker into the sample and running 
the system to check the quality of electropherogram signal of the known protein marker could 
provide an easier step to check the quality of protein sample by avoiding 2D gel result of 
each sample. This system could also be used for screening protein sample quality for other 
high-throughput analyses where the quality of protein samples are utmost important. 
Furthermore, the alternative set of dyes for differential proteome analyses and a suitable 
software package for the analyses of gel images have been investigated in chapter 3 and 4. 
This set of fluorescent dyes has been used in an experimental study for differential proteome 
analyses and also been used for optimisation process in chapter 5 with the stem cell samples. 
The experience in software analyses in the work of chapter 4 allowed more confidence in 
choosing the suitable software package and performing the analyses of 2D-DIGE gel images 
in chapter 5. The biological findings in chapter 5 revealed important different protein 
expression between human embryonic stem cells and human induced pluripotent stem cells. 
The primary objective of the differential protein study was to identify potential protein 
expression difference between these two cell populations, particularly proteins involving in 
carcinogenesis pathway. Due to genetic manipulation of the hiPSCs, these cells might pose a 
risk of cancer formation higher than hESCs. Thus, the profile of proteins involving in 
tumourigenicity may reveal the potential danger of hiPSCs when using in clinical 
therapeutics. Two of the differential proteins identified in the study played a role in cell cycle 
regulation and DNA repairing system of the stem cells, namely, mortalin and Ku80 proteins, 
respectively. Further functional analyses of these proteins using RNAi experiment would 
provide better understanding how these proteins regulate stem cell behaviour and whether 
hiPSCs pose more risk in tumour formation than hESCs.  In addition to these two proteins, 
other proteins involving in different functions also showed expressional difference such as 
alpha actinin and aminopeptidase B proteins. The overall set of differential proteins identified 
in Table 14 might provide essential information in the regulation of stem cell.  However, 
many proteins couldn’t be identified from the study possibly due to low abundance of the 
protein. Even some of the protein spots showed high Comassie staining but they by some 
means could not be identified by the mass spectrometry either. The differential proteome 
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study in chapter 5 can also be improved by using different proteomics approach such as 
SILAC and other mass spectrometry-based approach. The mass spectrometry–based approach 
might be able to analyse thousands of proteins at one single experiment. In addition, to 
fractionate whole proteome into subproteome would help providing more detailed results of 
protein expression particularly in the protein components of interest. In conclusion, as 
challenges in the field of stem cell biology increase, stem cell proteomics will be an 
important approach in deciphering the complexity of stem cells and providing better insights 
into stem cell behaviours. The development of the new proteomics technologies is essential to 
facilitate the robustness and accuracy in data acquisition in the field of stem cell proteomics.  
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Research Article
CE-based sample quality assessment prior to
2-D gel electrophoresis: Towards the
standardization of gel-based proteomics
2-DE remains one of the most commonly used separation techniques for complex protein
mixtures. This article describes a new approach to 2-DE sample assessment using SDS
capillary gel electrophoresis (in Beckman Coulter sieving medium) combined with multi-
pixel detection. The performance of this platform was investigated using protein samples
prepared for 2-DE. The capability to characterize 2-DE sample was tested and the results
show that the repeatability of peak migration time and intensity are better than 2% RSD.
The system gives good resolution, accurate molecular mass assignment, as well as
absolute and relative quantification of proteins. Notably, this study also demonstrates the
use of this platform to screen the quality of simple and complex 2-DE samples. Imple-
mentation of this technique in the proteomics workflow will not only improve the success
rate of 2-DE, but will also enable sample verification before 2-DE and allow the relative
quantification of proteins. The validation of differential protein expression is also
demonstrated using the combined information of relative molecular mass and relative
quantification. It is the first time that a rapid and visual evaluation method is reported for
the quality assessment of 2-DE samples.
Keywords: 2-D differential in-gel electrophoresis / 2-DE / CE / Gel-based
proteomics / Sample quality assessment
DOI 10.1002/jssc.200900819
1 Introduction
Proteomics, the study of proteins expressed by a genome, is
now an established field in the investigation of proteins
[1–3]. Since the term was first coined by Wilkins at a
scientific conference in Italy in 1994, proteomics has gone
through successive revolutions of method optimization and
technology development. A key aspect has been the
development of high-throughput methods and with the
introduction of immobilized pH gradients 2-DE has become
the workhorse of protein separation and a quick method for
comparing protein expression patterns. Up to 10 000
distinct protein and peptide spots can be separated on one
gel [4, 5]. In addition, proteins of interest can be easily
selected and identified using commercially available image
analysis software packages followed by proteolytic digestion
and protein identification by MS [6]. Nevertheless, there are
several drawbacks to this technique: it is limited to the
visualization of those proteins which are soluble in the 2-DE
buffer and have a pI and relative molecular mass within the
separation ranges of the first- and second-dimension gels.
2-DE is time consuming, does not lend itself to automation,
and, as a result of this, repeatability is poor. The sensitivity
and dynamic range of current visualization methods are
limited, which means that only the more abundant proteins
can be seen, and the low-abundant proteins cannot be
identified. Further drawbacks are that 2-DE is not quanti-
tative due to the staining technique used for the visualiza-
tion of protein spots, and each step requires lengthy
optimization and user intervention. In addition, sample
handling can easily introduce artefacts into the 2-DE
pattern, such as oxidation, side-chain modifications, and
spot elimination, if protein enrichment or fractionation is
used. In spite of these limitations, 2-DE is still the most
commonly used separation method because it is the
cheapest and yields visual results. The importance of
sample quality in 2-DE has led us to develop a new
application using CE combined with multi-pixel detection
for quality control of protein mixtures prior to separation by
2-DE.
CE is an efficient separation method that is widely used
in biochemical and pharmaceutical research [7–9]. Its
application in these fields stems from its speed as it allows
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high sample throughput, ease of automation, separation
efficiency, precision, and low sample volume. It makes the
analysis of volumes in the nanoliter range possible and is
low cost in terms of reagents, labor, and waste disposal
[10–12]. SDS capillary gel electrophoresis (SDS-CGE) is a
mode of CE that allows the separation of proteins coated
with SDS based on relative molecular mass. CGE has
advantages over slab gel electrophoresis in that the small
diameter of the capillaries allows better heat dissipation,
thereby minimizing band broadening due to Joule heating.
The typical internal diameter of the capillaries is between 25
and 100 mm, enabling high voltages to be used thereby
reducing run times. Very small amounts of sample can be
analyzed by CE and with high sensitivity, especially when
using fluorescent labels. CE can be automated and has the
potential for high throughput.
In SDS-CGE, the proteins are denatured and their
disulfide bonds are reduced. SDS binds to the dissociated
proteins in a constant ratio, which results in similar charge
densities for all the protein–SDS complexes [13–15]. Under
these conditions, separation using free solution electro-
phoresis would be impossible. Results from Takagi and
Karim [16] showed that protein–SDS complexes migrate
with similar velocities irrespective of the relative molecular
mass of the protein when separated in nonsieving CE
buffers. This study and that of others indicate that the
background electrolyte must contain an additive to aid
separation of protein–SDS complexes. The most common
way to achieve this is to add a polymer that acts as a
molecular sieve. Over the last two decades, a variety of
sieving matrices have been developed to aid the separation
of these complexes [17, 18].
In CE, proteins are typically detected using UV
absorption, LIF or by coupling to MS [19–23]. A significant
limitation when using UV absorbance detection is that
modest concentration LODs are attainable, in the range
from millimolar to micromolar. Detection sensitivity can be
considerably improved by performing multiple measure-
ments of an analyte [24, 25], although this is not usually
feasible in CE or other separation methods. Elution profiles
in separate traditional CE runs are not sufficiently repeat-
able simply to perform repetitive runs. Furthermore, the
time required to repeat sufficient runs to increase signifi-
cantly the S/N would be impractical because it varies
according to the square root of the number of runs. Alter-
natively, signal averaging may be achieved during a single
run by means of multiple point detection along the capillary
[24, 25]. The analyte signal from each detector pixel can then
be averaged to increase the S/N. The maximum S/N
enhancement achievable with this method then varies
according to the square root of the number of pixel detec-
tors.
The technology described in this article employs 512
consecutive photodiode pixel detectors, each having a width
of 25 mm, producing a 1.25 cm linear array along the capil-
lary. Each photodiode acquires the signal at up to 30 Hz
generating 512 multiply sampled electropherograms,
thereby improving significantly the LOD by UV absorbance.
For more detailed description, see [25, 26].
In this article, we describe the performance of CE
separation combined with multi-pixel detection for protein
analysis. The sensitivity, quantification, mass assignment,
and linear and dynamic range of the system were tested
along with repeatability and resolution. All protein samples
used were prepared in standard 2-DE buffer, enabling
complementary use of this multi-pixel CE platform
approach with established and canonical 2-DE techniques.
2 Materials and methods
2.1 Performance assessment of the multi-pixel
detection CE system using 2-DE protein samples
2.1.1 2-DE sample buffer
Briefly, 7 M urea (Bio-Rad, Hemel Hempstead, UK), 2 M
thiourea (Sigma, Gillingham, UK), 4%w/v CHAPS (Calbio-
chem, Nottingham, UK) and 30mM Tris (Sigma) was
prepared and mixed thoroughly.
2.1.2 CE system, procedures, and data processing
All protein samples were obtained from Sigma and
prepared in 2-DE sample buffer for separation in the CE
system. In total, 10 mL of the sample was added to 85 mL of
CE buffer (SDS-MW Sample Buffer, Beckman Coulter,
High Wycombe, UK) and 5 mL of b-mercaptoethanol
(Sigma). The samples were mixed thoroughly and degassed
before being loaded into the instrument. Separation was
performed on the Peregrine CE platform (deltaDOT,
London, UK). Samples were separated in a bare fused silica
capillary of 50 mm id (Composite Metal Services, Charles-
town, UK). The total length of the capillary was 34 cm and
the effective separation length was 22 cm. The instrument’s
Peltier thermal control system was held at 261C and the
absorbance was measured at 214 nm. The capillary was
conditioned by flushing with 0.1 M NaOH, 0.1 M HCl, and
water for 3 min at 2.07 105 Pa before every run. The CE
run buffer was flushed thoroughly through the capillary for
10 min at 4.14 105 Pa. Samples were loaded into the
capillary through electrokinetic injection at 5 kV (negative to
positive) for 25 s, and then separated between 12 and 17 kV
for 25–35min. The data obtained from the instrument were
processed using the P3EVA software package (deltaDOT).
2.1.3 Evaluation of repeatability and sensitivity
A sample of a-lactalbumin and ovalbumin in 2-DE sample
buffer was used to test repeatability. Twenty replicate runs
were performed. For sensitivity, a stock of 2 mg/mL
a-lactalbumin was used to create a sample series with
dilutions of 200, 100, 50, 20, 10, 5, 2, and 1 mg/mL. Three
replicate tests were performed at each concentration.
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2.1.4 Resolution evaluation
A mixture of five proteins in 2-DE sample buffer,
cytochrome c (12 400), a-lactalbumin (14 200), trypsin
inhibitor (20 100), carbonic anhydrase (29 000), and ovalbu-
min (44 300) was used to test resolution performance.
2.1.5 Evaluation of the relative molecular mass
assignment accuracy
Amixture of four proteins in 2-DE sample buffer was used for
mass calibration. The proteins used were ovalbumin (44 300),
albumin (67 000), phosphorylase b (97 400), and b-galactosi-
dase (166 000). A protein sample of glutamate dehydrogenase
was used to test the accuracy of the mass assignment.
2.1.6 Evaluation of the quantification accuracy
Five samples of albumin in 2-DE sample buffer at
concentrations of 100, 50, 25, 12.5, and 0 mg/mL were used
to construct a concentration calibration curve. Five different
concentrations of albumin were prepared and one sample
was selected randomly ‘‘blind’’ by the experimenter and
analyzed using the CE system. The 2D-Quant Kit (GE
Healthcare, Buckinghamshire, UK) was used to verify the
concentration of this blindly selected sample.
2.2 2-DE sample quality assessment with multi-pixel
detection CE system
2.2.1 Protein sample preparation
A mixture of five proteins, cytochrome c (12 400),
a-lactalbumin (14 200), carbonic anhydrase (29 000), ovalbu-
min (44 300), and glutamate dehydrogenase (55 000) was
prepared in three different sample buffers to represent the
satisfactory and poor 2-DE protein samples. The sample
buffers used were 2-DE sample buffer, 2-DE sample buffer
containing 50mM NaCl and 2-DE sample buffer without
denaturants (urea and thiourea). Three different qualities of
sample, prepared in three different sample buffers, were used
to perform the assessment on the multi-pixel detection CE
system complementary to the gel electrophoresis system.
2.2.2 Cell protein lysate preparation
Human type II pneumocyte tumor cell line ((A549 cells,
ATCC), VA, USA; ] CCL 183) were grown in F12K medium
(Invitrogen, Paisley, UK) supplemented with 10% v/v fetal
bovine serum (PAA, Yeovil, UK) and 2mM L-glutamine
(Invitrogen) in T75 flasks (Orange Scientific, Braine-
l’Alleud, Belgium). Cells were passaged at confluence and
washed three times with ice-cold PBS. Cells were then
removed from the flask using a cell scraper (Orange
Scientific) and dissolved in 2-DE sample buffer with
complete protease inhibitor (Roche, Hertfordshire, UK).
Finally, cells were sonicated for 30 s and samples were
centrifuged at 14 000 g for 30 min to remove cell debris.
Protein concentration was determined using the 2D-Quant
Kit. The 2D Clean-Up Kit (GE Healthcare) was used to
precipitate protein pellets. Protein pellets were resolubilized
with three different sample buffers and sample quality
assessment was performed as described previously.
2.2.3 Protein sample labeling for 2-DE
Protein samples were labeled with IC-OSu ethyl-Cy5 NHS
ester cyanine (IC5) dye (NBS Biologicals, Cambridgeshire,
UK) according to our previous protocol [27]. Briefly, a ratio
of 50 mg of protein samples was labeled with 400 pmol of
IC5 dye. The labeling reaction was carried out by incubation
on ice, in the absence of light for 30 min, at pH 8.5, and
quenched by the addition of 10 nmol of lysine. Subse-
quently, equal volumes of buffer containing 7M urea, 2 M
thiourea, 2% CHAPS, 2%w/v DTT, and 2%v/v IPG buffer
pH 3–10 nonlinear (GE Healthcare) were added to each
sample, in order to perform 2-DE.
2.2.4 2-DE and image acquisition
In total, 110 3 0.5 mm pH 3–11 nonlinear IPG strips
(catalogue no. 17-6003-74, GE Healthcare) were passively
rehydrated and subjected to IEF using the cup-loading
application as follows: (i) 500 V, 1 s, gradient; (ii) 500 V, 4 h,
step and hold; (iii) 1000 V, 1 h, gradient; (iv) 1000 V, 1 h,
step and hold; (v) 3500 V, 4 h, step and hold; (vi) 8000 V, 5 h,
step and hold for a total of 64 kVh. Prior to second-
dimension separation, the focused strips were equilibrated
in the equilibration buffer (50 mM Tris-HCl, pH 8.8, 7 M
urea, 2 M thiourea, 30%v/v glycerin, 2%w/v SDS, 20 mM
DTT, 0.01%w/v bromophenol blue) for 15 min. A second
equilibration was carried out in equilibration buffer contain-
ing 4%w/v iodoacetamide instead of DTT for 15 min.
Subsequently, equilibrated strips were overlaid onto a
precast Bis-Tris 4–12% polyacrylamide gel (Bio-Rad, Hert-
fordshire, UK) and ran at 40 V initially, then at 100 V until
the bromophenol blue dye migrated to the bottom of the
gels. Gels were imaged immediately using the Dyversity
(Syngene, Cambridge, UK) imaging system after the second
dimension. Gels were placed on a low-fluorescent glass plate
and the thick edges were removed to enable LED side
illumination. The exposure time was optimized to achieve
the maximum dynamic range.
2.3 Quantification validation for differential in-gel
electrophoresis with a multi-pixel detection CE
system
2.3.1 Protein sample preparation
Two samples, ‘‘A’’ and ‘‘B’’, containing different ratios of
the proteins of ovalbumin and albumin were prepared in
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2-DE sample buffer. Sample ‘‘A’’ consisted of 0.25 mg/mL
ovalbumin and 0.05 mg/mL albumin. Sample ‘‘B’’ consisted
of 0.05 mg/mL ovalbumin and 0.25 mg/mL albumin. The
samples were analyzed using the CE system and the 2-DE
system so that the relative quantification abilities of both
could be compared.
2.3.2 Liver protein lysate preparation
Two groups of 8-wk-old male C57BL/6 mice consisting of
five wild type (WT) mice and five IRS2/ mice were used
in this study. Livers were harvested and stored at 801C
immediately after removal. For protein lysate preparation,
whole livers were ground to a fine powder with a metal
mortar and under liquid nitrogen. This powder was then
added to a solution of 7 M urea, 2 M thiourea, and 4%
CHAPS at a ratio of 800 mL solubilization buffer/100 mg
powdered tissue, and solubilized using a glass homogeni-
zer. Samples were then centrifuged at 50 000 g for 45 min
and the supernatant was collected and stored in 200 mL
aliquots at 801C. The protein concentration was deter-
mined using a 2D-Quant Kit.
2.3.3 Relative quantification by differential in-gel
electrophoresis and relative molecular mass assign-
ment by MS
For the analytical differential in-gel electrophoresis (DIGE)
study, 50 mg of each protein extract was labelled with 400 pmol
of CyDye according to the manufacturer’s instruction (GE
Healthcare). The first-dimension IEF strips were rehydrated
overnight. First-dimensional focusing was performed using a
Multiphor IEF chamber (GE Healthcare) at 50mA/strip for
110 kVh at 201C, followed by the second-dimensional gel
electrophoresis. The analytical gels were imaged as above at
specific excitation/emission wavelengths. Gel image analysis
was performed with a Nonlinear Dynamics (Newcastle, UK)
software package by using more than 1.5-fold difference cut-
off. Protein spots of interest were extracted from the
preparative gels using a Coomassie blue post-staining
technique. Trypsin digestion coupled with Q-TOF II LC/
MS/MS was performed to determine the identities and
relative molecular masses of the proteins of interest.
2.3.4 Relative quantification and relative molecular
mass assignment by multi-pixel detection CE system
The WT and IRS2/ liver samples were used for the
conformation of DIGE results by CE. A total of 10 mL of the
homogenized liver sample was added to 85 mL sample buffer
and 5 mL b-mercaptoethanol. The sample was mixed
thoroughly and spun in a micro-centrifuge at 14 000 g
for 2 min. The supernatant was transferred to a glass
sample vial and run in the CE system. A protein molecular
ladder was also run in order to achieve the protein relative
molecular mass assignment and relative quantification,
based on the peak area, between the two samples.
3 Results and discussion
3.1 Establishment of the performance of the multi-
pixel CE platform
As described in Section 1, all performance tests were carried
out using protein samples prepared in 2-DE buffer. The
multi-pixel detection analysis software presents data in three
forms: single pixel electropherograms, Generalized Separa-
tion Transform (GST), the summed and averaged data, and
in the form of an equiphase vertexing map (EVA). The raw
electropherograms are processed to show a set of absorption
peaks. The GST algorithm maximizes S/N in such a way
that the shape information of the analyte peak is retained.
The EVA algorithm searches for and calculates the size and
position of analyte peaks by reference to the injection time
allowing a space–time equiphase map to be constructed.
The 3-D image generated enables the user to track the
macromolecule as it migrates past the detector. The slope of
the track generated may be used to calculate the linear
velocity of the analyte in the capillary. The height of the peak
relates directly to the concentration of analyte. A schematic
diagram of an equiphase map and the enhanced imaging
due to the vertexing process are shown in Fig. 1, with the
associated single pixel electropherogram that may be
derived from any single pixel in the detector. The tracks
observed in the detection window may be extrapolated back
to the injection zone so that peaks not originating in the
sample or moving in the opposite direction may be elimi-
nated from the processed signal. The improvement in S/N
between single pixel and multi-pixel data is shown in Fig. 2
and summarized in Table 1. The S/N values for the relative
molecular mass standards containing seven proteins are
listed. For the single pixel results, values were obtained
from the 256th pixel at the center of the detector.
Comparatively, an enhancement of between 10 and 15 times
S/N is observed for the multi-pixel GST-processed data.
The presence of EOF during a SDS-CGE separation
under reverse polarity can be simultaneously monitored. A
dual injection from inlet and outlet ends of the capillary was
performed; the protein relative molecular mass ladder was
injected from the inlet and the EOF marker (thiourea) from
the outlet. Figure 3 shows the equiphase maps produced
when analyzed from either direction, the band obtained from
the EOF marker is highlighted. Pixel reversibility in the
analysis software enables this function, allowing data analysis
from left to right or vice versa. The mobility of the EOF was
determined based on the migration time from the capillary
outlet with an effective length of 12 cm. An increase in
mobility values was observed after subtracting the effect of
the EOF from the mobility of the protein markers. In addi-
tion, the EOF was monitored under two inter-run capillary
rinses. The 1M NaOH rinse leads to higher apparent and
effective mobility values for all peaks when compared with
those determined for a 1M HCl rinse. The HCl rinse
conditions lead to a stable EOF (1.17 109m2V1 s1) with
a RSD value of 0.4% over ten separations.
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Repeatability and sensitivity were evaluated by running
a-lactalbumin and ovalbumin. Samples were prepared and
run under optimized conditions. The respective peak times,
proportional to protein relative molecular mass, and peak
areas, proportional to protein concentration, were recorded
for 20 replicate injections. The results showed high repeat-
ability in terms of peak time and peak area with RSD values
less than 2% in both parameters.
a-Lactalbumin was prepared at a stock concentration
of 2 mg/mL and a dilution series was set up from 200 to
1 mg/mL to test sensitivity. Figure 4 shows an overlay of
GST processed data for samples from 2mg/mL to 1 mg/mL.
The relationship between peak height or peak area and
protein concentration for unlabelled proteins depends on
the amino acid sequence of the protein. At 214 nm, the
peptide bond is the main absorbing moiety, with contribu-
tions from side chains particularly of the aromatic amino
acids, thus absorbance is a function of protein composition.
The observed LOD was 1 mg/mL for a-lactalbumin with an
S/N of 5 under the previously detailed separation para-
meters. Good linearity was observed over the concentration
range, R2 values being above 0.997 (data not shown). The
LOQ value obtained is also specific to the protein analyzed;
however, proteins which have comparable relative molecular
mass and show similar absorption profiles should have a
similar LOD and LOQ values in a label-free detection setup.
Resolution efficiency of separations was performed
using protein ladder consisting of five proteins of Mr 12 400,
14 200, 20 100, 29 000, and 44 300 (Fig. 5A). The separation
by relative molecular mass was shown to have a resolution
of at least 1800. The higher the relative molecular mass, the
wider the base of the peak appears. Separation matrices may
be tuned to attain a range of more appropriate pore sizes to
improve the resolution. However, if a wide range of relative
molecular masses needs to be covered, it is necessary to
select the optimum running conditions over a narrower
range of relative molecular masses in separate runs.
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Figure 1. A protein relative molecular mass ladder consisting of seven peaks of Mr of 10 000, 20 000, 35 000, 50 000, 100 000, 150 000, and
225 000 was separated to illustrate the enhanced imaging due to the vertexing process. Schematic diagram of equiphase (EVA) map and
single pixel electropherogram are shown. The detector also measures the intensity of the signal; this is shown by the color of the signal,
changing from darker to lighter. The analysis was performed on a capillary of effective length 10 cm and 50 mm id. The sample was
injected at 3 kV for 20 s and separated at a field strength of 456 V/cm.
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Figure 2. Single pixel and GST-processed data for protein
molecular mass ladder where peaks 1–7 represent relative
molecular masses 10 000, 20 000, 35 000, 50 000, 100 000,
150 000, and 225 000, respectively. Sample was separated on a
22 cm effective length capillary of 50 mm id. Sample was injected
at 5 kV for 20 s and separated under a field strength of 450 V/
cm. The enhancements in S/N are clearly shown. Table 1 lists the
improvements in S/N between them.
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The accuracy of relative molecular mass assignment
was also tested using a mixture of four standard proteins, in
a range of Mr (44 300, 67 000, 97 400, and 166 000). These
were prepared and run under the optimized conditions
(Fig. 5B) and the mobility value of each protein was used to
generate a mass calibration curve (Fig. 5B). Glutamate
dehydrogenase (55 000) was chosen as an ‘‘unknown’’
protein. The sample was prepared and run under similar
conditions as the calibration proteins. The results showed
two peaks whose relative molecular mass was estimated at
54 800 and 66 300 using the calibration curve (Fig. 5B). The
55 000 peak corresponded to the ‘‘unknown’’ protein
(glutamate dehydrogenase) and the 66 300 peak was iden-
tified as bovine serum albumin, which is used as a stabilizer
for the glutamate dehydrogenase sample.
Quantification is another important performance para-
meter for the characterization of 2-DE samples. The
proportionality of peak area to protein concentrations
enables accurate protein quantification. Albumin samples
of five different concentrations were prepared and run
under the optimized conditions (Fig. 5C) to create a
concentration calibration curve from a known standard.
The blind concentration sample was quantified using
both the CE calibration curve and the 2D-Quant Kit.
The estimated protein concentration of the blind sample
was 49.372.3 mg/mL (multi-pixel CE platform) and
48.772.0 mg/mL (2D-Quant Kit), compared with a notional
concentration of 50 mg/mL (Fig. 5C).
3.2 2-DE sample quality assessment using the multi-
pixel detection CE platform
High-throughput methods for protein expression profiling,
such as protein microarray [28], gel-based, or LC-based
proteomics [29], were developed to map the global proteome
profiles of cells, tissues, and whole organisms. These
techniques have gone through major technical development
in the last 10 years and provided the platform to countless
studies for the understanding of the relationship between
gene and protein expression profiles. The conclusions from
these large-scale experiments are that the most important
step of a successful study is the standardization of the initial
sample collection and preparation. Without paying special
attention to the consistency of sample collection, and
making sure that the protein samples are the highest
quality, the results cannot be interpreted and validated. The
genomics and transcriptomics community has already
developed methods for sample screening and quality
assessment of DNA and RNA samples [30, 31]. The
proteomics community is in the process of solving these
problems, particularly in respect of repeatability of
experimental methods and the establishment of standar-
dized protocols for the collection of clinical samples. Using
Table 1. S/N values for single pixel and GST-processed data for
protein molecular mass ladder of Fig. 2
Mr 10 000 20 000 35 000 50 000 100 000 150 000 225 000
S/N for
single pixel
73.77 41.97 21.62 23.53 10.17 3.18 3.82
S/N for GST-
processed
data
1295.84 794.79 445.52 486.45 154.33 35.37 41.17
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Figure 3. Separation of protein relative molecular mass ladder consisting of seven peaks – 10 000, 20 000, 35 000, 50 000, 100 000, 150 000,
and 225 000. (A and B) Equiphase maps processed from inlet and outlet ends of the capillary, respectively. The band generated by the
migration of the EOF marker (thiourea, 100 mg/mL) past the detector is labelled and highlighted. (C) The mobility versus size plots of
apparent and effective mobility of all seven protein peaks after 1 M NaOH or 1 M HCl preseparation capillary rinses.
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CE combined with multi-pixel detection proved to be
a very suitable platform for rapid screening of 2-DE
samples.
The two most common factors, which cause poor reso-
lution in 2-D gels, are the amount of salt in the sample and
the extent of denaturation of proteins. CE separation is also
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Figure 4. Sensitivity test: Left,
Overlay of EVA-processed data
for 200, 100, 50, 20, 10, 5, 2, and
1 mg/mL a-lactalbumin. Right,
Overlay of GST-processed data
for 10, 2, and 1 mg/mL a-lact-
albumin.
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adversely affected by salt concentration [32] and nondena-
tured proteins. This observation was confirmed by preparing
the protein samples in three different buffers (2-DE sample
buffer, 2-DE sample buffer containing 50mM NaCl, and
2-DE sample buffer without denaturants; urea and thiourea)
to reproduce low-quality 2-DE protein samples. A mixture of
five proteins was used to prove the concept and a protein
lysate from A549 cells, to test with a complex protein mixture.
Figure 6 shows the GST-processed electropherograms,
each showing the separation of the five proteins in different
sample buffers in comparison to the sample in the standar-
dized 2-D buffer (Fig. 6, top panel). In the presence of salt, all
five peaks were observed with a drop in signal intensity due
to preferential injection of highly charged salt ions. Increas-
ing salt content of the sample decreased the signal intensity
until they entirely disappeared (data not shown) and led to
current instability during the separation. Typically, electro-
kinetic injections are used in gel-based CE; here, the smaller
charged salt ions compete with proteins during the intro-
duction process. The disproportionate level of salt in the
sample and separation matrices leads to unstable current or
current stoppage and Joule heating. This caused inefficient,
broad peaks, and irregular baselines. The results, both in the
case of the known mixture and cell lysate, obtained in this
study agree with the literature: loss of resolution, unstable
baselines, and shorter peaks due to the bias in the electro-
kinetic injection were all observed. 2-DE samples with high
levels of salt also show loss of resolution and unresolved spots
compared with samples without salt (Fig. 6, middle and top
panels, respectively). The A549 cell lysate was prepared
containing the same salt concentration as the five known
proteins and separated both by CE and 2-DE. Results shown
in Fig. 7 further proved that salty samples produce low-
quality results both by CE and by 2-DE. Although for differ-
ent reasons, both CE and 2-DE are affected by salt contam-
ination and for this reason a poorly resolved CE run predicts
poorly resolved 2-DE of the same sample.
The five known proteins and the cell lysates were also
analyzed in the absence of denaturing reagents, urea, and
thiourea. The absence of urea also caused drop in signal
intensity as well as a loss in resolution as shown in the
bottom panels of Figs. 6 and 7. All the expected peaks of the
marker were observed, indicating that the SDS in the sample
buffer was sufficient to denature the protein. A similar result
was not observed in the lysates, the result obtained was one of
a few where the current remained stable. The instability
observed may be due to blockage of the gel by nondenatured
proteins and protein aggregates. In the lysate, fewer peaks
were observed with lower signal levels. 2-DE images were
poorly resolved as expected and very similar to the salty
versions (Figs. 6 and 7, bottom panels).
3.3 Relative quantification and confirmation of DIGE
results using the multi-pixel detection CE plat-
form
The recent advances in quantitative proteomics have opened
new avenues for a broad range of proteomic application,
providing tools to assess differential expression of protein
profiles in different samples [33, 34], which have become a
fundamental component of biomedical and clinical
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Figure 6. Proof-of-concept for
sample quality analysis using
five standard proteins. The
image shows the CE-GST-
processed data on the left and
the 2-DE results on the right.
The top panel, separation
under standard conditions;
middle panel, sample buffers
containing an additional
50 mM NaCl; and the bottom
panel, sample buffer without
denaturants. The 2-DE gels
were stained with Coomassie
blue. In standard panel, elec-
tropherograms showed six
peaks of proteins: 1, cyto-
chrome c (12 400); 2, a-lact-
albumin (14 200); 3, carbonic
anhydrase (29 000); 4, ovalbu-
min (44 300); and 5, glutamate
dehydrogenase (55 000),
including one extra protein,
albumin, 6, which is a stabilizer
for glutamate dehydrogenase
according to the product infor-
mation sheet (Sigma).
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research. DIGE is a method, which labels protein samples
with spectrally resolvable dyes prior to 2-DE, enabling
accurate analysis of differences in protein abundance
between samples [35–38]. DIGE is one of the most powerful
quantitative methods for comparative proteomics that offers
improved repeatability and confidence in spot matching and
quantification compared with traditional approaches. Quan-
titative and qualitative validation and further characteriza-
tion of large numbers of differentially expressed proteins are
both expensive and time consuming. Conventional methods
to confirm the quantity and identity of selected proteins are
ELISA and Western blotting. Both techniques rely on high-
quality antibodies. In many cases, the validation is limited
by the lack of availability of antibodies with high specificity.
CE combined with multi-pixel detection offers an alternative
high-throughput analytical method for quantification and
validation of differentially expressed proteins in complex
samples.
To test the performance for relative quantification of
proteins using the multi-pixel detection CE platform, two
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Figure 8. Left, GST-processed
mirror of fivefold mixture of
ovalbumin and albumin. Right,
Cy-dye-labeled 2-DE separa-
tion of fivefold mixture of oval-
bumin and albumin. CE peak
area gave a more accurate
relative quantification com-
pared with the 2-D image
analysis software.
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Figure 7. Quality analysis of
A549 whole cell lysates. The
image shows the CE-GST
processed data on the left
and the 2-DE results on the
right. The top panel, separa-
tion under standard condi-
tions; middle panel, sample
buffers containing an addi-
tional 50 mM NaCl; and the
bottom panel, sample buffer
without denaturants.
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different samples were prepared in 2-DE buffer, sample
A and sample B. Sample A consisted of ovalbumin
(250 mg/mL) and albumin (50 mg/mL). Sample B consisted
of ovalbumin (50 mg/mL) and albumin (250 mg/mL). The
electropherogram mirror plot showed that the differences of
ovalbumin and albumin were 4.8- and 5.1-fold, respectively,
between sample A and sample B (Fig. 8A). A fluorescent
prelabeling 2-DE comparison showed that the differences of
ovalbumin and albumin were 4.8- and 4.7-fold, respectively,
between sample A and sample B (Fig. 8B); therefore, a good
agreement between multi-pixel CE detection and 2-DE was
observed. High-quality multi-pixel CE detection electro-
pherogram results, which combine relative molecular mass
assignment with relative quantification performance, can be
used as a validation technique for 2-DE results for the
comparative analysis.
The complex biological samples, as an example, for the
validation of DIGE experiments were derived from two groups
of 8-wk-old male C57BL/6 mice. One group consisted of five
WT mice and the other group of five IRS2/ mice [39]. Mice
were housed under standard and identical conditions. Livers
were harvested and prepared for standard DIGE analysis as
described in the Supporting Information. Comparative analysis
of WT and IRS2/ groups using CE was employed to assess
changes in protein expression. Up and downregulation of the
most abundant proteins in the sample were observed over a
1.2- to 2-fold change. Mass assignments were also performed
for individual peaks and compared with those obtained by
DIGE coupled with MS and these are listed in Supporting
Information Table S1. Calculated masses of peaks in the CE
system were matched to the relative molecular mass obtained
from the MS identification, and then the fold change in protein
regulation was measured by both techniques and compared. A
common trend in expression levels between the two techni-
ques was observed (Supporting Information Table S1).
Complete resolution of all peaks in a cell lysate, using
commercially available CGE buffers, is currently unachievable,
even with long separation lengths and high voltages. This is
because of the resolving capability of the polymers employed.
In some cases, the signal observed may consist of several
peaks, which will affect the calculated changes in expression
levels and may lead to inconsistent interpretation when
compared with results obtained from DIGE coupled with MS.
High-quality multi-pixel CE detection electropherogram
results, which combine relative molecular mass assignment
with relative quantification performance, can be used as a
confirmation method of 2-DE results. The validation of relative
quantification is useful and potentially can be automated by
CE-MS platforms, which provide the capability to characterize
the identification and relative quantification simultaneously
toward the standardization of gel-based proteomics.
4 Concluding remarks
The aim of this study was to establish a method
complementary to 2-DE which enables the preelectrophore-
tic analysis of protein samples. The label-free multi-pixel
approach was combined with CE for the initial separation of
complex protein mixtures. All methods were optimized
using the standard 2-DE buffer system. As shown in Figs. 6
and 7, the suitability of sample for 2-D gel electrophoresis
could be presented by CE separation with multi-pixel
detection. This approach could be a rapid tool to predict
the suitability of the 2-DE samples, which is a significant
step toward the standardization of gel-based proteomics.
The CE platform will also support other high-throughput
proteomic technologies, standardizing protein quality
assessment across different methods. The rapid screening
method also saves time; a typical separation in 15–20min
lowers the consumable costs by improving 2-DE productiv-
ity and saves precious samples by using a small aliquot,
typically 10 mL, for quality screening. This method not only
proved to be satisfactory for the quality assessment of 2-DE
samples, but also allowed relative molecular mass assign-
ment and relative quantification. This method can be
further developed for other separations such as peptides
and monitoring of post-translation modifications using
other modes of CE.
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We report the use of IC-OSu ethyl-Cy3 and ethyl-Cy5 N-hydroxysuccinimide ester (NHS) cyanine
dyes, which have similar chemical properties as the CyDye™ DIGE fluor minimal dyes for pre-
electrophoresis labelling. Multiple sample analyses in different laboratories indicate that the use
of IC-OSu ethyl-Cy3 and ethyl-Cy5 NHS ester cyanine dyes produces equivalent results to those
obtained with DIGE CyDyes, and allows sample multiplexing and accurate quantitation for dif-
ferential proteome analysis.
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Comparative proteomics is widely used to analyse differ-
ential expression at the protein level due to disease or treat-
ment of cells with various stimuli. While the introduction of
heavy and light stable isotopic labelling enabled comparative
quantification using a direct LC and MS/MS approach, 2-DE
in conjunction with multiplexed fluorescence pre-electro-
phoresis labelling retains its merit, and is the method of
choice for protein separation and quantification due to its
high resolution and the parallel nature of the process. Dif-
ferential in-gel electrophoresis (DIGE) offers improved re-
producibility and confidence in spot matching and quantifi-
cation compared to traditional approaches [1–3]. Although
several new pre-electrophoresis labelling and multiplexing
strategies have been reported, e.g. using saturation mal-
eimide DIGE CyDye [4], BODIPY dyes [5] or Alexa fluor of
green and red (produced by Invitrogen), the use of CyDye™
DIGE fluor minimal dyes (GE Healthcare, Little Chalfont,
UK) is well established and widely accepted [2, 3, 6–8]. Two
cyanine dyes with similar chemical properties to the CyDye
DIGE fluor minimal dyes are commercially available for
antibody labelling. In this study, we explore the use of cya-
nine dyes for prelabelling and gel electrophoresis and report
comparative results demonstrating that these cyanine dyes
enable equivalent sample multiplexing and accurate quanti-
tation for differential proteome expression analysis.
Murine white blood cells (3 wk-old CD-1 (BR)), bacterial
Neisseria meningitidis (serogroup B) MC-58 DsiaD mutant
strain cells and human fibroblast cells (ATCC number
SCRC-1041) were harvested and washed. Cell pellets were
solubilised in a lysis buffer containing 30 mM Tris, 7 M urea,
2 M thiourea, 4% CHAPS, pH 8.5. Total protein concentra-
tion was determined using detergent-compatible Bradford
assay (BioRad, Hemel Hampstead, UK). CyDye DIGE fluor
propyl-Cy3 and methyl-Cy5 N-hydroxysuccinimide (NHS)
ester cyanine dyes (GE Healthcare, referred to as DIGE Cy3
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and DIGE Cy5, shown in Fig. 1) containing 5 nmol per tube
were freshly reconstituted in anhydrous DMF at 100 pmol/
mL. IC-OSu ethyl-Cy3 and ethyl-Cy5 NHS ester cyanine dyes
(1 mg, equivalent to ,1.5 mmol each, Dojindo Laboratories,
Kumamoto, Japan, distributed by NBS Biologicals, Hunting-
don, UK, referred to as IC3 and IC5, shown in Fig. 1) were
dissolved in 100% methanol (ChromaSolv grade, Sigma–
Aldrich, Dorset, UK), from a freshly opened bottle, and indi-
vidual aliquots of 100 nmol (25 mL) dispensed into clear
Eppendorf tubes. The dyes were immediately dried by
vacuum centrifugation. The closed tubes were packed in
aluminium foil and stored at 2207C. Secondary stocks were
prepared at 5 nmol per tube as above when needed. The
5 nmol dyes were used and prepared prior to labelling as
described for DIGE CyDyes. IC dye preparation was carried
out rapidly to minimise moisture uptake from the air.
A minimal labelling approach was used with a ratio of
50 mg total proteins and 400 pmol dyes. Equal amounts of
sample aliquots were labelled with either DIGE Cy3, DIGE
Cy5, IC3 or IC5 following protocols described by Yan et al. [3].
Samples labelled with DIGE Cy3 and DIGE Cy5, or IC3 and
IC5 were mixed prior to IEF, carried out in an IPGphor II
(GE Healthcare) using six phases of stepped or gradient
voltages from 300 to 10 000 V with a total focussing of 60–
100 kV?h. SDS-PAGE was run on 12% T SDS gels
(26 cm620 cm60.1 cm, prepared in-house using an auto-
matic gel casting system, NextGen Sciences, Huntingdon,
UK) using 26Laemmli SDS buffer at 8 mA/1 W/gel for 2 h
and then increased to 18 mA/1 W/gel until the dye front
migrated off the bottom of the gel. The DIGE Cy3 and IC3
images were scanned on a Typhoon 9410 using a green laser
at 532 nm and a 580 nm emission filter while the DIGE Cy5
and IC5 images were scanned using a red laser at 633 nm
and a 670 nm emission filter. The same PMTof 520 and 540
were used for either DIGE Cy3 and IC3, or DIGE Cy5 and
IC5, respectively. The images were analysed using DeCyder
Figure 1. Chemical structures of cyanine DIGE Cy3 and DIGE Cy5
[2], IC3 and IC5 (provided by Dojindo Laboratories on their certi-
ficates of analysis).
v 6.5 (GE Healthcare), Progenesis SameSpots PG240 (Non-
linear Dynamics, Newcastle upon Tyne, UK) and PDQuest
Advanced v 8.0.1 (Bio-Rad). Identical cropped images for
both DIGE Cy3 and Cy5, and IC3 and IC5 were analysed
using the default detection parameters. No manual editing
was used, to eliminate bias.
Figure 2 shows the separation of the three biological
extracts, namely murine white blood cells, N. meningitidis
(serogroup B) MC-58 DsiaD mutant cells and human fibro-
blast cells, labelled with either DIGE Cy3 and DIGE Cy5 or
IC3 and IC5 using the methods described above. Each label-
led sample produced highly comparable results, in terms of
2-D gel profiles and spot detection, whether labelled with IC3
and IC5 or the well-established DIGE Cy3 and DIGE Cy5.
Labelling and gel electrophoresis were performed in two
laboratories using different gel systems (i.e. Bio-Rad 4–12%
Bis-Tris Criterion XT gels run in a Criterion cell) with 11 cm
IPG strips and a different image capture system (i.e. Dyver-
sity, Syngene, Cambridge, UK) to assess interlaboratory
comparability. The results were similar, in that IC3 and IC5
had equivalent performance to DIGE Cy3 and DIGE Cy5
(data not shown here). Interestingly, as previously observed
for DIGE Cy5 compared to DIGE Cy3, IC5 produced higher
florescent intensity than IC3 as revealed on the 2-D gel ima-
ges shown in Fig. 2.
When using a multiplexing approach for differential in-
gel analysis, prelabelling of the samples with two spectrally
different fluorescent dyes must employ the same reactive
group to ensure equivalent labelling of two samples, and
allow quantitative analysis. The dyes, IC3 and IC5 have the
same NHS-ester reactive group as the CyDyes, which reacts
with the epsilon amino group of lysine residues in proteins.
The net charge of all the dyes is positive, thus retaining the
positive charge of protonated lysine residues, and the overall
pI of a protein molecule is unaffected. The fluorophores of
DIGE Cy3 and IC3 or DIGE Cy5 and IC5 can be determined
using the same excitation and emission wavelengths. The
DIGE Cy3 and DIGE Cy5 have matched molecular masses,
in which methylene groups compensate for structural varia-
tion elsewhere, see Fig. 1. This guarantees comigration of
proteins prelabelled with either DIGE Cy3 or DIGE Cy5.
Both IC3 and IC5 have ethyl side chains, and a mass differ-
ence of 26 Da. In the minimal labelling strategy, each protein
molecule has one dye molecule attached [1–3]. Therefore, the
26 Da difference in the dyes produces a difference of less
than 0.3% over the total mass of a protein, for a protein of
10 kDa. The difference in protein migration between IC3
and IC5 labelled proteins on 2-D gels should not be detect-
able.
Gel images of samples labelled with either (i) DIGE Cy3
and DIGE Cy5, or (ii) IC3 and IC5 in a single gel were co-
detected using both DeCyder and Progenesis SameSpots
software, which is designed for DIGE-type experiments,
allowing automatic spot matching. When two- and five-fold
changes in volume ratios (increased or decreased) were
specified, % similarity (i.e. number of spots with change in
© 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
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Figure 2. Separation and detection of protein spots of cell lysates, i.e. Murine white blood cells, N. meningitidis (serogroup B) MC-58 DsiaD
mutant cells and human fibroblast cells, on the 2-D gels using IPG 3-11 NL, 24 cm strips with an in-gel rehydration technique.
Table 1. Spot matching and comparison using three different 2-D gel analysis software
Cell lysates % Similarity between DIGE dyes % Similarity between IC dyes
2-fold change (no. of gels) 5-fold change (no. of gels) 2-fold change (no. of gels) 5-fold change (no. of gels)
DeCyder analysis – DIA mode
Murine white blood 91.3 6 1.5 (n = 3) 96.0 6 1.1 (n = 3) 91.7 6 1.3 (n = 4) 98.6 6 0.5 (n = 4)
MenB MC-58 DsiaD mutant 94.1 6 2.6 (n = 4) 98.3 6 1.2 (n = 4) 91.6 6 0.7 (n = 4) 98.5 6 0.7 (n = 4)
Human fibroblast 75.8 6 5.1 (n = 3) 98.2 6 1.4 (n = 4) 83.7 6 4.4 (n = 3) 98.2 6 1.3 (n = 3)
Progenesis SameSpots PG240 – codetection without internal standard mode
Murine white blood 90.7 6 3.1 (n = 3) 97.7 6 0.9 (n = 3) 93.9 6 2.5 (n = 4) 97.8 6 0.9 (n = 4)
MenB MC-58 DsiaD mutant 93.6 6 1.0 (n = 4) 98.8 6 0.2 (n = 4) 93.9 6 0.6 (n = 4) 98.4 6 0.5 (n = 4)
Human fibroblast 78.6 6 4.6 (n = 3) 88.0 6 3.1 (n = 3) 94.3 6 0.3 (n = 3) 97.7 6 0.6 (n = 3)
PDQuest advanced – single detection mode
Murine white blood 95.8 6 1.6 (n = 3) 99.2 6 0.7 (n = 3) 93.9 6 1.5 (n = 4) 98.8 6 0.6 (n = 4)
MenB MC-58 DsiaD mutant 94.3 6 1.2 (n = 4) 99.0 6 0.7 (n = 4) 92.0 6 1.8 (n = 4) 98.2 6 0.5 (n = 4)
Human fibroblast 74.4 6 8.9 (n = 3) 92.1 6 3.1 (n = 3) 84.1 6 4.1 (n = 3) 96.0 6 1.4 (n = 3)
volume ratio,2 or,5 divided by total detected and matched
spots) was calculated between either (i) DIGE Cy3 and DIGE
Cy5, or (ii) IC3 and IC5, and is reported in Table 1. With
equal amounts of labelled proteins applied to the gel, inten-
sity differences in spots indicate variation in spot migration
or shape arising from the dyes used. It is clear that the per-
formance of these two combinations of the dyes is highly
comparable. Spot detection and matching were also per-
formed using the single detection algorithm in PDQuest and
similar results were obtained, as shown in Table 1. No visible
© 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.proteomics-journal.com
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mass shifts were found between the two IC3 and IC5 labelled
spots by examining their 3-D views, especially in the low
molecular mass region. Therefore, we conclude that IC3 and
IC5 dyes are suitable for minimal pre-electrophoresis label-
ling, multiplexing and differential quantitative analysis. It is
worth pointing out that in a DIGE experiment design with
two-colour dyes, DIGE Cy3 is used to label pooled internal
standard and DIGE Cy5 to label individual biological var-
iants. Once normalisation and spot matching are completed
with the aid of DIGE Cy3 images, quantitative comparison
amongst biological variants is done exclusively through
DIGE Cy5 labels. Therefore, accurate quantitation is assured
with no interference or variation due to the difference in dye
structure. The same approach for differential in-gel analysis
could be used for the IC3 and IC5 pair.
The IC3 and IC5 combination provides a useful approach
for staff training, optimisation of experimental methods and
for preliminary experiments. In time, improving access to
staff training and proof-of-principle studies will encourage
use of the DIGE approach and enhance technique develop-
ment.
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Abstract: The success of high-performance differential gel
electrophoresis using fluorescent dyes (DIGE) depends on
the quality of the digital image captured after electro-
phoresis, the DIGE enabled image analysis software tool
chosen for highlighting the differences, and the statistical
analysis. This study compares three commonly available
DIGE enabled software packages for the first time: DeCy-
der V6.5 (GE-Healthcare), Progenesis SameSpots V3.0
(Nonlinear Dynamics), and Dymension 3 (Syngene). DIGE
gel images of cell culture media samples conditioned by
HepG2 and END2 cell lines were used to evaluate the
software packages both quantitatively and subjectively
considering ease of use with minimal user intervention.
Consistency of spot matching across the three software
packages was compared, focusing on the top fifty spots
ranked statistically by each package. In summary, Pro-
genesis SameSpots outperformed the other two software
packages in matching accuracy, possibly being benefited
by its new approach: that is, identical spot outline across
all the gels. Interestingly, the statistical analysis of the
software packages was not consistent on account of
differences in workflow, algorithms, and default settings.
Results obtained for protein fold changes were substan-
tially different in each package, which indicates that in
spite of using internal standards, quantification is software
dependent. A future research goal must be to reduce or
eliminate user controlled settings, either by automatic
sample-to-sample optimization by intelligent software, or
by alternative parameter-free segmentation methods.
Keywords: Progenesis SameSpots • DeCyder • Dymen-
sion • proteomics • gel image analysis
Introduction
Two dimensional difference gel electrophoresis (2D-DIGE)
is a powerful tool for the study of differential protein expression.
Since samples prelabeled with fluorescent cyanine (Cy)-dyes
are simultaneously run on the same gel using a pooled sample
as a third internal standard,1,2 DIGE gives higher confidence
when the differential protein profile is analyzed, minimizing
gel-to-gel experimental variation. The inclusion of an internal
standard pooled from aliquots of all biological samples to be
studied in an experiment, usually labeled with Cy2, improves
the matching of intra- and intergel images and allows normal-
ization across all gels.1,2 The benefit of DIGE can only be
realized by analyzing gel images with software tools specifically
written for DIGE analysis. The evaluation of software packages
dedicated to DIGE analysis is necessary so that users do not
compromise valuable DIGE data by using a poor quality
evaluation tool.
Several reports have been published addressing comparative
evaluation between commercially available 2-DE software
packages.3-10 Raman et al.6 provided guidelines by comparing
two software packages (Z3 and Melanie) according to three
criteria: spot detection, gel matching, and spot quantitation.
They also listed the features of 10 available 2-DE analysis
software packages. According to their study, Z3 performed
better in spot detection while Melanie was able to predict much
better in spot quantitation. Recently, Karp et al.10 compared
the quantitative aspect of pre- and postelectrophoresis stained
gels using two different methods of image analysis, traditional
(DeCyder) and SameSpots (Progenesis) approaches. In their
study, it was deduced that the SameSpots is particularly good
for the analysis of poststained gels by increasing the proportion
of low volume spots.
The software packages that can be used for the analysis of
2-DE gel images are: ImageMaster2D, DeCyder (GE Healthcare),
Progenesis (Nonlinear Dynamics), MELANIE (Geneva Bioin-
formatics), AlphaMatch 2D (Alpha Innotech), PDQuest (Bio-
Rad Laboratories), Delta2D (Decodon) and Dymension (Syn-
gene). Some of these software packages have been further
developed for DIGE-based experiments. The three commer-
cially available DIGE analysis software tools we compared,
using stem cell culture media samples conditioned by HepG2
and END2 cell lines, were DeCyder V6.5 (GE Healthcare),
Progenesis SameSpots V3.0 (Nonlinear Dynamics), and Dy-
mension 3 (Syngene).
The purpose of the experiment was to identify the commonly
expressed proteins by two cell lines: HepG2 (human hepato-
cellular carcinoma cell line) and END2 cells (mouse endoderm-
like P19 embryonal carcinoma subcell line).11,12 In our previous
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work, we identified factors present in HepG2 and END2
conditioned media that had a great effect on embryonic stem
cell development.13,14 Identifying these factors is necessary for
the understanding of embryonic stem cell differentiation as well
as the signaling pathways of embryogenesis. When analyzing
two proteomes, the use of DIGE, together with the most
suitable software tool, is essential. First, we used three different
packages to analyze these difficult images to establish how each
package handled the difficult aspects of this experiment, and
second, we tested the user friendliness of each package. We
report here the results we obtained from the perspective of a
proteomics user. The user intervention was kept to a minimum
for two reasons, first, because our future aim is to establish a
standardized 2D based proteomics workflow and second to
make sure that the user-friendly aspect of each software
package was compared objectively. Our study includes quan-
titative tests as well as a general evaluation of the three software
packages. Quantitative assessment was performed by compar-
ing the number of detected spots, the cross-matched spots, and
the expression differences of selected spots. A second study
was also performed using breast cancer cell lines to confirm
the performance of the three software packages on a different
set of images.
Materials and Methods
Cell Culture and Sample Preparation. All chemicals, unless
stated, were purchased from Sigma, UK. HepG2 cells (ATCC
HB-8605, UK) were cultured in T-75 flasks (Fisher Scientific,
UK) using Dulbecco’s modified eagle’s medium (DMEM; In-
vitrogen, UK) supplemented with insulin-transferrin-sodium
selenite supplement (ITSS; Roche, Germany), 0.1 mM -mer-
captoethanol, HEPES, 1 mM L-glucose and 1% Penicillin/
streptomycin at a seeding density of 5 × 104/cm2. END2 cells
(gift from Prof. Mummery, Hubrecht Laboratory, Holland) were
also cultured in the medium described above. Four batches
were prepared from consecutive passage for each cell line to
create biological replicates. After culturing for four days 50 mL
of each conditioned media (CM) was collected and filter-
sterilized through a 0.22 µm filtration unit and stored at -80
°C. Thawed CM were 1000-fold concentrated to the final
volume of 50 µL and buffer-exchanged into a solution (20 mM
Tris, 1 mM EDTA, 1 mM PMSF) using Centricon plus-70
(Millipore, UK; 5000 MWCO) and Microcon centrifugal filter
device (Millipore, UK; 3000 MWCO). The protein concentrate
was resuspended into a sample buffer containing 2 M Thiourea,
7 M Urea, 4% w/v CHAPS, 1% w/v ASB14, 1% w/v DTT, 1%
v/v IPG buffer pH 3-10 NL. The amount of protein was then
quantified using 2-D Quant Kit (GE Healthcare, UK).
Minimal Cy-dye Labeling. The proteins were labeled with
Cy-dyes (CyDye DIGE Fluor, minimal labeling kit, 25-8010-65;
GE Healthcare, UK) according to the manufacturer’s protocol.
Briefly, the pH of the sample was adjusted to pH 8.5 for Cy-
dye labeling. 50 µg of each batch of HepG2-CM and END2-
CM protein samples was labeled with 400 pmol of Cy3 or Cy5
dyes respectively in a reciprocal manner. The internal standard
pooled from the aliquots of all the samples was labeled with
Cy2. The labeling reaction was carried out by incubation on
ice for 30 min and quenched by the addition of 10 nmol of
lysine. Subsequently, equal volume of 2 × sample buffer
containing 2% w/v DTT, 2% v/v IPG buffer pH 3-10 NL was
added to each sample. Cy2, Cy3 and Cy5 labeled samples were
then pooled and applied by cup loading.
Two Dimensional Gel Electrophoresis. Eleven cm IPG strips
(GE Healthcare, UK) with a nonlinear gradient over the pH
range of 3-11 were passively rehydrated overnight with 200
µL of Rehydration solution (2 M Thiourea, 7 M Urea, 4% w/v
CHAPS, 1% w/v ASB14, 0.3% w/v DTT, 0.5% v/v IPG buffer pH
3-10 NL). Cy-dye labeled protein samples were loaded using
cup-loading application and focused as follows: (1) 500 V, 1 s,
gradient; (2) 500 V, 4 h, Step and hold; (3) 1000 V, 1 h, gradient;
(4) 1000 V, 1 h, Step and hold; (5) 3500 V, 4 h, Step and hold;
(6) 8000 V, 5 h, Step and hold for a total of 70 kVhr. Prior to
second dimension separation the focused strips were equili-
brated in the equilibration buffer (50 mM Tris-HCl pH 8.8, 6
M urea, 30% v/v glycerin, 2% w/v SDS, 20 mM DTT, 0.01% w/v
bromophenol blue) for 15 min. Second equilibration was
carried out in the equilibration buffer containing 4% w/v
iodoacetamide instead of DTT for 15 min. Subsequently,
equilibrated strips were overlaid onto a precast Bis-Tris 4-12%
polyacrylamide gel (Bio-Rad, UK) and ran at 150 V till the
bromophenol blue dye migrated to the bottom of the gels.
Image Acquisition. DIGE gels were imaged using the Dy-
versity (Syngene, Cambridge, UK) imaging system immediately
after the second dimension SDS-PAGE to prevent diffusion of
protein spots and subsequent signal loss. Gels were first placed
on a low fluorescent glass plate and the thick edges of the gels
were removed with a scalpel blade to enable LED side il-
lumination. The exposure time was optimized to achieve
maximum dynamic range. Images were then cropped together
by applying the same region of interest to all the gels making
sure that the regions analyzed in the different software packages
were identical. Images were then exported in tagged image file
format (TIFF) which is the required format for the software
analysis packages. For DeCyder analysis images were saved
with a specific file name format, such as Gel01 Cy2 Standard-
.gel, that allows for DeCyder software to recognize the files.
Image Analysis. Four biological replicate gels from each
group, namely HepG2-CM and END2-CM, and four internal
standard gels were aligned and analyzed using three different
software packages; DeCyder V6.5 (GE-Healthcare, Bucking-
hamshire, UK), Progenesis SameSpots V3.0 (Nonlinear Dynam-
ics, Newcastle, UK), and Dymension 3 (Syngene, Cambridge,
UK). In each software package the statistically ranked top fifty
spots were selected based on p-value of ANOVA (p < 0.05) and
then maximum fold change. Among the selected fifty spots,
mis-matched spots were counted by manual screening under
two conditions: (1) aligned without landmark (definition of
landmark: spots determined by users to represent same
proteins across replicate gels) and (2) aligned with five
landmarks.
Spot Detection and Analysis by DeCyder. Spots were
codetected in each gel-set using the Differential In-Gel Analysis
(DIA) mode of DeCyder. The area of interest was set to the
whole image since images were already cropped for uniform
analysis to enable unbiased comparison of the software pack-
ages. Spots were eliminated for the BVA (Biological Variation
Analysis) by applying the exclude filter based on the following
threshold: Slope >1.1, Area <100, Volume <100 000, Peak
Height <100 and >64 000. All the threshold values were default
except for the volume, which was chosen following manual
assessment of the exclusion of artifacts. The estimated number
of spots for each gel was set to default, 2500. Background
subtraction and normalization was also performed on the
images using default settings. Each sample was grouped in BVA
mode and gel images were automatically aligned in two ways,
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with no user intervention or with minimal user intervention
based on five landmarks set by the user on each gel. Gels were
then matched and the spots were compared.
Spot Detection and Analysis by Progenesis SameSpots. Gel
images were aligned by automated calculation of alignment
vectors after assigning five landmark vectors. To make a fair
comparison with other software packages, gels were also
processed without setting any landmarks. Automatic analysis
was performed on all the aligned images using the analysis
wizard. The aligned images were grouped to reflect the biologi-
cal grouping and the statistically ranked list of spots were
evaluated in the review stage of the software package. In
addition, separate analysis for each gel was performed in order
to calculate total spot number of individual gel. All the settings
were left as defaults throughout the analysis.
Spot Detection and Analysis by Dymension. Cropped gel
images were loaded and grouped using the multiplexed ex-
perimental wizard. Region of interest was selected as the whole
image. Spots of the whole gels (those from internal standard
as well as both groups) were detected automatically with default
spot detection settings: Blur radius: 1.2, Peak limit threshold:
0.01, Splitting threshold: 0.001. Detection confidence ratio was
set at 20 and separation confidence ratio was set at 20
according to the company’s recommendation. Noise filtering
and background correction was performed automatically as
default using the following parameters: Raw Volume/Height
>10, Height >5. Gels were then automatically warped or
‘manual warping’ function was applied to each gel, which was
the only possibility to improve the matching. Pool matching
was carried out by automatic gel alignment. Statistical analysis
was automatically done when pool matching was carried out.
Results
General Comparison. The general evaluation was carried out
on the three software packages in terms of visualization,
normalization method and workflow. All packages gave good
graphical user interfaces, which make analysis easy and ef-
ficient to perform. Normalization is used for the accurate
comparison of spot measurements. In DIGE experiments
normalization should be calculated by using the internal
standard since it should be the same on each gel. This
ratiometric normalization was provided in all of the three
software packages as a default setting. All three packages
provided univariate and multivariate statistical analysis tools
which enable users to compare experimental groups easily.
Student’s t-test and ANOVA were used as basic statistical
analysis tools in all three software packages. Each software
company also markets their own statistical packages separately
and these provide additional functionality. Minimal user
intervention was needed in all three software tools. In the
previous version of Progenesis SameSpots user intervention was
only required or possible in the alignment stage of setting
landmark vectors while the latest version provides prefilter
function allowing users to exclude artifacts. DeCyder and
Dymension required more manual intervention at the align-
ment stage as well as at spot detection, although it can be kept
to the minimum using settings recommended by the companies.
The general workflow was compared among the three
software packages. The analysis in the three software packages
had three main steps: spot detection, alignment, and statistical
analysis of spots. Progenesis SameSpots has incorporated a new
approach leading to a different workflow from the other two
software packages. While spots of each gel were detected before
the matching in DeCyder and Dymension, Progenesis SameS-
pots performed alignment at the beginning and spots were
subsequently detected with same spot outlines. In Progenesis
SameSpots, aligned spots were automatically detected across
gels and full matching was performed based on the identical
spot outlines without the need of user intervention. In DeCyder,
nonprotein spots were screened using the “exclusion filter” in
DIA mode, whereas Progenesis SameSpots carried out this task
as default. In our experience not enough artifacts were removed
in DeCyder, therefore strict threshold in the “exclude filter”
must be applied by the user because the default setting is too
liberal. Full matching in DeCyder was carried out similarly to
Progenesis SameSpots. Dymension had a different approach
from the other two software packages: the spots were accepted
and matched only when they were present in all the internal
standard gels.
Spot Detection and Alignment. All the gel images were
cropped together prior to loading into the software packages
to make sure that the region of interest analyzed was identical.
The aligned DIGE gel images in each software package were
shown in Figure 1. Table 1 shows the result of spot detection
performance. Overall, DeCyder detected more spots than the
other two software packages. The spot numbers detected by
DeCyder were highly dependent on the detection settings using
2000 spots as the initial default setting. When the ‘exclude filter’
was applied (see methods section for details), almost 1000 spots
were excluded in all gels apart from gel 3 which had more spots
filtered. The higher spot numbers observed in DeCyder results
from the choice of inflection points for spot splitting. A spot,
which was detected as a single spot in Progenesis SameSpots,
was often interpreted as multiple spots in DeCyder as shown
in Figure 2. In general, DeCyder is more liberal at spot splitting
at inflection points, which often results in oversplits, whereas
Progenesis SameSpots and Dymension are more conservative
at spot splitting which results in the amalgamation of poten-
tially different protein spots (Figure 2).
For the fair comparison of alignment, we carried out two
experiments. In the first, we aligned gels without setting any
landmark vectors, and in the second, we aligned with the five
landmarks selected manually. We then analyzed the matching
performance in each case. Since each software package pro-
vides different matching algorithms, the results were not
directly comparable. In Progenesis SameSpots the first step of
matching was the creation of an averaged gel which contained
all the spots from each gel set including both the matched and
the unmatched spots. Unmatched spots are matched to the
virtual spots of the same boundary in Progenesis SameSpots.
Dymension only accepted those spots which appeared in all
the internal standard gels as mentioned above. This explains
the relatively low matched numbers, 73, found by Dymension
as compared to those by Progenesis SameSpots and DeCyder
(Table 1). In DeCyder a master gel with the greatest number
of spots was chosen and subsequently each gel was matched
to this gel.
Cross-Matching of the Most Highly Ranked Spots. The
statistical analysis tools of the three software packages ranked
all spots according to the greatest fold changes across groups
at 95% confidence level (p < 0.05), and we selected the top
fifty of each for comparison. Dymension automatically high-
lighted the spots which appeared in all the internal standard
gels passing only 73 spots across four gel sets. Among those 73
spots, only 3 spots were significantly different at the p < 0.05
level while Progenesis SameSpots and DeCyder passed ap-
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proximately 150 spots (Table 2). In Dymension, therefore, we
chose the top 50 spots, independent of the p value, to compare
against the other two packages.
Cross-matched spots were confirmed manually, one by one,
and multiple spots, which were detected as a single spot on
the other package, were counted as one. Among those fifty
spots we counted spots up-regulated in HepG2-CM and those
up-regulated in END2-CM. Interestingly, in DeCyder 48 out of
50 spots were up-regulated in HepG2-CM, whereas only 32 and
34 spots were found to be HepG2-CM up-regulated by Pro-
genesis SameSpots and Dymension respectively (Table 2). We
found that DeCyder are more liberal in spot splitting, which
might result in the generation of multiple spots. Only 5 spots
were common to the three sets of 50 top ranked spots selected
by the three software packages (Figure 3). Progenesis SameS-
pots and DeCyder shared the greatest number of cross-matched
spots.
The accuracy of matching by each software package was also
confirmed manually by judging if the top 50 spots were well-
matched or mis-matched. When landmark vectors were not
used, all the software packages gave poor matching perfor-
mance (Table 2). DeCyder and Progenesis SameSpots correctly
matched 29 and 33 spots out of the top 50, while Dymension
matched 12 without landmarks. By using five landmarks,
DeCyder and Progenesis SameSpots improved their matching
performance, and Progenesis SameSpots outperformed the
other two software packages by correctly matching 92% of spots
(Table 2). Dymension only matched 22 spots correctly, even
when the ‘manual warping’ function was used (this is the
closest function to landmark setting).
Quantitative Analysis. Out of the 5 cross-matched spots we
selected 3 (two of the cross-matched spots were discarded after
the manual check of mis-matched spots) for quantitative
analysis and compared the fold changes of the spots calculated
by each software package. Surprisingly, whereas it was expected
that the estimates of fold change between the three cross-
matched spots would be the same, the three packages actually
reported significant discrepancies in the estimates of fold
changes. DeCyder estimated a much higher differential expres-
sion ratio ranging from 60 to 90 fold as compared to Progenesis
SameSpots which gave a range from 15 to 40 (Figure 4a). In
both cases these values are greater than those reported in most
proteomics experiments; this is because our values are reflect-
ing on/off differences between samples. We therefore selected
four well-resolved spots, which appeared in both groups, to
evaluate real quantitative difference rather than on/off changes
(Figure 5b). Nevertheless, fold changes calculated by each
software package remained significantly different as shown in
Figure 1. (a) Representative image of the DIGE gels. Red, Cy3 labeled END2-CM; blue, Cy5 labeled HepG2-CM; green, Cy2 labeled
internal standard. Aligned gel image by (b) DeCyder, (c) Progenesis SameSpots, (d) Dymension. The circled spots are statistically
highly ranked top 50 spots.
Table 1. Detected and Matched Spot Numbers in Each Gel
Seta
DeCyder
Progenesis
SameSpotsb Dymension
Spot No.
in gel c set1
979 610 479
Spot No.
in gel set2
984 593 524
Spot No.
in gel set3
661 654 482
Spot No.
in gel set4
1019 648 383
w/o.l w.l w/o.l w.l. w/o.l w.l
Matched
spot No.
Gel set1 443 495
Gel set2 489 544
620 548 73 73
Gel set3 405 415
Gel set4 1019 1019
a w/o.l., without landmark; w.l, with landmarks. b Separate experiment
was created for each gel in order to calculate total spot number per gel.
c “Spot No. in gel set” represents spots from each image that includes all
three Cy-dyes.
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Figure 5a. In general, the fold changes calculated by Progenesis
SameSpots were less than those found by DeCyder and
Dymension. The most obvious explanation of the observed
differences is the way spot boundaries are defined by each
software package. For example, the spot boundary for one of
the well-resolved spots, spot 4, varied according to the software
package as shown in Figure 5(c-e).
Discussion
In our experience spot detection is a critical step necessary
for achieving high quality results at the end of data processing
workflow. The advantage of using 2-DE image analysis software
is that it performs objective spot detection and quantitation
which cannot be done manually. Since none of the software
packages are perfect, manual editing cannot be completely
eliminated on account of incorrectly detected spots, namely
oversplit or undersplit spots. Moreover, software may fail to
detect some significant spots while incorrectly identifying
artifacts as protein spots. Manual evaluation of detected spots
is essential if minimal user intervention is used as a strategy
for alignment and matching. Since Progenesis SameSpots does
not detect spots from single gels, we loaded gels separately in
new experiments in order to compare detected spot numbers
from each individual gel. In Progenesis SameSpots the spot
detection parameters are already set which leaves no option
Figure 2. Two examples of different spot splits at inflection points in three software packages. Spot splits in (a,d) Progenesis SameSpots,
(b,e) DeCyder, and (c,f) Dymension.
Table 2. Number of Spots That Are Significantly Different at
p < 0.05% Level by ANOVA among the Groupsa
DeCyder
Progenesis
SameSpots Dymension*
No. of significantly
different spots at 0.05%
level (Without landmark)
157 146 3
No. of significantly
different spots at 0.05%
level (With landmarks)
139 132 3
HepG2 up-regulated
(Top 50 highly ranked spots
by fold change)
48 32 34
END2 up-regulated
(Top 50 highly ranked
spots by fold change)
2 18 16
No. of well-matched spots
(Without landmark)
29 33 12
No. of well-matched
spots (With landmark)
36 46 22
a Spots up-regulated in HepG2-CM or END2-CM and well-matched
spots among the top 50 highly ranked spots by fold change are also
included. * Due to Dymension’s different algorithm, the number of
significantly different spots was not exactly comparable. In Dymension,
the top 50 were chosen, independent of the p value, to carry out
comparisons with other packages.
Figure 3. Diagram of number of cross matched spots among 50
spots which showed the greatest fold changes in three software
applications.
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for user intervention. In Dymension users can set the detection
parameters such as detection confidence or separation confi-
dence ratios. DeCyder also allows users to set the initial
detected spot number although it is recommended to be set
at 2500. Spot detection and segmentation are two controversial
areas since the number of real spots is not known. The spot
segmentation approach is different in each software package.
Some use spot boundaries (edge detection algorithm) while
others collect continuous pixel groupings (pixel value collec-
tion).15 In particular the split points of partially overlapping
spots are judged differently. Our sample contained abundant
proteins that appeared as overlapping spots highlighting the
segmentation problem (Figure 2). Our results show that each
software package interprets spot detection and segmentation
in a different manner, which results in different spot numbers.
Dymension estimated less spots than the other two software
packages possibly due to the conservative settings of spot
detection. DeCyder estimated more spots than the other two
software packages due to oversplitting as shown in this study.
If the segmentation settings are too conservative, spots are
amalgamated and post-translationally modified proteins might
be missed. Spot detection algorithms require a number of
parameters to be set by the operator and these must be tailored
subjectively to the data set under consideration in order to
achieve optimal segmentation; this takes a significant propor-
tion of the operator’s time. For this reason full automation can
only be achieved if the user-set parameters are reduced or
eliminated. This may be done by automatic optimization with
domain models which are themselves created by intelligent
software; software which takes into consideration the sample
type, equipment used and image quality. Alternatively, full
automation may be achieved by parameter-free segmentation
methods. In Progenesis SameSpots, the spot detection param-
eters cannot be edited in the main workflow, which results in
the user not being able to add spots ignored by the software;
however spot segmentation or mergence can be corrected by
users after spot detection.
During the matching process of DIGE gels, the software
packages started with the alignment of the internal standards
before spot matching. Since the internal standard represents
all the spots among the groups and replicates, the alignment
is more accurate when using internal standard gels. In spite of
the inclusion of the internal standard there were several
discrepancies in matched spots because each software package
provided different alignment and subsequent matching algo-
rithm. Since Dymension’s matching algorithm is based on the
perfectly matched spots across all the replicates it could be
favored when stricter criteria of experimental variation are
Figure 4. (a) Comparison of quantitative analysis on the completely cross-matched spots in three software packages and (b) 2D images
of the three cross-matched spots.
Figure 5. (a) Comparison of quantitative analysis on four well-resolved spots, (b) 2D image of four well-resolved spots, and 3D images
of spot 4 in (c) Progenesis SameSpots, (d) DeCyder, and (e) Dymension.
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required. However this could result in missing spots when users
need to take into consideration the interinternal standard
experimental variation. The experiment discussed in this
assessment was a good example for this problem. Dymension
only included 73 spots for the statistical analysis, missing out
some spots of interest. Since our sample is a complex mixture
of proteins with biological replicates the matching became
more challenging in the analysis. When ‘landmark’ function
was used the accuracy of matching was dramatically increased
in all the software packages. Progenesis SameSpots improved
the matching accuracy up to 92% with landmarks. In Progenesis
SameSpots the “landmark” function was integrated in the
alignment step as default before spots were detected. Since spot
boundaries were determined after alignment in Progenesis
SameSpots, the spots of the same boundary on each gel were
matched up maybe improving spot-matching efficiency. As a
result of this if alignment was corrected Progenesis SameSpots
had to recalculate the whole data set with the new corrections.
Nonetheless none of the packages gave perfect matching
suggesting that without user intervention this cannot be
achieved for the types of samples analyzed in this study. The
conditioned media samples are particularly difficult to analyze
due to the presence of highly abundant proteins resulting in
unresolved protein spot chains. Samples with higher resolution
might provide different matching results. Therefore, the analy-
sis was also carried out with gels that include more discrete
spots and Progenesis SameSpots also outperformed the other
two software packages in terms of matching accuracy (See
supplementary data).
When we looked at the cross-matched spots among the top
50 ranked proteins to assess the consistency of analysis, only
5 proteins were completely matched across the three software
applications. Since alignments and subsequent matching were
performed in a different manner in each software package,
inconsistencies of the ranked spots were expected.
Results of this study show that the software packages
exhibited different expression levels when analyzed on several
randomly selected spots as well as the completely cross-
matched spots. DeCyder and Dymension showed wider range
of responses to the investigated spots in terms of differential
spot volumes. Quantitation, one of the most important infor-
mation from the biologist’s point of view, depends on the
results of the detection and matching steps. Researchers have
studied the performance of different software packages on gel-
based protein quantitation.5,6 These studies evaluated spot
quantitation using ideal-Gaussian-distributed spots in artifi-
cially created gels only.6 In reality, spots may not be elliptical
and gels usually have streaks, artifacts and other noises and
the inclusion of these affects background subtraction and
quantitation subsequently. The huge discrepancy observed in
quantitation of spots with large fold changes between software
packages must be due to different background estimation.
Although each software package gave a relatively linear re-
sponse to the wide dynamic ranges of spot intensity, different
spot boundaries and matches resulted in the discrepancy in
quantitation. Our study also showed that the spot boundaries
of well-resolved spots were differently drawn as well in each
software package, which affected the final data processing,
quantitation of spots and statistical analysis (Figure 5).
All three packages offer the standard statistical tools of
Student’s t-test and ANOVA. Recent papers have highlighted
the pitfalls surrounding conventional application of these
techniques, especially when concerned with the small sample
sizes employed.16 It is particularly important to adjust the p
values to avoid the dangers of multiple hypothesis testing.
Bonferoni correction is a widely used technique, where the p
value is divided by the number of tests to be performed, but
this has been found to be too conservative. More advanced
techniques involve performing a power analysis. For example,
Student’s t-tests can be modified with a data permutation
technique that estimates the false discovery rate.17 Experimen-
tal power is typically improved by increasing the number of
replicates under study, either using the same sample (technical
replicates) or with different samples from the same treatment
group (biological replicates). Karp et al.18 showed that mixing
the two types in the same statistical test, greatly increases the
false positive rate when conventional tests are applied. They
advocate the use of nested-ANOVA, where the test statistic is
corrected by the ratio of biological variance to technical
variance. In the three packages under test such nesting is not
possible, so a correct analysis of mixed replicate types is
inconvenient. One must also note that it has now been formally
proved that technical replicates should not be run at the
expense of biological replicates unless there is no choice e.g.
unavailability of samples.16
Another important consideration regarding differential ex-
pression analysis is the impact of systematic errors such as
channel-specific and spatial biases between gels. A recent study
of DIGE experiments showed a loss of sensitivity with three
multiplexed dyes compared to two, and different system gains
and offsets for each dye.19 It is likely that the three packages
under examination are limited to a global linear correction for
each channel. Unfortunately, a nonlinear relationship has been
demonstrated between measured and actual protein abun-
dances,20 which has also been shown to vary across each gel’s
surface.21 Methods from microarray gene analysis can be used
to estimate this relationship from stable expression in a pair
of experiments. Academic projects have applied these tech-
niques to proteomics, including global quantile normalization17,22
and spatial calibration through loess smoothing (local poly-
nomial regression fitting).23 It is hoped that similar techniques
are in future incorporated into commercial gel analysis packages.
Removal of stochastic bias (expression-variance dependence)
is particularly important for meaningful statistical testing.
Employing a log-transformation of the data to account for a
purely multiplicative dependence between the expression level
and variance of protein spots is inaccurate at low expression
levels due to an underlying additive dependency caused by
image capture noise and background variation. A more elabo-
rate two parameters model (multiplicative and additive) has
been proposed in the microarray community24 and robust
automated techniques developed to estimate the parameters
and so variance stabilize on a per-gel basis.25 This arsinh
transform is approximately linear for small expression levels
and logarithmic for large expression levels. Difference detection
on variance stabilized data is clearly a more principled and
precise reflection of statistical confidence, and has recently
been applied successfully to DIGE spot-list data20,26 and now
appears to be incorporated into Progenesis SameSpots.27
However, as demonstrated in this paper, there is still significant
ambiguity in the spot detection process, with arbitrary decisions
made when delineating spot boundaries. This variance con-
tributes significantly to the overall problem, and while this issue
still exists, the advantages of these new statistical and stochastic
techniques will be constrained by suboptimal input data.
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Conclusion
DIGE is a high throughput technology, which overcomes the
disadvantages of contemporary conventional 2-DE. To obtain
the best from DIGE applications it is essential that appropriate
software be used which effects the most accurate and reliable
data analysis for the sample type. Our results show that all three
software packages provide fully automated image analysis with
minimal user intervention. They performed in a generally
satisfactory manner, each with strengths and weaknesses. Based
on matching accuracy, Progenesis SameSpots performed best.
The mis-matches found in DeCyder and Dymension were
caused by errors in spot detection and alignment. By optimizing
detection settings and making manual vector corrections, the
accuracy of analysis can be significantly increased. This was
shown by increased matching accuracy after inclusion of
landmarks, therefore user intervention is essential in order to
achieve the best analysis results, even in fully automated and
apparently sound software analysis. Moreover, users should be
cautious when drawing inferences based on the magnitude of
differences between samples as calculated by software pack-
ages; statistical analysis must be validated by alternative
methods such as Western blot.
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